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II. Abbreviations 
Measures and units  
aa = amino acid bp = base pair(s)   U = units (enzyme activity) 
M = molar, mol l-1 OD600 = optical density at 600 nm rpm = revolutions per minute 
kDa = kilo-Dalton Tm = melting point in °C 
 
Chemicals   
ABTS = 2,2'-azino-di-(3-ethylbenzthiazoline-6-sulfonic acid) 
AcOH = acetic acid  
APS = ammonium persulphate  
BCIP = 5-bromo-4-chloro-3-indolyl phosphate 
DTT = dithiothreitol  
DOP = deoxypodophyllotoxin 
EDTA = ethylenediaminetetraacetic acid 
EtOH = ethanol 
EtOAc = ethyl acetate 
KPi = potassium phosphate buffer 
LARI = lariciresinol 
MATAI = matairesinol 
MeOH = methanol 
6-MPTOX = 6-methoxypodophyllotoxin 
NBT = nitro blue tetrazolium chloride 
PINO = pinoresinol 
PTOX = podophyllotoxin  
SDS = sodium dodecyl sulphate  
SECO = secoisolariciresinol 
TEMED = tetramethylethylenediamine 
TRIS = tris(hydroxymethyl)aminomethane 
 
Species names and abbreviations 
E. coli = Escherichia coli, Enterobacteriaceae 
Fi = Forsythia x intermedia, forsythia, Oleaceae 
La = Linum album, Linaceae 
Lf = Linum flavum, Linaceae 
Lu = Linum usitatissimum, flax, Linaceae 
Lp = Linum perenne, Linaceae 
S. cerevisiae = Saccharomyces cerevisiae, Saccharomycetaceae  
Tp = Thuja plicata, western red cedar, Cupressaceae 
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Genes and proteins 
3H = 4-coumaroylshikimate 3-hydroxylase  
4CL = hydroxycinnamic acid CoA ligase 
BSA = bovine serum albumin 
C4H = cinnamate 4-hydroxylase 
CAD = cinnamyl alcohol dehydrogenase  
CCoAOMT = caffeoyl-CoA O-methyltransferase  
CCR = cinnamoyl CoA:NADP oxidoreductase  
COMT = caffeic acid O-methyltransferase  
CPR = cytochrome P450 reductase 
CYP = cytochrome P450 
DIR = dirigent protein 
DOP6H = deoxypodophyllotoxin 6-hydoxylase 
DOP7H = deoxypodophyllotoxin 7-hydoxylase 
HCT = shikimate O-hydroxycinnamoyltransferase  
PAL = phenylalanine ammonia-lyase  
PLR = pinoresinol-lariciresinol reductase 
SDH = secoisolariciresinol dehydrogenase 
  
Nucleic acids and nucleotides 
A = adenine C = cytosine G = guanine  T = thymine U = uracil 
cDNA = complementary DNA 
dNTP = deoxynucleotide triphosphate 
mRNA = messenger RNA 
gDNA = genomic DNA 
 
Proteinogenic amino acids  
A = alanine (Ala)  C = cysteine (Cys)  D = aspartic acid (Asp) 
E = glutamic acid (Glu) F = phenylalanine (Phe) G = glycine (Gly) 
H = histidine (His)  I = isoleucine (Ile)  K = lysine (Lys) 
L = leucine (Leu)  M = methionine (Met) N = asparagine (Asn) 
P = proline (Pro)  Q = glutamine (Gln)  R = arginine (Arg) 
S = serine (Ser)  T = threonine (Thr)  V = valine (Val) 
W = tryptophan (Trp)  Y = tyrosine (Tyr)  
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III. Introduction 
 
1. Lignans – Occurrence and general structure 
Lignans belong to the group of polyphenolic substances and are derived from L-
phenylalanine. Hydroxycinnamyl alcohols  termed monolignols, usually coniferyl alcohol, are 
precursors for the biosynthesis of lignans. Two molecules of these phenylpropanes dimerize 
stereospecifically via a C-C linkage. If the bond is formed via the C8-C8' atoms of the side 
chains of monolignols, the compounds are called lignans. If the monolignols are linked in a 
different way, they belong to neolignans. In addition, norlignans lack the C9 or the C9' atom 
or a methoxy group on the aromatic ring. Lignans occur almost exclusively in plants. They are 
found in more than 55 plant families of both gymnosperms and angiosperms, as well as in 
mosses and ferns (Lewis and Davin, 1999). Juniperaceae, Cupressaceae, some Linum species 
(Linaceae), Podophyllum species (Berberidaceae), Polygalaceae, Apiaceae, Pinaceae, 
Hernandaceae, Euphorbiaceae, and Ranunculaceae contain significant amounts of lignans 
(Imbert, 1998). 
 
 
 
 
 
 
 
2. Biological activity of lignans  
Lignans show a wide range of activities in plants, mainly in the defense against pathogens and 
herbivores. There are antifungal, antiviral and antibacterial lignans (Deyama and Nishibe, 
2010). Hence, lignans are interesting for application as medicinal products in humans. 
Secoisolariciresinol and matairesinol, the main lignans from linseed, are converted in the 
intestine by bacteria to the hormone-like structures enterolactone and enterodiol, which have a 
protective effect against hormone-dependent cancer, such as breast cancer. This protective 
effect has been demonstrated in clinical studies (Adlercreutz, 1999; Cho et al., 1999).  
Figure 1: Lignan backbone with 8-8' linkage of two monolignols 
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Podophyllotoxin (PTOX) is an aryltetralin-type lignan (Figure 2). It is strongly cytotoxic and 
was first isolated from roots and rhizomes of plants of the genus Podophyllum, whose 
representatives are found in North America (P. peltatum) and the Himalayan region (P. 
hexandrum, synonym P. emodi). Both species are known as traditional medicinal and/or 
poisonous plants and have been used for a variety of purposes. For example, the natives of 
North America used aqueous extracts from P. peltatum as laxans, cathartics and anthelmintics. 
Among the European immigrants, Podophyllum extracts were used as emetics, cathartics, and 
cholagogum (Imbert, 1998; Lloyd, 1910).  
 
 
 
 
 
 
 R1 R2 R3 
Podophyllotoxin OH H OCH3 
6-Methoxypodophyllotoxin OH OCH3 OCH3 
Deoxypodophyllotoxin  H H OCH3 
-Peltatin H OH OH 
-Peltatin H OH OCH3 
ß-Peltatin A methyl ether 
 
H OCH3 OCH3 
 
Podophyllin, a resinous extract from Podophyllum roots and rhizomes, has been used against 
genital warts (Condyloma acuminata) in America since 1850 (Lloyd, 1910). In the 40s and 50s 
of the 20th century, PTOX was identified and isolated as an effective substance in podophyllin. 
PTOX binds to the α/β tubulin dimer and inhibits the construction of microtubules, thereby 
prevents mitotis (Canel et al., 2000). However, PTOX is too toxic for use as a cytostatic agent 
and is thus limited to external application. The semisynthetic derivatives Etoposide and 
Teniposide (Fig. 3) are formed by demethylation on the C4 atom of ring E, epimerization on 
the C4 atom of ring C, and by substitution at the OH groups. These derivatives are less toxic 
Figure 2: Aryltetralin lignan derivatives  
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but equally effective (Canel et al., 2000). Interestingly, Etoposide and Teniposide have a 
completely different mechanism of action compared to PTOX. They are inhibitors of 
topoisomerase II and thus prevent DNA replication. Today Etoposide, Etopophos® and 
Teniposide are used as cytostatics against most hormone-dependent types of cancer 
(leukaemia, ovarian, breast, pancreatic and lung cancer) and non-Hodgkin's lymphome. 
Etopophos® is Etoposide phosphate, a prodrug with better water solubility that is converted by 
alkaline phosphatase to Etoposide. 
 
                    
  
 
 
 
Figure 3: Podophyllotoxin derivatives with anticancer effect: (A) Etoposide, (B) Teniposide  
 
3. Lignans in Linum and in plant cell cultures 
3.1 Lignans in Linum  
The genus Linum of the family Linaceae comprises about 230 representatives (Van Uden et al., 
1994). Based on morphological and phytochemical data, the genus can be divided into different 
sections. There are different publications on the substructure of the genus Linum. Here, the 
genus Linum is divided into five sections according to Davis (1970) and Ockendon and Walters 
(1968). These sections are Linum, Syllinum, Dasylinum, Linastrum and Cathartolinum. 
Particularly interesting for this work are the representatives of the section Syllinum, since there 
are many species containing lignans of the PTOX-type. Within this section, there is a further 
division into three groups. The first group is perennial, has white flowers and produces mainly 
PTOX, whereas the second group contains perennial plants with yellow flowers which produce 
predominantly 6-MPTOX, and third group is annual, has yellow and homostylous flowers 
(Mohagheghzadeh et al., 2003; Broomhead et al.,1990; Weiss et al., 1975).  
 
 
A B 
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3.2 Linum flavum - description and distribution 
Linum flavum (golden flax, yellow flax) is a species in the family Linaceae, section Syllinum. 
The plants are growing perennially with semi-evergreen leaves and five-petalled, yellow 
flowers. L. flavum has the chromosome number 2n = 30 (Erich, 2001). It prefers calcareous 
and nitrogen-poor, warm sites in a sunny to semi-shaded position. The species is common in 
Central and South-eastern Europe up to Central Russia in high altitude. The occurrence in 
Germany on the Swabian Alb and in the Illertal form the western edge of the area of Linum 
flavum. The plants are strongly endangered, only a few hundred exist here (Simon et al., 2002).  
 
3.3 Lignans in plant cell cultures 
Cell cultures can be obtained from seeds which are germinated on solid medium under sterile 
conditions or from plant material collected from nature after treatment with sterilizing agents. 
Callus formation can be obtained on hormone-containing culture media. Callus cells are mainly 
undifferentiated cells that can be cultivated on a solid medium containing macro- and 
micronutrients as well as a carbon source and suitable hormone concentrations (usually auxins 
and cytokinins) over several years and can serve as the starting culture for cell suspension 
cultures (Empt et al., 2000; Seidel et al., 2002; Smollny et al., 1998). A major disadvantage in 
the work with cell suspension cultures is their possible genetic instability in comparison to 
callus cultures, particularly regarding secondary metabolite production (Alfermann and 
Petersen, 1993; Deus-Neumann and Zenk, 1984). These changes are presumably due to the 
modification of the genetic material. In addition to the changes in the number of chromosomes, 
DNA methylations, genomic rearrangements and point mutations have been observed (Bayliss, 
1973; Phillips et al., 1994; Sunderland, 1977).  
Different species were used to produce PTOX and similar cytotoxic lignans in cell cultures. In 
Linum spec., the largest amount of PTOX (28 mg per litre after 11 days) was found in a 
suspension culture of Linum album (Smollny et al., 1998; Empt et al., 2000). 6-MPTOX was 
detected in the largest amount (121 mg per litre) in suspension cultures of Linum flavum (Berlin 
et al., 1986).  
The investigations carried out in this study were made with suspension cultures of Linum 
flavum. 
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4. Biosynthesis of lignans 
4.1 General phenylpropanoid pathway 
Phenylpropanoids are generally referred to as compounds which consist of a phenolic group 
with a bound C3 side chain and are derived from phenylalanine or tyrosine (Heldt, 1999). Since 
the formation of coniferyl alcohol is decisive for the synthesis of the aryltetralin lignans, only 
this biosynthetic route is described (Fraser and Chapple, 2011) (Fig. 5). Phenylalanine is non-
oxidatively converted into trans-cinnamic acid by phenylalanine ammonia-lyase (PAL, E.C. 
4.3.1.5). PAL is a stress-inducible, soluble homotetrameric protein with subunits between 77 
and 83 kDa. Cinnamic acid 4-hydroxylase (C4H, EC 1.14.13.11) is a cytochrome P450 enzyme 
that introduces a hydroxyl group in para position of trans-cinnamic acid. The resulting p-
coumaric acid can be converted to p-coumaroyl-CoA by hydroxycinnamic acid CoA ligase 
(4CL, E.C. 6.2.1.12) and p-coumaroyl-CoA then transformed to p-coumaroyl shikimic acid by 
shikimate O-hydroxycinnamoyltransferase (HCT, EC 2.3.1.133). The conversion of p-
coumaroyl shikimic acid to caffeoyl shikimic acid is catalysed by the p-coumaroyl ester 3-
hydroxylase (C3H, E.C. 1.14.13.36). Caffeoyl shikimic acid is converted into caffeoyl-CoA 
and shikimic acid by HCT and caffeoyl-CoA can be methylated into feruloyl-CoA by caffeoyl-
CoA OMT (CCoAOMT, E.C. 2.1.1.104). Cinnamoyl-CoA:NADP oxidoreductase (CCR, E.C. 
1.2.1.44) can convert  caffeoyl-CoA or feruloyl-CoA into the corresponding cinnamic 
aldehydes, which are converted into the corresponding cinnamyl alcohol derivatives by 
Figure 4: Linum flavum (A) and cell suspension culture of L. flavum (B) 
B A 
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cinnamyl alcohol dehydrogenase (CAD, E.C. 1.1.1.195). Aromatic hydroxyl groups can be 
methylated by caffeic acid O-methyltransferase (COMT, E.C. 2.1.1.68). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Main biosynthetic pathway to coniferyl alcohol  
1: phenylalanine ammonia-lyase (PAL); 2: tyrosine ammonia-lyase; 3: cinnamic acid 4-hydroxylase (C4H); 4: 
hydroxycinnamic acid CoA ligase (4CL); 5: shikimate O-hydroxycinnamoyltransferase (HCT); 6: p-coumaroyl 
shikimic acid 3-hydroxylase (C3H); 7: cinnamoyl-CoA:NADP oxidoreductase (CCR); 8: caffeoyl-CoA O-
methyltransferase (CCoAOMT); 9: caffeic acid O-methyltransferase (COMT); 10: cinnamyl alcohol 
dehydrogenase (CAD) 
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4.2 Early stages of lignan biosynthesis - from coniferyl alcohol to matairesinol 
In the first step of this stage, two molecules of coniferyl alcohol are linked to each other 
stereospecifically resulting in pinoresinol (PINO). It is generally assumed that this reaction 
occurs via radical intermediates and the mechanism of the pinoresinol synthase resembles that 
of a laccase. Stereospecificity is ensured by the so-called dirigent protein, which itself has no 
enzymatic activity, but determines the stereochemistry of the product (Davin et al., 1997; Davin 
and Lewis, 2000). Since in Forsythia spec., Linum perenne and Linum album (+)-PINO is 
found, while in Linum usitatissimum (-)-PINO, there are presumably different dirigent proteins 
in different species (Kuhlmann, 2004). 
Pinoresinol-lariciresinol reductase (PLR) catalyses the conversion of PINO via lariciresinol 
(LARI) into secoisolariciresinol (SECO) in the dependence of NADPH. These reactions are 
also stereospecific and different isoforms have been found for this enzyme in different plants, 
each of which leads to either (+)- or (-)-SECO. The cloning and crystallisation of PLR showed 
a relationship to isoflavone reductases (Chu et al., 1993, Dinkova-Kostova et al., 1996, Min et 
al., 2003) (see III.7). 
The NAD-dependent secoisolariciresinol dehydrogenase (SDH) forms the lactone ring 
between C9 and C9' of SECO to produce matairesinol (MATAI). Secoisolariciresinol 
dehydrogenase was purified from Forsythia intermedia and Podophyllum peltatum and 
heterologously expressed in bacteria (Xia et al., 2001). The reaction of SDH had previously 
been demonstrated in cell-free extracts of F. intermedia (Umezawa et al., 1991).  
 Figure 6: Lignan biosynthesis - from coniferyl alcohol to matairesinol  
(1) pinoresinol synthase; (2) pinoresinol-lariciresinol reductase, (3) secoisolariciresinol dehydrogenase  
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4.3 Lignan biosynthetic pathway downstream of matairesinol - different models and 
hypotheses 
In contrast to the formation of MATAI, the further biosynthesis of PTOX and derivatives such 
as 6-MPTOX is not fully understood. To clarify the reaction sequence, different hypotheses 
were used (Fig. 7): 
Podophyllum spec.: Feeding experiments with radioactive precursors have shown that MATAI 
is the common precursor for the 4'-O-Methyl series (DOP, β-peltatin, PTOX) as well as the 4'-
demethyl series (4'-demethyl-DOP, α-peltatin, 4'-demethyl-podophyllotoxin) (Broomhead et 
al., 1991). At the stage of the C2-C7'-cyclolignans such as DOP, these two series were no 
longer interleaved (Jackson and Dewick, 1984). As a direct precursor of α- and β-peltatin, 4'-
demethyl DOP and DOP in P. peltatum and P. hexandrum were confirmed (Kamil and Dewick, 
1986). In 2013, Marques et al. (2013) have identified two genes for pluviatolide synthases 
(CYP719A23 and CYP719A24) after sequencing the transcriptome of P. hexandrum and P. 
peltatum. These cytochrome P450s use (-)-matairesinol and form the methylenedioxy bridge 
thus establishing the A-ring of (-)-pluviatolide and further derived lignans. In 2015, by coupling 
transcriptome mining with combinatorial expression of candidate enzymes in tobacco, Lau and 
Sattely (2015) have discovered other six enzymes to complete the biosynthetic pathway to (-)-
4′-desmethylepipodophyllotoxin in Podophyllum hexandrum (mayapple), including an 
oxoglutarate-dependent dioxygenase that closes the core cyclohexane ring of the aryltetralin 
scaffold, two O-methyltransferases and three cytochrome P450 enzymes (Fig. 8). 
Anthriscus sylvestris: The biosynthesis of yatein was developed from MATAI in Anthriscus 
sylvestris (Sakakibara et al., 2003). For these studies, A. sylvestris plants were fed with 13C-
labeled phenylalanine. The hydroxylation and subsequent methylation on the pendant aromatic 
ring took place first, followed by the methylation of the OH group at C4', and finally the 
formation of the methylenedioxy bridge on the second benzene ring between C4 and C5. 
However, biotransformation experiments with suspension cultures showed that PTOX was 
formed from DOP, but not from yatein (Koulman et al., 2003).  
Linum spec.: Biotransformation experiments with suspension cultures of Linum flavum have 
shown the transformation of DOP and β-peltatin into 6-MPTOX and 6-MPTOX glucoside (Van 
Uden et al., 1995; Van Uden et al., 1997). In the same cultures, PTOX was transformed to 
PTOX-β-D-glucoside instead of 6-MPTOX glucoside, although this is the mainly formed 
lignan (Van Uden et al., 1992). These experiments suggest that DOP in Linum flavum could be 
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the branching point in the biosynthetic pathways to PTOX and 6-MPTOX. The hydroxylation 
at position 7 of DOP to PTOX catalysed by deoxypodophyllotoxin 7-hydroxylase still needs to 
be characterized. On the way to 6-MPTOX, hydroxylation at position 6 of DOP is catalysed by 
deoxypodophyllotoxin 6-hydroxylase (DOP6H), which was characterised in L. flavum as a 
cytochrome P450 enzyme (Molog et al., 2001). This metabolic step results in the formation of 
ß-peltatin. This compound is converted to ß-peltatin A methyl ether (PAM) by ß-peltatin 6-O-
methyltransferase. This enzyme was first characterised in 2003 in L. nodiflorum (Kranz and 
Petersen, 2003). The enzyme for the last hydroxylation step to form 6-MPTOX (ß-peltatin A-
methyl ether 7-hydroxylase) is not known yet. In cell cultures of Linum album, the conversion 
of DOP to PTOX has also been shown by biotransformation experiments (Seidel et al., 2002; 
Empt et al., 2000).  
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Figure 7: Overview of late stages of lignan biosynthesis (Robinson, 2018). 
Known reactions are represented by continuous arrows and unknown with dashed arrows. 
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Figure 8: Six enzymes in the biosynthetic pathway to (-)-4′-desmethylepipodophyllotoxin in Podophyllum 
hexandrum (Lau and Sattely, 2015) 
 
5. Cytochrome P450 systems in plants 
Cytochromes P450 (CYP; E.C. 1.14.13., 1.14.14., 1.14.15.) are referred to as monooxygenases, 
as well as mixed function oxygenases. When CYPs are reduced and complexed with carbon 
monoxide, the enzymes have a spectrophotometric peak at the wavelength 450 nm (Kleinig 
and Mayer, 1999; Omura and Sato, 1964). The reactions catalysed by CYPs are complex 
electron transfers, which take place over several protein components.  
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An iron-protoporphyrin IX (heme chromophore type b), that is attached to a highly-conserved 
cysteine, is the recipient of the electrons in the CYP protein (Fig. 9). The first 17-29 amino 
acids of CYPs in the N-terminus are hydrophobic and serve to anchor the protein in the ER 
membrane. CYPs are named and classified according to their amino acid sequence in families 
and subfamilies. Sequence homologies over 40% are characterised as family, over 55% as 
subfamily and over 97% as allelic variants (Nelson et al., 1996; Werck-Reichhart et al., 2002).  
 
 
The sequence identity within the plants’ CYPs (Mw 45-65 kDa) is extremely low (<20%). The 
conserved sequence motifs of CYPs are shown in Fig. 10. The "hinge" region consisting of a 
"cluster" of basic and proline-rich amino acids [consensus sequence (P/I)PGPx(G/P)xP] is 
followed by the I helix, the "ERR" triad and the heme binding region (Durst and Nelson, 1995; 
Schuler, 1996; Werck-Reichhart et al., 2002). The I helix encodes the oxygen binding and 
activation site [consensus sequence (A/G)Gx(E/D)T(T/S)]. The "ERR" triad [consensus 
sequence ExxR......R] presumably assists in the stabilisation and positioning of the heme in the 
binding pocket. The heme-binding region [consensus sequence FxxGxRxCxG] contains the 
conserved cysteine for binding the iron of protoporphyrin (Werck-Reichhart and Feyereisen, 
2000). 
Figure 9: Iron-protoporphyrin IX (copied from Gasteiger and Schunk, 2003) 
Iron-protoporphyrin IX consists of four linked pyrrole rings that complex an iron ion. The iron is bound to a 
cysteine residue of the apoprotein and oxygen by two further ligands at the fifth and sixth coordination sites.  
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The catalytic reaction cycle of CYP is described in Fig. 11 (Meunier et al., 2004). In the resting 
state (I), the iron is present as a Fe3+ "low-spin" complex. This is converted into the "high-spin" 
state (II) by binding the substrate to Fe3+ and reduction to Fe2+. The missing electron is supplied 
by NADPH via the NADPH:cytochrome P450 reductase (III). The binding of molecular 
oxygen leads to the formation of a CYP dioxygen complex (IV) which is activated by a second 
reduction equivalent and becomes a Peroxo-Fe2+ (VI). Protonation and cleavage of the O-O 
bond releases a molecule of water and leaves the reactive Fe3+-O complex (VII). This complex 
attacks radically the bound substrate and transfers its O-radical by taking over an H-radical of 
the substrate and thus forms the alcohol group. 
A simplified reaction scheme is the following: 
RH + O2 + NADPH + H
+ → ROH + H2O + NADP+ 
Figure 10: Conserved sequence motifs in CYPs (copied from Werck-Reichhart et al., 2002) 
Figure 11: Catalytic reaction cycle of CYPs (copied from http://metallo.scripps.edu/promise/P450.html) 
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In addition to the "classical" hydroxylations, many different reactions can be catalysed by 
cytochrome P450-dependent enzymes, such as isomerisation, dimerisation, epoxidation, 
dealkylation and decarboxylation, oxidation of nitrogen and sulphur, dehalogenation and 
deamination (Schuler and Werck-Reichhart, 2003; Halkier, 1996). 
Cytochrome P450 enzymes are involved in many plant biosynthetic pathways such as 
phenylpropan metabolism, the biosynthesis of alkaloids, terpenoids, glucosinolates, fatty acids, 
flavonoids, isoflavonoids (Humphreys and Chapple, 2000) and the detoxification of 
xenobiotics such as herbicides (Bolwell et al., 1994; Durst, 1988).  
The great variety of the described cytochrome P450-catalysed reactions makes it clear that 
many oxidative steps of lignan biosynthesis in Linum species might be P450-dependent. A 
publication of Molog (2001) has shown that the C6-hydroxylation of DOP to β-peltatin in cell 
cultures of Linum album and Linum flavum is catalysed by a cytochrome P450 enzyme 
(DOP6H). Furthermore, studies with a suspension culture of Linum album suggested the 
participation of a cytochrome P450 oxygenase (DOP7H) in the formation of PTOX from DOP 
(Henges, 1999). 
 
6. Cytochrome P450 reductase in plants 
NADPH:cytochrome P450 reductase (CPR, EC 1.6.2.4) is located in the endoplasmic 
reticulum (Williams and Kamin, 1962). CPR was isolated for the first time from yeast and 
annotated as cytochrome c reductase based on its ability to reduce cytochrome c as artificial 
substrate (Haas et al., 1940). CPR contains flavin adenine dinucleotide (FAD) and flavin 
mononucleotide (FMN) (Benveniste et al., 1991) and transfers electrons from NADPH via 
FAD and FMN to the prosthetic heme group of the CYP protein (Porter, 2004).  
CPR harbours a FMN-binding domain in the N-terminal and a NADPH/FAD-binding domain 
in the C-terminal domain. A membrane-spanning anchor anchoring the protein in the 
endoplasmic reticulum is formed by 50-60 hydrophobic amino acid residues in the N-terminus 
(Bonina et al., 2005). Ro et al. (2002) suggested differentiating CPR into two classes depending 
on their N-terminal membrane anchoring sequences. Members of class I present short N-
terminal ends with appr. 50 amino acids, whereas class II show an extended N-terminal end 
with appr. 80 amino acids.  
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FMN-containing flavodoxin (Fld) is a small soluble electron carrier protein which participates 
in many redox reactions. Reversible electron transfer between NADP(H) and Fld is catalysed 
by a monomeric FAD-containing ferredoxin-NADP+ reductase (FNR). FNRs are present in 
photosynthetic as well as heterotrophic organisms (Kenneth et al., 2010). The FNR domain 
present in CPR is derived from the plant-type FNRs (Aliverti et al., 2008). The fusion of genes 
encoding Fld and FNR resulted in the FAD and FMN-binding domains of CPR (Fig. 12) (Porter 
and Kasper, 1986).  
 
 
 
Figure 12: Molecular evolution of NADPH-cytochrome P450 oxidoreductase (CPR) (copied from Kenneth et 
al., 2010) 
In 1997, Wang et al. identified conserved cofactor- and substrate-binding regions in the 
crystallised CPR from rat liver. The FMN-binding domain is located at the C-terminal side of 
the β-strands (see Fig. 13). The isoalloxazine ring of FAD lies at the boundary between the 
FAD- and NADP(H)-binding domains, and the interface between the FAD-binding domain 
and the connecting domain contains the other part of FAD.  
 
 
 
 
 
 
 
 
 
 
Figure 13: Overall polypeptide fold and topology diagram for CPR (copied from Wang et al., 1997)  
A: The FMN-binding domain is represented in blue, the FAD- and NADP(H)-domains are shown in green, and the 
connecting domain in red. The cofactor FMN is represented in light blue, FAD in yellow, and NADP+ in orange. 
The “hinge” region is shown in pink.  
B: Topology diagram of the CPR protein. The domain arrangement in the CPR structure is shown in a linear 
diagram at the bottom. 
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7. Bifunctional pinoresinol-lariciresinol reductase with different stereospecificities  
Most lignans are chiral compounds and only one enantiomer can be found in each plant or 
organ. The enantiomeric purity appears to be determined at various levels in lignan 
biosynthesis. The binding of the two achiral coniferyl alcohol molecules with the help of the 
dirigent protein leads to enantiomerically pure (+)-PINO in Forsythia intermedia (Davin and 
Lewis, 2003). In contrast, the enantiomeric purity is achieved at the level of MATAI in 
Wikstroemia sikokiana (Umezawa et al., 2003). Interestingly, opposite lignan enantiomers can 
be found in different plants or organs. Enzyme preparations of flowers of Arctium lappa 
catalyse the formation of (+)-PINO, (+)-LARI and (-)-SECO, while enzyme preparations from 
maturing seeds of this plant species catalyse the formation of the opposite enantiomers (Suzuki 
et al., 2002). Seeds of Linum usitatissimum contain pure (+)-SECO diglucoside, whereas Linum 
album accumulates pure (-)-PODO, which should have (-)-SECO as a precursor (Davin and 
Lewis, 2003; Petersen and Alfermann, 2001). 
The enantiospecificity and diastereomeric preferences of pinoresinol-lariciresinol reductase 
were first investigated by Katayama et al. (1992) when the (+)- and (-)-enantiomers of PINO 
were incubated with Forsythia intermedia cell-free extracts. In the presence of NADPH, PINO 
was converted preferably into (+)-LARI and (-)-SECO. Incubation with (±)-LARI revealed that 
only the (+)-antipode was converted to (-)-SECO. This result shows the existence of a 
bifunctional enantiospecific pinoresinol-lariciresinol reductase (PLR) in the soluble protein 
extract of F. intermedia. The isolation of a cDNA encoding a PLR of F. intermedia (PLR-Fi1) 
and its heterologous expression showed the same enantiospecificity as for the crude extract 
(Dinkova-Kostova et al., 1996).  
In 1999, Fujita et al. reported the presence of cDNAs corresponding to two stereochemically 
distinct PLR classes in a single plant species, Thuja plicata. Four cDNAs were grouped into 
two different classes of PLRs. In the first class PLR-Tp1 had high similarities with PLR-Tp3 
and in the second class PLR-Tp2 showed high similarities to PLR-Tp4. Heterologously 
expressed PLR-Tp1 reduces (-)-PINO to (+)-SECO. On the other hand, the transformation of 
(±)-PINO with recombinant PLR-Tp2 led to the accumulation of both (+)- and (-)-LARI, in 
which only the (+)-LARI was converted to (-)-SECO. (-)-LARI was not further converted to 
(+)-SECO. Thus, T. plicata PLRs can reduce both the (+) and (-) enantiomers of PINO, but are 
highly enantiospecific with regard to (+)-LARI.  
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The enantiospecificity of a recombinant PLR from a cell suspension culture of Linum album 
(PLR-La1) has been reported by Heimendahl et al. (2005). It reduces (+)-PINO to (-)-SECO 
via (+)-LARI. In addition, Heimendahl et al. (2005) cloned a cDNA encoding PLR from a cell 
suspension culture of L. usitatissimum (PLR-Lu1). The recombinant protein PLR-Lu1 converts 
(-)-PINO to (+)-SECO. 
  
Hydride transfer by PLR is highly stereospecific. In partially purified PLR from F. intermedia, 
Chu et al. (1993) and Dinkova-Kostova et al. (1996) have shown that PLR abstracts the 4pro-
R hydrogen from NADPH and the incoming hydride occupies the Pro-R position at C-7' in 
LARI and at C-7/C-7' in SECO (Fig. 15).  
 
 
 
 
Figure 14: Different bifunctional PLRs with different stereospecificities 
Figure 15: Mechanism of hydride transfer by PLR (copied from Fujita et al., 1999) 
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8.  Secoisolariciresinol dehydrogenase (SDH) 
Secoisolariciresinol dehydrogenase (SDH, EC 1.1.1.331) is an oxidoreductase involved in 
lignan biosynthesis. SDH catalyses the stereospecific conversion of SECO to MATAI via a 
lactol intermediate. The enzymatic activity of SDH has been identified in F. intermedia and P. 
peltatum (Xia et al., 2001) and classified into the enzyme family of short-chain 
dehydrogenases/reductases (SDRs). The SDR family was established in 1981 when the 
members were only a prokaryotic ribitol dehydrogenase and an insect alcohol dehydrogenase 
(Jörnvall et al., 1981). Since then, the SDR family has grown enormously and currently around 
47000 members including species variants are known (Kallberg et al., 2010). 
The SDRs can be divided into two large families, "classical" with appr. 250 amino acids and 
"extended" with appr.  350 amino acids. The classical SDRs have single-domain subunits that 
catalyze NAD(P)(H)-dependent oxidation/reduction reactions. The cosubstrate is bound at the 
N-terminal part, while the substrate binding is at the C-terminal part. The classical SDRs have 
a TGXXX[AG]XG cofactor binding motif and a YXXXK active site motif, with the Tyr 
residue of the active site motif serving as the critical catalytic residue. In addition to the Tyr 
and the Lys, there is often an upstream Ser and/or an Asn contributing to the active site. 
Extended SDRs have additional elements in the C-terminal region and typically have a 
TGXXGXXG cofactor binding motif (Jörnvall et al., 1995).  
In the crystal structure SDH exists as a homotetramer (Moinuddin et al., 2006). Based on 
homology comparisons with other SDRs, SDH shows a conserved catalytic triad (Ser, Tyr and 
Lys). Analysis of the SDH X-ray structure, site-directed mutagenesis, and NMR spectroscopic 
data conducted by Moinuddin et al. (2006) have led to the delineation of the catalytic 
mechanism of SDH, including the role of the conserved catalytic triad (Ser, Tyr and Lys) (see 
Fig. 16). 
Structural data for SDH (Fig. 16A) showed that several water molecules form a hydrogen-
bonded network with the hydroxyl, quaternary ammonium, and phenolic groups of the highly 
conserved catalytic triad residues. The binding of NAD+ releases the bound water molecules 
and increases the reaction entropy. Binding of NAD+ to Lys promotes the deprotonation of the 
phenolic Tyr group, thereby lowering its pKa (Fig. 16B). Hydrogen bonding to the Ser 
hydroxyl group further stabilises the phenolate anion. The Tyr phenolate group serves as a 
general base in the deprotonation of substrates, thus facilitating hydride transfer during SDH 
catalysis. Deprotonation of the bound (-)-SECO is followed by intramolecular cyclisation/ 
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hydride transfer to give the intermediate lactol (Fig. 16C). The last step is the release of the 
resulting neutral NADH and lactol from the active site (Fig. 16D). Analogously, the subsequent 
conversion of the lactol intermediate to (-)-MATAI involves the binding of a second molecule 
of NAD+, repeating the catalytic process (Figs. 16E and 16F), hence generating a second 
molecule of NADH and the final product (-)-MATAI.  
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Figure 16: Proposed catalytic mechanism of SDH (taken from Moinuddin et al., 2006) 
(1): (-)-secoisolariciresinol; (2): lactol intermediate; (3): (-)-matairesinol 
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9. Objective  
The aryltetralin lignan podophyllotoxin (PTOX) and its semisynthetic derivates, e.g. etoposide 
and teniposide, play an important role in medicine. They are cytotoxic by binding to 
DNA/topoisomerase II complexes and thus induce DNA strand breaks. Since the biosynthetic 
capacity of PTOX in plants is comparatively low to produce pharmaceutically important active 
ingredients, attempts are made to improve these by targeted interventions or artificial imitation 
of the synthetic pathway. However, this is only possible if the complex relationships in the 
biosynthesis of each substance are known. Cell cultures of Linum flavum accumulate 
considerable amounts of 6-MPTOX and traces of PTOX. Therefore, these cell cultures can 
serve as suitable systems for the elucidation of the biosynthesis of aryltetralin lignans. The aim 
of this work was to gain insight into biosynthetic pathways to podophyllotoxin-type lignans in 
Linum flavum. Of particular interest are the roles of pinoresinol-lariciresinol reductase (PLR), 
secoisolariciresinol dehydrogenase (SDH), deoxypodophyllotoxin 6-hydroxylase (DOP6H) 
and deoxypodophyllotoxin 7-hydroxylase (DOP7H). In addition, mutagenesis of the enzyme 
PLR from Linum flavum was carried out to study protein structure-function relationships of 
PLR. Furthermore, experiments were made to identify NADPH:cytochrome P450 reductase 
(CPR), which is essential for cytochrome P450-dependent reactions, to which the above-
mentioned enzymes DOP6H and DOP7H potentially belong. 
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IV. Material  
1. List of chemicals
Product Company 
1-naphthaleneacetic acid (NAA) Duchefa 
2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic 
acid) (ABTS) 
Sigma 
5-bromo-4-chloro-3-indolyl 
phosphate (BCIP) 
Roth 
5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-gal) 
Roth 
7-hydroxysecoisolariciresinol Gift from 
Dr. Patrik 
Eklund 
acetic acid, glacial Roth 
acetone Roth 
acrylamide/bisacrylamide (30%, 
37.5:1) 
Roth 
agar-agar Cero 
agarose  Biozym /  
Roth 
ammonium iron (II) sulfate Merck 
ammonium nitrate Roth 
ammonium persulphate (APS) Sigma 
ammonium sulphate Roth 
ampicillin Roth 
benzylaminopurine Sigma 
boric acid Roth 
bovine serum albumin (BSA) Roth 
bromophenol blue Merck 
calcium chloride dihydrate Roth 
cetyltrimethylammonium bromide 
(CTAB) 
Roth 
chloroform Roth 
cobalt (II) chloride Merck 
Coomassie Brilliant Blue G250 Fluka 
Coomassie Brilliant Blue R250 Fluka 
copper (II) sulfate pentahydrate Fluka 
Product Company 
D-(+)-galactose Acros 
Organics / 
Roth 
D-(+)-glucose Roth 
diethyl ether Roth 
dimethylformamide (DMF) Merck 
dipotassium hydrogen phosphate Roth 
disodium 
ethylenediaminetetraacetate 
dihydrate (EDTA-Na2) 
Roth 
dithiothreitol (DTT) Roth 
dNTPs (dATP, dCTP, dGTP, 
dTTP) 
Fermentas 
D-sorbitol Fluka 
ethanol Roth 
ethidium bromide AppliChe
m 
ethyl acetate Roth 
fish sperm DNA (carrier DNA) Serva 
formic acid (98%) Roth 
glycerol Roth 
glycine Merck 
guanidine thiocyanate  Roth 
guanidine-HCl Roth 
hydrochloric acid (37%) Roth 
indole-3-acetic acid (IAA)  Duchefa 
iron(II) sulphate heptahydrate Fluka 
isopropyl-β-D-
thiogalactopyranoside (IPTG) 
Roth 
L-adenine Roth 
L-arginine Roth 
L-aspartic acid Roth 
lauryl sarcosine Sigma 
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Product Company 
L-cysteine Roth 
5-Aminolevulinic acid Roth 
L-histidine Roth 
L-isoleucine Roth 
lithium acetate Sigma 
L-leucine Roth 
L-lysine Serva 
L-methionine Roth 
L-phenylalanine Roth 
L-proline Roth 
L-serine Roth 
L-threonine Roth 
L-tryptophan Roth 
L-tyrosine Fluka / 
Merck 
L-valine Roth 
magnesium chloride hexahydrate  Roth 
magnesium sulfate heptahydrate Merck 
manganese (II) sulfate 
pentahydrate 
Duchefa 
matairesinol  Lab's 
collection 
methanol Fisher 
Scientific 
myo-inositol Sigma / 
Roth 
naphthalenacetic acid  Duchefa 
nicotinamide-adenine-
dinucleotide phosphate, reduced 
(NADPH) 
Roth 
Nicotinamide-adenine-
dinucleotide, oxidized (NAD)  
Biomol 
nitro-blue tetrazolium chloride 
(NBT) 
Roth 
N-Z-Amine®, casein hydrolysate Sigma 
phenol (citrate buffer saturated) Sigma 
phenol/chloroform (1:1) Roth 
Product Company 
phenylmethylsulfonyl fluoride 
(PMSF) 
Roth 
phosphoric acid (85%) Roth 
pinoresinol Sigma 
Polyclar 10 ISP 
polyethylene glycol 4000 (PEG) Roth 
polyvinylpyrrolidone MW 40000 Sigma 
potassium acetate Acros 
potassium dihydrogen phosphate Roth 
potassium hydroxide Merck 
potassium iodide Merck 
potassium nitrate Roth 
secoisolariciresinol Sigma 
sodium chloride Roth 
sodium dodecyl sulphate (SDS) Roth 
sodium hydroxide Merck 
sodium molybdate dihydrate Fluka 
ß-peltatin Lab's 
collection 
ß-peltatin A methyl ether Lab's 
collection 
sucrose Aldi Nord 
tetrabutylammonium hydrogen 
sulphate 
Sigma 
tetracycline Sigma 
tetramethylethylenediamine 
(TEMED) 
Roth 
thiamine hydrochloride Roth 
tris(hydroxymethyl)-
aminomethane (TRIS) 
Roth 
tryptone/peptone Roth 
tween 20 Sigma 
yatein Lab's 
collection 
yeast extract Roth 
yeast nitrogen base Conda 
zinc (II) sulfate heptahydrate Merck 
α-peltatin  Lab's 
collection 
All chemicals were of p.a. or purest available quality. 
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2. Reagents and kits 
Product Company 
T4 DNA Ligase (5 U µl-1) Fermentas 
goat anti-Mouse IgG Fc Fisher Scientific 
cytochrome c (horse 
heart) 
Fluka 
GeneRuler™ 1 kb DNA 
Ladder 
Fisher Scientific 
GeneRuler™ DNA Ladder 
Mix 
Fisher Scientific 
GoTaq® Flexi DNA 
Polymerase Kit (5 U µl-1) 
Promega 
Ni-NTA His-Bind® 
Superflow™ 
Novagen 
NucleoSpin®-Extract II 
Kit 
Macherey-Nagel 
PageRuler™ Protein 
Ladder 
Fermentas 
PCR Cloning kit Qiagen 
Product Company 
PD-10 Columns Sephadex 
G-25M 
GE Healthcare 
Phusion® Polymerase (2 
U µl-1) 
NEB 
Pierce™ 6x-His Epitope 
Tag Antibody (HIS.H8) 
Fisher Scientific 
Qiaprep® Spin Miniprep 
Kit 
Qiagen 
restriction enzymes: XbaI, 
EcoRI, HindIII, NdeI, 
NotI, XhoI 
Fermentas / 
Fisher Scientific 
Revert Aid First Strand 
cDNA Synthesis Kit 
Fisher Scientific 
RNase H (5 U µl-1) Fermentas 
Roti®-Mark Standard Roth 
Roti®-Mark TRICOLOR 
Protein marker, prestained 
Roth 
 
3. Instruments 
Instrument Product Manufacturer/Distributor 
autoclaves Systec VX-150 Systec GmbH 
AL02-02-100 Advantage–Lab 
benchtop homogeniser Minilys® Bertin Instruments 
Bunsen burner Flammy S Schütt 
  
cell culture shakers 
  
Certomat SII B. Braun Biotech. 
RS-306 Infors AG 
TR-150 
  
  
centrifuges 
  
  
  
Biofuge 17RS   
Heraeus Sepatech 
  
Fresco 17 
Pico 17 
Centrifuge 5415D Eppendorf 
Sorvall RC6+ Thermo Scientific 
water purifier OmniaPure Stakpure GmbH 
electroporation apparatus Agagel Mini Biometra Biomed Anaytik GmbH 
MultiSUB Mini Cleaver Scientific 
homogeniser Ultra Turrax T25 Basic IKA 
freeze dryer Christ L1 B. Braun Biotech 
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Instrument Product Manufacturer/Distributor 
freezer C585 Innova New Brunswick Scientific 
gel documentation systems FAS-Digi Nippon Genetics 
HPLC columns 
  
Hypersil HypurityTM Elite Thermo Scientific 
 
Chiralcel OD-H  Daicel 
HPLC systems 
  
  
L-4000UV Detector Merck/Hitachi 
 
 
L-6200A Intelligent Pump 
D-2500 Chromator 
Integrator 
ice machine AF 80 Scotsman 
magnetic stirrer MR 3001 Heidolph Instr. 
PCR thermocycler Eppendorf Mastercycler 
gradient 
Eppendorf 
MyCycler Bio-Rad 
pH-electrode Accumed Basic Fisher Scientific 
photometer 
  
BioPhotometer Eppendorf 
Specord 200 plus Analytik Jena 
rocking platform Duomax 1030 Heidolph Instr. 
rotary evaporator Rotavapor RE120 Büchi 
scales H64 Mettler 
PT 310 Sartorius 
EW Kern 
shaking incubator Ecotron Infors HT 
10X 400 Gallenkamp 
laminar flow bench Gelaire Laminar Air Flow 
Class 100 
Gelman Instrument 
thermomixer Thermomixer Comfort Eppendorf 
ultrasonic bath Sonorex Super RK 510 H Bandelin 
ultrasonic processor UP 200S Dr. Hielscher 
vacuum centrifuge Univapo 100 H UniEquip 
RVC 2-18 CDplus Christ 
vacuum pump MZ 2C NT  Vacuubrand 
  
voltage controller 
  
  
E835   
Consort 
  
  
E143 
EV2310 
EV3020 
mixer Vortex-Genie 2 Scientific Industries 
Vortex Mixer VELP Scientifica 
 water bath Thermomix ME B. Braun Biotech. 
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4. Genotypes of laboratory strains 
Information on the following genotypes was taken from the respective handbooks of the 
bacterial strains and yeast strain. 
E. coli EZ (Qiagen) 
E. coli str. [F'::Tn10 (Tcr) proA+B+ lacIqZΔM15] recA1 end A1 hsdR17 (rK12- mK12+) lac 
glnV44 thi-1 gyrA96 relA1 
SoluBL21TM Competent E. coli (Amsbio) 
E. coli str. F- ompT hsdSB (rB- mB-) gal dcm (DE3)
† 
 
Saccharomyces cerevisiae InvSc1 (Invitrogen) 
S. cerevisiae str. MATa his3D1 leu2 trp1-289 ura3-52 MAT his3D1 leu2 trp1-289 ura3-52 
 
5. Vector sequences, maps and features 
All information on the following vector maps are taken from the manufacturer's manuals. 
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5.1  pDrive (Qiagen) 
 
 
 
 
 
Location of specific vector 
features 
Vector size (bp): 3851 Multiple 
cloning site: 266–393 LacZ α-
peptide: 216–593 
T7 RNA polymerase promoter: 
239–258 T7 transcription start: 
256 
SP6 RNA polymerase promoter: 
398–417 SP6 transcription start: 
400 
Ampicillin resistance gene: 
1175–2032 Kanamycin resistance 
gene: 2181–2993 pUC origin: 
3668 
Phage f1 origin: 588–1043 
Primer binding sites: 
M13 forward (–20): 431–447 
M13 forward (–40): 451–467 
M13 reverse: 209–224 
T7 promoter primer: 239–258 
SP6 promoter primer: 400–418 
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5.2 pET-15b (Novagen) 
 
 
 
 
 
 
 
 
 
Location of specific vector features 
T7 promoter: 463-479 
T7 transcription start: 452 
His-Tag coding sequence: 362-380 
Multiple cloning sites (Nde I - BamH 
I): 319-335 T7 terminator: 213-259 
lacI coding sequence: (866-1945) 
pBR322 origin: 3882 
bla coding sequence: 4643-5500 
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5.3 pYes2/NT C (Invitrogen) 
 
 
 
 
 
 
Location of specific vector 
features 
GAL1 promoter: 1-451 
GAL1 forward priming 
site: 414-437 T7 
promoter/priming site: 
475-494 ATG initiation 
codon: 510-512 
Polyhistidin (6xHis) 
region: 522-539 Xpress™ 
epitope: 579-602 
Enterokinase (EK) 
recognition site: 588-602 
Multiple cloning site: 602-
669 
V5 epitope: 682-723 
Polyhistidine (6xHis) 
region: 733-750 
CYC1 transcription 
termination signal: 783-
1036 CYC1 reverse 
priming site: 800-818 
pUC origin site: 1220-
1893 Ampicillin resistance 
gene: 2038-2898 
(complementary) 
URA3 gene: 2916-4023 
(complementary) 2µ 
origin: 4027-5498 
f1 origin: 5566-6021 
(complementary) 
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6. Primer list  
6.1 Primers for CYP candidates 
Name Sequence (5’–3’) Tm 
[°C] 
Restriction 
site 
Comment 
CYP-11511-f  ATGGATTTCTTCACTTCTCTCT 54.7 
 
Full-length primer 
CYP-11511-r  TTATGTCTAACATATATCGAT
CATTC 
55.3 
 
Full-length primer 
CYP-11862-f  ATGGATTCTCTCTTTGCTTCAA
TTG 
58.1 
 
Full-length primer 
CYP-11862-r  TTAAACATAAGCATCGTGAGA
CAATC 
58.5 
 
Full-length primer 
CYP-2114-f ATGGAGCTCCTCCAAATGTTA
CCTG 
63 
 
Full-length primer 
CYP-2114-r  CTAAACGGTTGGTACAGGGTT
GC 
62.4 
 
Full-length primer 
CYP-2227-f  ATGGAATGCTCCTACTCCCAA
TTC 
61 
 
Full-length primer 
CYP-2227-r  CTAGTGGTATGGGGTTGGAAT
CAAT 
61.3 
 
Full-length primer 
CYP-2405-f  ATGTTCATAAGGCCAAGTCCC
AA 
58.9 
 
Full-length primer 
CYP-2405-r  TCATCCATAAACTTCAGGAGC
CAA 
59.3 
 
Full-length primer 
CYP-2408-f  ATGGCCGCCTCGCTCACCT 63.1 
 
Full-length primer 
CYP-2408-r  CTAATTTGCAACAGCCTCTAA
CATTTCAG 
62.4 
 
Full-length primer 
CYP-2702-f   ATGACTCTAATGGAACTAGCA
CTAG 
59.7 
 
Full-length primer 
CYP-2702-r  TCATAGTTTCAAGGCATTAGC
ATCATA 
58.9 
 
Full-length primer 
CYP-27263-f ATGGCCGACAAGTACGGC 58.2 
 
Full-length primer 
CYP-27263-r TTAGCCGTACAAATGAGCTGG 57.9 
 
Full-length primer 
CYP-31728-f  ATGGAGCTTCTTCAACTACTC 55.9 
 
Full-length primer 
CYP-31728-r  TTAAGCAATGACAGGAACTAA
TGA 
55.9 
 
Full-length primer 
CYP-3458-f  ATGGAGAGGAATATCAGAGCT
TTCT 
59.7 
 
Full-length primer 
CYP-3458-r  TCAAGCTGCCATGCCATCGT 59.4 
 
Full-length primer 
CYP-38991-f  ATGGATATCATCATCTCCCAC
C 
58.4 
 
Full-length primer 
CYP-38991-r  CTAAAGTACTCCATACAACTC
GG 
58.9 
 
Full-length primer 
CYP-4152-f  ATGGCGGCCGGGAGGGAT 62.8 
 
Full-length primer 
CYP-4152-r  CTATGTACATGCCACGGGGAT
AAG 
62.7 
 
Full-length primer 
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CYP-4471-f ATGCCTTCACTACTTATCTACC
TT 
58.6 
 
Full-length primer 
CYP-4471-r TTATAAAAACTTTGTAGCTAC
TAGACATAG 
57.6 
 
Full-length primer 
CYP-5627-f  ATGGATCTGTTCCTTCCATCCC
T 
60.6 
 
Full-length primer 
CYP-5627-r  TTATTGGTAGAGCCTCCAAGG
CAA 
61 
 
Full-length primer 
CYP-74047-f  ATGGATTCCATAGCTCTACCC 57.9 
 
Full-length primer 
CYP-74047-r  TCAAGAAATTATTGGTGGAGG
ATAG 
58 
 
Full-length primer 
CYP-9893-f  ATGGATTGGATCAGTCAATTT
GGC 
59.3 
 
Full-length primer 
CYP-9893-r  TCAGAAGAGATTTGGCAGCAG
C 
60.3 
 
Full-length primer 
CYP-11511-
Hin-f  
ATAAGCTTACCATGGATTTCT
TCACTTCTCTCTC 57.1 HindIII 
Full-length primer 
CYP-11511-
Xba-r  
ATTCTAGATTCATACAGATGC
GGTGGC 56.7 XbaI 
Full-length primer 
CYP-11862-
Hin-f  
ATAAGCTTACCATGGATTCTC
TCTTTGCTTCAATTGC 60.1 HindIII 
Full-length primer 
CYP-11862-
Xba-r  
ATTCTAGAAACATAAGCATCG
TGAGACAATCG 59.3 XbaI 
Full-length primer 
CYP-2408-
Hin-f  
ATAAGCTTACCATGGCCGCCT
CGCTCACCT 63.1 HindIII 
Full-length primer 
CYP-2408-
Xba-r  
ATTCTAGAATTTGCAACAGCC
TCTAACATTTCAGAAG 62.4 XbaI 
Full-length primer 
CYP-27263-
Hin-f  
ATAAGCTTACCATGGCCGACA
AGTACGGCTCC 63.7 HindIII 
Full-length primer 
CYP-27263-
Xba-r  
ATTCTAGAGCCGTACAAATGA
GCTGGAAGCC 64.2 XbaI 
Full-length primer 
CYP-4471-
Hin-f  
ATAAGCTTACCATGCCTTCAC
TACTTATCTAC 54 XbaI 
Full-length primer 
CYP-4471-
Xba-r  
ATTCTAGATAAAAACTTTGTA
GCTACTAGACA 54.2 HindIII Full-length primer 
CYP-2114-
Hind-f  
ATAAGCTTACCATGGAGCTCC
TCCAAATGTTACC 60.6 HindIII 
Primer for fusion- 
PCR 
CYP-2114-f2  
AGGCTTTCCTTCTGGACATTTT
CTTAGCCG 72.3  
Primer for fusion- 
PCR 
CYP-2114-r1  
CGGCTAAGAAAATGTCCAGAA
GGAAAGCCT 72.3  
Primer for fusion- 
PCR 
CYP-2114-
Xba-r 
ATTCTAGAAACGGTTGGTACA
GGGTTGC 59.4 XbaI 
Primer for fusion- 
PCR 
CYP-2227-
Hind-f  
ATAAGCTTACCATGGAATGCT
CCTACTCCCAATT 58.9 HindIII 
Primer for fusion- 
PCR 
CYP-2227-f2  
AGGCCGTCATTCTCGATATAT
TTATTGCTG 68.5  
Primer for fusion- 
PCR 
CYP-2227-r1  
CAGCAATAAATATATCGAGAA
TGACGGCCT 68.5  
Primer for fusion- 
PCR 
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CYP-2227-
Xba-r 
ATTCTAGAGTGGTATGGGGTT
GGAATCAATTT 59.3 XbaI 
Primer for fusion- 
PCR 
CYP-3458-
Hind-f  
ATAAGCTTACCATGGAGAGG
AATATCAGAGCTTTC 59.3 HindIII 
Primer for fusion- 
PCR 
CYP-3458-f2  
AAGCGGTCACTTTGGAACTGT
TCATAGCTG 72.5  
Primer for fusion- 
PCR 
CYP-3458-r1  
CAGCTATGAACAGTTCCAAAG
TGACCGCTT 72.5  
Primer for fusion- 
PCR 
CYP-3458-
Xba-r 
ATTCTAGAAGCTGCCATGCCA
TCGTATAAAAT 59.3 XbaI 
Primer for fusion- 
PCR 
CYP-38991-
Hind-f  
ATAAGCTTACCATGGATATCA
TCATCTCCCACC 58.4 HindIII 
Primer for fusion- 
PCR 
CYP-38991-f2  
CAGGCTACCGCCATG 
TCTTTGATCGTGGCG 78  
Primer for fusion- 
PCR 
CYP-38991-r1  
CGCCACGATCAAAGA 
CATGGCGGTAGCCTG 78  
Primer for fusion- 
PCR 
CYP-38991-
Xba-r 
ATTCTAGAAAGTACTCCATAC
AACTCGGGA 58.4 XbaI 
Primer for fusion- 
PCR 
CYP-5627-
Hind-f  
ATAAGCTTACCATGGATCTGT
TCCTTCCATCCC 60.3 HindIII 
Primer for fusion- 
PCR 
CYP-5627-f2  
CGATCATGGTACCGTTCACGC
TTTATAATT 68  
Primer for fusion- 
PCR 
CYP-5627-r1  
AATTATAAAGCGTGAACGGTA
CCATGATCG 68  
Primer for fusion- 
PCR 
CYP-5627-
Xba-r 
ATTCTAGATTGGTAGAGCCTC
CAAGGCAA 59.8 XbaI 
Primer for fusion- 
PCR 
CYP-74047-
Hind-f  
ATAAGCTTACCATGGATTCCA
TAGCTCTACCC 57.9 HindIII 
Primer for fusion- 
PCR 
CYP-74047-f2  
CAAAGCGGTTATTGGGGATGT
GTTTATTGC 70  
Primer for fusion- 
PCR 
CYP-74047-r1  
GCAATAAACACATCCCCAATA
ACCGCTTTG 70  
Primer for fusion- 
PCR 
CYP-74047-
Xba-r 
ATTCTAGAAGAAATTATTGGT
GGAGGATAGC 57.1 XbaI 
Primer for fusion- 
PCR 
CYP-11511-
Xba-rn  
ATTCTAGACTATTCATACAGA
TGCGGTGGC 56.7 XbaI 
Full-length reverse 
primer with stop 
codon 
CYP-11862-
Xba-rn  
ATTCTAGACTAAACATAAGCA
TCGTGAGACAATCG 59.3 XbaI 
Full-length reverse 
primer with stop 
codon 
CYP-2114-
Xba-rn  
ATTCTAGACTAAACGGTTGGT
ACAGGGTTGC 59.4 XbaI 
Full-length reverse 
primer with stop 
codon 
CYP-2227-
Xba-rn  
ATTCTAGACTAGTGGTATGGG
GTTGGAATCAATTT 59.3 XbaI 
Full-length reverse 
primer with stop 
codon 
CYP-2408-
Xba-rn  
ATTCTAGACTAATTTGCAACA
GCCTCTAACATTTCAGAAG 62.4 XbaI 
Full-length reverse 
primer with stop 
codon 
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CYP-27263-
Xba-rn  
ATTCTAGACTAGCCGTACAAA
TGAGCTGGAAGCC 64.2 XbaI 
Full-length reverse 
primer with stop 
codon 
CYP-3458-
Xba-rn  
ATTCTAGACTAAGCTGCCATG
CCATCGTATAAAAT 59.3 XbaI 
Full-length reverse 
primer with stop 
codon 
CYP-38991-
Xba-rn  
ATTCTAGACTAAAGTACTCCA
TACAACTCGGGA 58.4 XbaI 
Full-length reverse 
primer with stop 
codon 
CYP-4471-
Xba-rn  
ATTCTAGACTATAAAAACTTT
GTAGCTACTAGACA 
54.2 
XbaI 
Full-length reverse 
primer with stop 
codon 
CYP-5627-
Xba-rn  
ATTCTAGACTATTGGTAGAGC
CTCCAAGGCAA 59.8 XbaI 
Full-length reverse 
primer with stop 
codon 
CYP-74047-
Xba-rn  
ATTCTAGACTAAGAAATTATT
GGTGGAGGATAGC 57.1 XbaI 
Full-length reverse 
primer with stop 
codon 
 
Restriction sites are written in bold letters. Underlined nucleotides stand for the part of the 
primer corresponding to the sequence.  
6.2 Primers for CPR candidates 
Name Sequence (5’–3’) Tm 
[°C] 
Restriction 
site 
Comment 
CPR-4753-f ATGGACTCGTCCTCGTCTG 58.8 
 
Full-length primer 
CPR-4753-r  TTACCAAACGTCGCGCAGG 58.8 
 
Full-length primer 
CPR-5254-f   ATGGACTCGCCGTCTTCGT 58.8 
 
Full-length primer 
CPR-5254-r  TTACCATACGTCACGAAGGTAC 58.4 
 
Full-length primer 
CPR-5729-f  ATGAGTTCCAGCGGTCCGG 61 
 
Full-length primer 
CPR-5729-r  TCACCATACATCTCTAAGATAT
CGCC 
61.6 
 
Full-length primer 
CPR-66401-f  ATGAGTTCCAGCGGTCTGGA 59.4 
 
Full-length primer 
CPR-66401-r  TCACCATACATCTCTAAGATAC
CG 
59.3 
 
Full-length primer 
CPR-4753-
Not-f  
ATGCGGCCGCTCATGGACTCG
TCCTCGTCTG 
58.8 NotI Full-length primer 
CPR-4753-
Xba-r 
TATCTAGATTACCAAACGTCG
CGCAGG 
58.8 XbaI Full-length primer 
CPR-66401-
Kpn-f  
ATGGTACCCATGAGTTCCAGC
GGTCTGGA 
59.3 KpnI Full-length primer 
CPR-66401-
Xba-r  
TATCTAGATCACCATACATCTC
TAAGATACCG 
59.4 XbaI Full-length primer 
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Restriction sites are written in bold letters. Underlined nucleotides stand for the part of the 
primer corresponding to the sequence.  
6.3 Primers for SDH candidates 
Name Sequence (5’–3’) Tm 
[°C] 
Restriction 
site 
Comment 
SD-28880-f ATGGGCTCTGATATCTGTGCA
C 
60.3 
 
Full-length primer 
SD-28880-r  TCATGCTTCAGCGGAAGCGC 61.4 
 
Full-length primer 
SD-36067-f  ATGGCGGCAGCAGCACCAG 63.1 
 
Full-length primer 
SD-36067-r  TCATGAAGATCCATCTTCCGG
GTAATT 
61.9 
 
Full-length primer 
SD-5591-f  ATGGCCGCCACTAACTTCGTT
T 
60.3 
 
Full-length primer 
SD-5591-r  TCAAGCGAACCTCAAATCATC
AAAG 
59.7 
 
Full-length primer 
SD-73995-f  ATGTCTTCTTCCTACCAGCCG
G 
62.1 
 
Full-length primer 
SD-73995-r  TCAAGCACTCTTCAAACTACA
ACCG 
61.3 
 
Full-length primer 
SD-7665-f  ATGTCGAAGCTGGTCATGGGT
TCT 
62.7 
 
Full-length primer 
SD-7665-r  TCACTGGCTATTCCTTGGAGG
CAA 
62.7 
 
Full-length primer 
SD-28880-
Nde-f 
ATACATATGGGCTCTGATAT
CTGTGCACCCT 
64.6 NdeI Primer for fusion-
PCR 
SD-28880-1    GGCTCTGATATCTGTGCACCC
TCTGTCACCAAGACGCTAGA
AGGCAAAGT 
82 
 
Primer for fusion-
PCR 
SD-28880-f2  CTCTGTCACCAAGACGCTAGA
AGGCAAAGT 
73.3 
 
Primer for fusion-
PCR 
SD-28880-
Xho-r 
TACTCGAGTCATGCTTCAGC
GGAAGCGCCAAA 
64.4 XhoI Primer for fusion-
PCR 
SD-36067-
Nde-f 
ATACATATGGCGGCAGCAGC
ACCAGCTTCCTTTAT 
69.5 NdeI Primer for fusion-
PCR 
SD-36067-1   CAGCACCAGCTTCCTTTATCT
CCTCCGTCGCCAGAAGGCTG
GAAGGCAAA 
84 
 
Primer for fusion-
PCR 
SD-36067-f2  TCCTCCGTCGCCAGAAGGCTG
GAAGGCAAA 
81 
 
Primer for fusion-
PCR 
SD-36067-
Xho-r 
TACTCGAGTCATGAAGATCC
ATCTTCCGGGTAATTGAAGAT
C 
67.1 XhoI Primer for fusion-
PCR 
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SD-5591-
Nde-f 
ATACATATGGCCGCCACTAA
CTTCGTTTCTTCCATCATAAA
AAGGCTGGA 
57.1 NdeI Primer for fusion-
PCR 
SD-5591-f1  TCTTCCATCATAAAAAGGCTG
GAAGGCAAA 
70 
 
Primer for fusion-
PCR 
SD-5591-r1 CTCCCCGCCGGTACCATCACC
CTGGCGGCG 
87 
 
Primer for fusion-
PCR 
SD-5591-f2  CGCCGCCAGGGTGATGGTAC
CGGCGGGGAG 
87 
 
Primer for fusion-
PCR 
SD-5591-
Xho-r  
TACTCGAGTCAAGCGAACCT
CAAATCATCAAA 
57.6 XhoI Primer for fusion-
PCR 
SD-73995-
Nde-f  
ATACATATGTCTTCTTCCTAC
CAGCCGGCGGCGGCGAGTTC
TCACAGACT 
67.8 NdeI Primer for fusion-
PCR 
SD-73995-f1 GCGGCGGCGAGTTCTCACAG
ACTAGAAGGCAAGGTGGCAG
T 
84 
 
Primer for fusion-
PCR 
SD-73995-
Xho-r  
TACTCGAGTCAAGCACTCTT
CAAACTACAACCGCCG 
66.6 XhoI Primer for fusion-
PCR 
SD-7665-
Nde-f  
ATACATATGATGTCGAAGCT
GGTCATGGGTTCTTCCAGAG 
59.8 NdeI Primer for fusion-
PCR 
SD-7665-f1  TGGTCATGGGTTCTTCCAGAG
ATCTGGCGTT 
76 
 
Primer for fusion-
PCR 
SD-7665-r1  AGCTTCCTGCTGGTTTCATTG
CCACTTGCA 
76 
 
Primer for fusion-
PCR 
SD-7665-f2  TGCAAGTGGCAATGAAACCA
GCAGGAAGCT 
76 
 
Primer for fusion-
PCR 
SD-7665-
Xho-r  
TACTCGAGTCACTGGCTATTC
CTTGGAGG 
59.1 XhoI Primer for fusion-
PCR 
SD-28880-
Hin-f  
ATAAAGCTTACCATGGGCTC
TGATATCTGTGCACC 
62.4 HindIII Full-length primer 
SD-28880-
Xba-r 
ATTCTAGATGCTTCAGCGGA
AGCGCCAAA 
61.8 XbaI Full-length primer 
SD-36067-
Hin-f  
ATAAAGCTTACCATGGCGGC
AGCAGCACCAGCTT 
65.8 HindIII Full-length primer 
SD-36067-
Xba-r 
ATTCTAGATGAAGATCCATC
TTCCGGGTAATTGAAG 
63.7 XbaI Full-length primer 
SD-5591-
Hin-f  
ATAAAGCTTACCATGGCCGC
CACTAACTTCGTTTCTT 
63 HindIII Full-length primer 
SD-5591-
Xba-r  
ATTCTAGAAGCGAACCTCAA
ATCATCAAAGATCG 
61.6 XbaI Full-length primer 
SD-73995-
Hin-f  
ATAAAGCTTACCATGTCTTCT
TCCTACCAGCCGGC 
64.2 HindIII Full-length primer 
SD-73995-
Xba-r  
ATTCTAGAAGCACTCTTCAA
ACTACAACCGCCG 
64.6 XbaI Full-length primer 
SD-7665-
Hin-f  
ATAAAGCTTACCATGTCGAA
GCTGGTCATGGGTTCTT 
63 HindIII Full-length primer 
SD-7665-
Xba-r  
ATTCTAGACTGGCTATTCCTT
GGAGGCAACC 
64.2 XbaI Full-length primer 
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SD-28880-
Xba-rn 
ATTCTAGACTATGCTTCAGCG
GAAGCGCCAAA 
62.8 XbaI Full-length primer 
SD-36067-
Xba-rn 
ATTCTAGACTATGAAGATCC
ATCTTCCGGGTAATTGAAG 
63.9 XbaI Full-length primer 
SD-5591-
Xba-rn 
ATTCTAGACTAAGCGAACCT
CAAATCATCAAAGATCG 
62.1 XbaI Full-length primer 
SD-73995-
Xba-rn 
ATTCTAGACTAAGCACTCTTC
AAACTACAACCGCCG 
64.8 XbaI Full-length primer 
SD-7665-
Xba-rn 
ATTCTAGACTACTGGCTATTC
CTTGGAGGCAACC 
64.8 XbaI Full-length primer 
Restriction sites are written in bold letters. Underlined nucleotides stand for the part of the 
primer corresponding to the sequence.  
6.4 Primers for PLR candidates 
Name Sequence (5’–3’) Tm 
[°C] 
Restriction 
site 
Comment 
PLR-10318-
Nde-f    
ATACATATGGGTTCCCTGGG
GAAAG   
58.8 NdeI Full-length primer 
PLR-10318-
Xho-r  
TACTCGAGCTAGATGTAAC
GCTTTAGATATTCCT 
58.5 XhoI Full-length primer 
PLR-G280Y-f CGTGATAATAGTGCGTCAGA
TAAACTTGCTGTGCATAATT
TGCTTCTCTC 
79.4  Primer for site-
directed mutagenesis 
PLR-G280Y-r GAGAGAAGCAAATTATGCA
CAGCAAGTTTATCTGACGCA
CTATTATCACG 
79.4  Primer for site-
directed mutagenesis 
PLR-Y284G-f CTCGTAACACACGTGATAAC
CGTGCGTCAGTCCAACTTGC 
79.1  Primer for site-
directed mutagenesis 
PLR-Y284G-r GCAAGTTGGACTGACGCACG
GTTATCACGTGTGTTACGAG 
79.1  Primer for site-
directed mutagenesis 
Restriction sites are written in bold letters. Underlined nucleotides stand for the part of the 
primer corresponding to the sequence.  
7. Culture media 
7.1 MS-Lf 
MS-Lf medium is a modification of the MS medium according to Murashige & Skoog (1962). 
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MS macro elements (25x): 
KNO3  190 g/l 
MgSO4 x 7 H2O  37 g/l 
KH2PO4 x H2O 17 g/l 
CaCl2 x 2 H2O 44 g/l 
NH4NO3  165 g/l 
This solution is autoclaved after preparation. 
MS microelements (100x): 
H3BO3  620 mg/l 
ZnSO4 x 7 H2O  860 mg/l 
MnSO4 x H2O  1690 mg/l 
KI  83 mg/l 
Na2MoO4 x H2O  25 mg/l 
CuSO4 x 5 H2O  2.5 mg/l 
CoCl2 x 6 H2O  2.5 mg/l 
FeSO4 x 7 H2O  2.78 g/l 
Na2 x EDTA  3.37 g/l 
This solution is autoclaved after preparation. 
Vitamin solution: 
Thiamine dichloride 1 mg/ml; pyridoxine x HCl and nicotinic acid each 5 mg/ml 
1-Naphthalenacetic acid stock solution (NAA): 
20 mg NAA were dissolved in an Eppendorf tube in 1 ml pure ethanol and added to 80 ml 
water. The solution was then made up to exactly 100 ml in a volumetric flask. The stock 
solution was stored at 4 °C. 
Indole-3-acetic acid solution (IAA): 
50 mg IAA were initially pre-dissolved in 1 ml pure ethanol, added to 80 ml water and then 
made up to 100 ml. The stock solution was stored at 4 °C. 
Benzylaminopurine solution (BAP): 
20 mg BAP were dissolved in an Eppendorf tube in 1 ml warm 0.5 M HCl and then added with 
stirring to about 80 ml water. It was then made up to 100 ml in a volumetric flask. The stock 
solution was stored at 4 °C. 
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Composition of 1 l MS-Lf: 
Solution of macroelements  40 ml 
Solution of microelements  10 ml 
Sucrose 40 g 
Myo-inositol 100 mg 
Glycine solution (200 mg/100 ml) 1 ml 
vitamin solution 1 ml 
IAA solution 2 ml 
BAP solution 5 ml 
The pH of the medium was adjusted to 5.9 with 0.5 M KOH and the medium was autoclaved 
after preparation. 
 
7.2 Lysogeny Broth (LB) 
LB is the standard medium for the cultivation of bacteria such as Escherichia coli (Bertani, 
1951).  
Composition of 1 l LB: 
Tryptone / peptone  10 g 
Yeast extract  5 g 
NaCl  10 g 
± Agar  10 g 
 
The solution was adjusted with 0.5 M NaOH to pH 7.0 and autoclaved. 1% agar was added 
additionally to produce solid medium for plates.  
 
7.3 Super Optimal broth with catabolite repression (SOC) 
SOC medium is a nutritious bacterial growth medium that is adjusted from the LB medium. It 
provides a higher transformation efficiency. Hence, it was used to regenerate bacteria after heat 
shock (Hanahan, 1983).  
Composition of 1 l SOC: 
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Tryptone / peptone  20 g 
Yeast extract  5 g 
NaCl  0.5 g  
 
The solution was adjusted with 1 M NaOH to pH 7.0 and autoclaved. Then sterile solutions of 
1 M glucose (20 ml), 1 M KCl (2.5 ml), 1 M MgCl2 (10 ml) were added. 
 
7.4 Yeast extract Peptone Dextrose medium (YPD) 
This specially adapted medium was used for S. cerevisiae cell lines for simple cultivation 
purposes. It aimed to increase the cell mass of precultures.  
Composition of 1 l YPD: 
Tryptone / peptone  20 g 
Yeast extract  10 g 
Glucose  20 g 
± Agar  20 g 
Agarose was added only to make solid medium for plates. In order to prevent possible heat-
induced degradation processes, the glucose solution was filter-sterilised and added after 
autoclaving. YPD media and plates were stored at 4 °C in the dark. 
 
7.5 SC and SC+ medium 
SC+ is a variant of Synthetic Complete Minimal Defined Medium (SC). SCD / SCG / SC+G 
(synthetic glucose or galactose) medium was used for expression of recombinant S. cerevisiae 
strains. The SCD was used mainly for the accumulation of biomass in precultures and the 
galactose-containing SCG / SC+G medium for induction.  
The amino acid and nucleobase composition for media omit uracil explicitly was used to 
produce selective medium for growing pYes2/NT C transformants. The following amino acid 
and nucleobase mixture was used: 
1 g each: adenine, arginine, cysteine, leucine, lysine, threonine, tryptophan 
0.5 g each: aspartic acid, histidine, isoleucine, methionine, phenylalanine, proline, serine, 
tyrosine, valine 
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Composition of 1 l SCD:  
Yeast Nitrogen Base   6.7 g 
Glucose  20 g 
Amino acid mix 1.15 g 
± Agar   20 g 
 
Composition of 1 l SCG: 
Yeast Nitrogen Base   6.7 g 
Galactose 20 g 
Amino acid mix 1.15 g 
± Agar   20 g 
 
Composition of 1 l SC+G: 
Yeast Nitrogen Base   6.7 g 
Galactose 20 g 
Amino acid mix 1.15 g 
± Agar   20 g 
Ammonium iron (II) sulfate 28 mg 
5-Aminolevulinic acid 75 mg 
 
Agar was added only to make solid medium for plates. 100 ml of 200 g/L filter-sterilised 
glucose or galactose were added later to 900 ml of the pre-cooled medium. Plates and media 
were stored at 4 °C. 
 
8. Buffers and solutions 
Uses Buffers and solutions Components Concentration 
Agarose gel 
electrophoresis 
1x TAE buffer  
TRIS 40 mM 
Acetic acid 20 mM 
Na2-EDTA 1 mM 
6x loading buffer  
Bromophenol blue 0.03% 
Xylene cyanol  0.03% 
Glycerol 60% 
EDTA  60 mM  
Genomic DNA 
extraction 
2x CTAB  
Cetyltrimethylammonium-
bromide   
2% w/v 
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TRIS-HCl, pH 8 100 mM 
EDTA 20 mM 
NaCl 1.4 M 
Polyvinylpyrrolidone MW 
40000 
1% w/v 
10x CTAB  
Cetyltrimethylammonium-
bromide   
10% w/v 
NaCl 0.7 M 
CTAB precipitation 
buffer  
Cetyltrimethylammonium-
bromide   
1% w/v  
TRIS-HCl, pH 8 50 mM 
EDTA 10 mM 
High Salt TE  
TRIS-HCl, pH 8 10 mM  
EDTA 1 mM  
NaCl 1 M  
Isolation of 
microsomes  
Microsome buffer 1 (for 
cytochrome P450) 
TRIS-HCl, pH 7.5 0.1 M 
Dithiothreitol 1 mM 
Diethyldithiocarbamate 1 mM 
Microsome buffer 2 (for 
cytochrome P450 
reductase) 
TRIS-HCl, pH 7.6 0.5 M 
Dithiothreitol 1 mM 
Diethyldithiocarbamate 1 mM 
Isolation of 
recombinant 
proteins 
Breaking buffer  
KH2PO4/K2HPO4 buffer, pH 
7.4 
50 mM 
Glycerol  5% 
Phenylmethylsulfonyl 
fluoride 
1 mM  
His-tag binding buffer 
KH2PO4/K2HPO4 buffer, pH 
8.0 
50 mM  
NaCl 300 mM  
Imidazole 10 mM 
Wash buffer 
KH2PO4/K2HPO4 buffer, pH 
8.0 
50 mM  
NaCl  300 mM 
Imidazole  20 mM 
Elution buffer  
KH2PO4/K2HPO4 buffer, pH 
8.0 
50 mM  
NaCl  300 mM 
Imidazole  250 mM 
 Plasmid 
preparation 
Buffer P1 
TRIS-HCl, pH 8.0 50 mM  
EDTA 10 mM 
RNase A 100 μg/ml 
Buffer P2  
NaOH 200 mM  
SDS 1% 
Buffer N3  
Guanidine-HCl 4.2 M  
Potassium acetate, pH 4.8 0.9 M  
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Buffer PB   
Guanidine-HCl 5 M  
Isopropanol 30% 
Buffer PE 
TRIS-HCl, pH 7.5 10 mM  
Ethanol  80% 
RNA 
extraction 
Solution D 
Guanidinium thiocyanate 
solution 
4 M 
Citrate buffer, pH 7.0 25 mM 
Lauryl sarcosine 0.50% 
SDS-PAGE SDS running buffer  
Glycine 192 mM 
TRIS-HCl, pH 8.3 25 mM 
SDS  0.10% 
Transformation 
of yeast 
TE buffer  
TRIS-HCl 10 mM  
Na2-EDTA, pH 8.0 1 mM  
Western Blot 
TBS buffer 
TRIS-HCl, pH 7.4 10 mM  
NaCl  0.90% 
TBS-T buffer  
TRIS-HCl, pH 7.4 10 mM 
NaCl  0.90% 
Tween 20 0.05% 
Washing buffer  
KH2PO4/K2HPO4 buffer, pH 
8.0 
50 mM  
NaCl  300 mM 
Imidazole 20 mM  
Western Blot transfer 
buffer  
TRIS-HCl, pH 8.3 25 mM 
Glycine 192 mM 
MeOH 20% 
Western Blot substrate 
buffer  
TRIS-HCl, pH 9.5 100 mM 
NaCl  100 mM  
MgCl2  5 mM 
 
9. Bioinformatic tools 
Bioinformatic tool Web address 
Blastp  http://blast.ncbi.nlm.nih.gov 
Blastx  http://blast.ncbi.nlm.nih.gov 
Clustal Omega https://www.ebi.ac.uk/Tools/msa/clustalo/ 
ExPASy translate https://web.expasy.org/translate/ 
ExPASy-Compute pI/Mw https://web.expasy.org/compute_pi/ 
Oligo Calc https://www.eurofinsgenomics.eu/ 
ORF Finder http://www.bioinformatics.org 
PSI- and PHI-BLAST https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi 
Phyre2 Investigator http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index 
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V. Methods 
1. Cultivation of suspension cultures 
As a basis for this investigation, Linum flavum was available as a suspension culture. The 
cultures were inoculated every two weeks under the sterile bench into fresh MS-Lf medium. 5 
g of cells were transferred with a perforated spoon into 50 ml medium. The cultures were 
shaken on an orbital shaker (150 rpm) at 25 °C to supply the cells with O2. 
2. Molecular biology 
2.1 Genomic DNA (gDNA) extraction 
The isolation of genomic DNA was carried out according to a modified protocol of Rogers and 
Bendich (1985).  
The cells were separated from the medium via a Büchner funnel and then pulverised in liquid 
nitrogen. 200 mg of this powder was mixed in a 1.5 ml reaction tube with 300 µl pre-warmed 
(65 °C) 2x CTAB and incubated at 65 °C for 10-30 minutes, then chilled on ice for 5-30 
minutes. After the addition of 300 μl chloroform and vigorous shaking, the cells were 
centrifuged at 16000 g for 5 minutes. The aqueous supernatant from the extraction was pipetted 
into a new tube with 30 μl pre-warmed (65 °C) 10x CTAB, mixed with 300 μl chloroform and 
again centrifuged for 5 minutes at 16000 g. After that, 250 μl of the aqueous supernatant was 
mixed in a new tube with 250 μl CTAB precipitation buffer and centrifuged for 5 minutes at 
16000 g and the liquid discarded. The pellet was gently resuspended in 200 μl High Salt TE, 
then mixed with 400 μl 96% ethanol and precipitated at -20 °C for 15 minutes. After 
centrifugation for 15 minutes at 16000 g, the pellet was washed with 70% ethanol and air-dried. 
The gDNA was re-dissolved in 20-50 μl water and remaining RNA digested with 0.75 μl RNase 
H for 15-30 minutes at 37 °C. Subsequently, the concentration and purity of the DNA were 
measured photometrically. 
 
2.2 RNA extraction 
Total RNA from fresh leaves and suspension cultures of Linum flavum was prepared by using 
a phenol-chloroform extraction according to Chomczynski and Sacchi (1987). 
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All materials required for RNA extraction were autoclaved twice or heated to 200 °C for 2 
hours. The cells were separated from the medium via a Büchner funnel and the cells or leaves 
were frozen in liquid nitrogen and then finely ground in a mortar. All material was kept cold 
to prevent any enzymatic activity that could destroy the RNA. About 50 mg of this powder was 
mixed with 500 µl Solution D and incubated at room temperature. The solution was mixed 
gently after addition of 50 μM 2 M sodium acetate pH 4. Thereafter, 500 μl phenol saturated 
with citrate buffer pH 2 and 100 μl ice-cold chloroform were added. The reaction tube was 
mixed for 10 seconds and incubated at 4 °C for 15 minutes. Subsequently, the tube was 
centrifuged for 15 minutes at 12000 g and 4 °C. 400 μl of the supernatant was transferred to a 
new tube and mixed with the same volume of ice-cold isopropanol. The RNA was precipitated 
by incubation at -20 °C for at least 20 minutes. Afterwards, the samples were centrifuged for 
10 minutes at 12000 g and 4 °C. The supernatant was then removed and the pellet was washed 
twice with ethanol (70% and 100%). The pellet was dried at 37 °C and dissolved with 20 µl 
water at 50 °C. The amount of RNA and the purity were measured photometrically, the integrity 
was monitored on an agarose gel. The RNA was kept at -20 °C. Samples containing a high 
amount (> 500 ng μl-1) of pure RNA (ratio 260/280 nm > 1.6) were selected for further 
experiments. 
 
2.3 cDNA synthesis 
The cDNA was synthesized by using the RevertAid First Strand cDNA Synthesis Kit. 
1 μg RNA and 1 µl Oligo(dT)18 primers were incubated at 65 °C for 5 min with sterile H2O in 
a total volume of 12 μl and then cooled on ice. Subsequently, 4 μl of the 5x reaction buffer, 1 
μl Ribolock RNase inhibitor and 2 μl 10 mM dNTP mix were added. The mixture was 
incubated for 5 minutes at 37 °C and 1 μl RevertAid reverse transcriptase was added. 
Thereafter, the mixture was incubated at 42 °C for one hour. The reaction was stopped by 
heating for 5 min at 70 °C. The cDNA was stored at -20 °C. 
 
2.4 PCR 
2.4.1 Standard PCR with GoTaq® polymerase 
The standard PCR with GoTaq® polymerase was used to amplify the candidate-genes from 
cDNA or gDNA of Linum flavum. The primers were designed based on the sequences of 
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candidate-RNA in Linum flavum, which is available on the website 
http://www.medplantrnaseq.org/. The standard PCR had a total volume of 25 µl and was 
composed as below: 
Template (cDNA or gDNA) 
GoTaq® buffer (5x) 
dNTP mix (10 mM) 
MgCl2 (25 mM) 
Primer forward (100 µM) 
Primer reverse (100 µM) 
GoTaq® polymerase 
Dist. H2O 
1.0 µl 
5.0 µl 
0.5 µl 
3.0 µl 
0.5 µl 
0.5 µl  
0.1 µl 
14.4 µl 
 
The PCR cycles were the following: 
1st cycle:  94 °C, 120 sec / Annealing temperature, 60 sec / 70 °C, 90 sec  
2nd - 39th cycle: 94 °C, 30 sec / Annealing temperature, 60 sec / 70 °C, 90 sec  
40th cycle:  94 °C, 60 sec / Annealing temperature, 60 sec / 70 °C, 10 min  
End:   cooling at 4 °C. 
Annealing temperature was usually chosen at Tm - 5 °C. Tm (the melting point of primers) was 
calculated with a bioinformatic tool on the Eurofins® website.  
Agarose gel electrophoresis (see V.2.5) was used to analyse the product of the PCR. Products 
of the expected size were cut out and purified via gel extraction (as described in V.2.6). 
 
2.4.2 PCR with Phusion® High-Fidelity DNA polymerase  
The PCR was performed with a Phusion® High-Fidelity DNA polymerase to avoid replication 
errors due to proofreading activity. PCR reactions were composed as follows: 
HF buffer + MgCl2 (5x)  
dNTP Mix (10 mM) 
Primer forward (100 µM) 
Primer reverse (100 µM) 
Template 
Phusion® High-Fidelity DNA polymerase 
Dist. H2O 
5 µl 
1 µl 
0.5 µl 
0.5 µl 
1 µl 
0.25 µl 
ad 25 µl 
 
The PCR cycles were the following: 
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1st cycle:  98 °C, 30 sec / Annealing temperature, 30 sec / 72 °C, 30 sec  
2nd - 39th cycle: 98 °C, 10 sec / Annealing temperature, 30 sec / 72 °C, 30 sec  
40th cycle:  98 °C, 10 sec / Annealing temperature, 30 sec / 72 °C, 10 min  
End:   cooling at 4 °C. 
 
The PCR products were analysed by agarose gel electrophoresis (see V.2.5). The products of 
expected size were cut out and purified by gel extraction (as described in V.2.6). 
 
2.4.3 Fusion-PCR 
Fusion-PCR was used for the in vitro removal of introns from genomic DNA to generate a full-
length continuously coding sequence when the genes of interest could not be amplified 
successfully from complementary DNA. Prior to designing the primers, it is important to define 
the boundaries for each exon and intron. The two outer (sense and antisense) primers contain 
restriction enzyme recognition sites, which are important for the ligation into an expression 
plasmid. The internal primers are constructed to span the fusion point between two adjacent 
exon fragments. All internal primers were 30 nucleotides in length to ensure that primers bind 
specifically to the target region of gDNA and include an exon. The first half of internal forward 
primers were identical to the last 15 nucleotides of an upstream exon and the second half 
corresponded to the first 15 nucleotides of a downstream exon. The inverse internal primers 
were the reverse complement sequences of the respective forward primers.  
A first-round amplification is used to generate different exon fragments. The PCR was 
performed with a Phusion® High-Fidelity DNA polymerase to avoid replication errors. PCR 
reactions were composed as follows: 
HF buffer + MgCl2 (5x)  
dNTP Mix (10 mM) 
Primer forward (100 µM) 
Primer reverse (100 µM) 
Template 
Phusion® High-Fidelity DNA Polymerase 
Dist. H2O 
5 µl 
1 µl 
0.5 µl 
0.5 µl 
1 µl 
0.25 µl 
ad 25 µl 
  
The PCR cycles were the following: 
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1st cycle:  98 °C, 30 sec / Annealing temperature, 30 sec / 72 °C, 30 sec  
2nd - 39th cycle: 98 °C, 10 sec / Annealing temperature, 30 sec / 72 °C, 30 sec  
40th cycle:  98 °C, 10 sec / Annealing temperature, 30 sec / 72 °C, 10 min  
End:   cooling at 4 °C. 
 
The PCR products were separated by agarose gel electrophoresis (see V.2.5). The products of 
expected size were cut out and purified via gel extraction (see V.2.6). After purification and 
determination of product concentrations, the first-round PCR products were diluted to the same 
concentration and used as a template in a second-round amplification. A second-round of 
fusion-PCR used only the outermost sense and antisense oligonucleotide primers. PCRs were 
set up to contain the following components:  
HF buffer + MgCl2 (5x)  
dNTP Mix (10 mM) 
Primer forward (100 µM) 
Primer reverse (100 µM) 
Template 1 (exon 1) 
Template 2 (exon 2) 
Phusion® High-Fidelity DNA Polymerase 
Dist. H2O 
5 µl 
1 µl 
0.5 µl 
0.5 µl 
0.5 µl 
0.5 µl 
0.25 µl 
ad 25 µl 
  
The second round of fusion-PCR was set up in an identical protocol to that employed for the 
first-round amplification. 
The PCR products were separated by agarose gel electrophoresis (see V.2.5). The distinct PCR 
products were excised and purified from agarose gel (see V.2.6). After purification, the 
products were ligated into pDrive (as described in V.2.7.1) and sequenced before being used 
in further experiments to determine the function of the candidate genes. 
 
2.4.4 Colony-PCR 
Colony-PCR is a convenient method for confirmation of the successful transformation of yeast 
expression cell lines. The colony that was later used for expression was picked from the agar 
plate and suspended in 100 μl 200 mM LiAc, 1% SDS solution and incubated for 5 minutes at 
70 °C. 300 μl 96% EtOH were added and mixed vigorously for further purification. Afterwards, 
the preparation was centrifuged at 15000 g for 3 min and the resulting pellet was washed in 
70% EtOH. After drying, it was resuspended in 50 µl H2O and centrifuged for 15 s at 15000 g. 
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The supernatant was then used as template for a standard PCR reaction with specific primers 
for the respective candidate genes. The verified colonies were inoculated in 2 ml SCD medium 
in test tubes for 36 hours at 30 °C and mixed with glycerol (ratio 1:1) then stored at -70 °C for 
further expression analysis. 
 
2.5 Agarose gel electrophoresis 
0.7% agarose gels were used for the separation of DNA and RNA as a matrix. 1.4 g agarose 
was dissolved in 200 ml 1x TAE buffer by heating in a microwave oven. Approximately 50 ml 
were filled into a suitable gel tray with a slot-forming comb. 0.7 µl 1% ethidium bromide 
solution was added to the gel and mixed well. The samples were mixed with 6x loading buffer 
and applied to the slots of the gel. The size marker was the GeneRuler DNA Ladder Mix from 
Thermo Fisher Scientific with a size range of 100 to 10,000 bp. The RNA or DNA mixtures 
were separated with 220 V. The run was terminated when the lower dye band (bromophenol 
blue) had reached 2/3 of the gel. The photographic documentation was done digitally using 
blue-green LED light and an amber filter. 
 
2.6 Purification of DNA fragments from agarose gels 
The bands containing a DNA fragment with the correct calculated length were excised 
completely from the gel after gel electrophoresis. A NucleoSpin® Extract II kit was used for 
gel extraction and purification. 200 μl NT binding buffer per 100 mg of the gel was added to 
the gel and heated to 50 °C with shaking until liquefaction. The solution was completely 
centrifuged through a NucleoSpin® silica filter at 11000 g for one minute. The flow-through 
was discarded. The silica filter was washed with 700 μl buffer NT3. Subsequently, the silica 
filter was dried by centrifugation at 11000 g for 2 minutes. Elution was carried out with 15-50 
μl water and incubation for 2-5 minutes at room temperature. The eluate was collected in 
reaction tubes by centrifugation of the silica filter at 11000 g for one minute. The DNA 
concentration of the sample was measured photometrically. 
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2.7 Ligation 
2.7.1 UA-ligation 
UA- or TA-ligation is a simple way to incorporate inserts into vectors. It is based on the 
attachment of an adenine at the end of the PCR reaction of DNA polymerase type A to the 
finished strand. This adenine can interact with an overhanging thymine or uracil of the linear 
plasmid, hence facilitating the incorporation of the insert into the vector. The UA-ligation was 
performed with Qiagen's PCR cloning kit. 2 µl insert and 0.5 µl pDrive cloning vector were 
pipetted to 2.5 µl 2x ligation mix in a total volume of 5 µl and incubated at 4 °C overnight or 
at 19 °C for at least 2 hours. The ligation was then heated to 65 °C for 10-15 minutes, cooled 
and used for transformation. 
 
2.7.2 T4-ligation 
T4-ligation was performed with T4 DNA ligase and DNA fragments, which were previously 
cut by a restriction endonuclease. The ligase occurs naturally in the bacteriophage T4. The 
DNA fragment and plasmid were digested separately with the same restriction enzymes. 
Different restriction endonucleases used for the two restriction sites lead to a directional 
incorporation of the insert. The ligation mixture had a total volume of 10 μl.  
Plasmid  
T4 ligase buffer (10x)  
T4 DNA ligase  
DNA fragment solution 
1 μl 
1 μl 
1 μl 
7 μl 
The mixture was incubated for 20 hours at 4 °C. Subsequently, the reaction was stopped at 65 
°C for 10 minutes. 
 
2.8 Restriction enzyme digest 
Standard digestion was performed in 20 μl volume. The pipetting scheme described here was 
used: 
10x buffer  
Restriction enzyme 1 
Restriction enzyme 2 (optional) 
Water 
2 µl 
1 μl  
1 μl 
10 µl 
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DNA solution ad 20 µl 
The choice of final buffer concentration was dependent on the enzyme(s) used. It was aimed 
to maximise enzyme activity and exclude nonspecific digestion (star activity). The choice of 
enzyme followed the restriction sites in the gene or vector. The samples were incubated for 3 
hours at 37 °C. The digested DNA fragments and plasmid were analysed on an agarose gel, 
then purified on silica columns. 
When the confirmation of the presence of an insert in pDrive vector was needed, only 
restriction enzyme EcoRI was used and the total volume was cut in a half. A brief microwave 
heating of the preparation (30 seconds) was sufficient to detect bands after agarose gel 
electrophoresis. 
 
2.9 Site-directed mutagenesis 
In vitro site-directed mutagenesis was done according to instruction of Stratagene’s 
QuikChange® Site-Directed Mutagenesis Kit. It is a technique for carrying out gene 
modification and was used to make point mutations to switch amino acids. The site-directed 
mutagenesis method is performed using PfuTurbo® DNA polymerase and a temperature 
cycler. PfuTurbo® DNA polymerase replicates both plasmid strands with high fidelity and 
without displacing the mutant oligonucleotide primers. The  reaction was prepared as indicated 
below: 
10x reaction buffer 
dsDNA template (5-50 ng) 
Oligonucleotide primer 1 (125 ng) 
Oligonucleotide primer 2 (125 ng) 
dNTP mix (10 mM) 
PfuTurbo® DNA polymerase (2.5 U/μl) 
H2O 
5 µl 
1 μl   
1 μl 
1 μl 
1 μl 
1 μl 
ad 50 μl 
 
The temperature cycles were the following: 
1st cycle:  95 °C, 30 sec  
2nd - 18th cycle: 95 °C, 30 sec / 55 °C, 60 sec / 68 °C, 8 min  
End:   cooling at 4 °C. 
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The oligonucleotide primers, each complementary to opposite strands of the vector, are 
extended during temperature cycling by PfuTurbo® DNA polymerase. Incorporation of the 
oligonucleotide primers generates a mutated plasmid containing staggered nicks. Following 
temperature cycling, 1 µl of the Dpn I (10 U/µl) was added directly to each amplification 
product and incubated at 37°C for 1 hour. The DpnI endonuclease is specific for methylated 
and hemimethylated DNA and is used to digest the parental DNA template and to select for 
mutation-containing synthesized DNA.  
 
3. Genetic engineering 
3.1 Chemically competent E. coli cells 
E. coli strains EZ from Qiagen and SoluBL21 from AmsBio were used for the genetic 
engineering work. The EZ and SoluBL21 strains were propagated and made competent in the 
laboratory. EZ cells served to increase the number of plasmids and SoluBL21 to express 
proteins. 
Cells of the old batch are inoculated by means of a sterile toothpick in a test tube with 2 ml 
liquid LB medium with 2 μl tetracycline (12.5 mg/ml tetracycline in ethanol). The test tubes 
are closed with a lid and shaken overnight at 37°C and 220 rpm (overnight culture). The next 
morning, from a 250 ml Erlenmeyer flask with ~90 ml sterile LB + 90 μl tetracycline, 0.75 ml 
of solution was taken and used as a reference for the determination of optical density value at 
600 nm (OD600). 2 ml of the overnight culture are added into the Erlenmeyer flask and 
incubated at 37 °C, 220 rpm until an OD600 of 0.6 is reached. When the required OD600 is 
reached, the suspensions are centrifuged in two sterile 50 ml tubes for 10 minutes at 4 °C and 
3000 g. The supernatant was discarded and the pellet was resuspended in 10 ml cold sterile 100 
mM CaCl2 solution. The suspensions were combined and centrifuged for 12 minutes at 4 °C, 
2500 g. Again, the supernatant was then discarded and the pellet resuspended in 10 ml cold 
sterile 100 mM CaCl2 solution. The solution is incubated on ice for 20 minutes and 
recentrifuged (12 minutes, 4 °C, 2500 g). Finally, the supernatant was discarded and the cells 
were resuspended in 2 ml 100 mM sterile CaCl2 containing 15% glycerol. The bacteria were 
distributed to 150 µl in sterile 1.5 ml reaction tubes, pre-frozen in liquid nitrogen and stored at 
-80 °C. 
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3.2 Transformation of E. coli by heat shock 
Prior to the transformation, the LB agar plates were prepared. 100 ml solid LB medium was 
heated by microwave and mixed with 500 μl ampicillin (20 mg/ml in water, sterile-filtered), 
For transformation of E.coli EZ, 160 μl X-gal (50 mg/ml in dimethylformamide) and 50 μl 
IPTG (0.1 M in water, sterile-filtered), then poured into Petri-dishes. The plates containing 
approximately 7.5 ml of the mixture were cooled in a sterile bench.  
The competent cells were thawed on ice shortly before use. 70 μl of the bacterial suspension 
were pipetted into the reaction tubes with the vector and incubated on ice for 30 minutes. The 
cells were heat-shocked in a water bath at 42 °C for 90 seconds, followed by cooling on ice for 
1-2 minutes. 150 μl SOC medium was added to the preparation. The cells were regenerated in 
a Thermomixer® at 37 °C for 45 minutes. Subsequently, the mixture was spread on LB agar 
plates with a heat-sterilised Drigalski scoopula and cultured at 37 °C overnight. Clones 
containing pDrive could be selected via blue-white screening for integrated DNA fragments. 
 
3.3 Transformation of yeast strain INVScI 
The transformation of S. cerevisiae strains was carried out using the lithium acetate method 
according to Gietz and Schiestl (2002). Carrier DNA (fish sperm) in TE buffer (2 mg/ml) was 
dissolved by stirring at 4 °C for 1-2 hours. Prior to transformation, carrier DNA was heated to 
99 °C for 5 minutes and stored on ice. The plasmid DNA was diluted with dist. H2O to a 
concentration of 50 ng/µl. An amount of yeast cells (appr. 50 µl) was picked from a fresh YPD 
plate and transferred into a tube with 1 ml dist. H2O. The suspension was centrifuged at 3000 
g for 30 seconds and the supernatant was then removed. The following was pipetted onto the 
cell pellet: 
Polyethyleneglycol (50 % w/v)  
1 M lithium acetate  
Carrier DNA (2 mg/ml)  
Plasmid (50 ng/μl) 
240 μl 
36 μl 
50 μl 
34 μl 
The samples were incubated for 3 h at 42 °C, then centrifuged at 16000 g and resuspended in 
200 µl H2O. In the final step, the preparation was spread on SCD plates and incubated for 3-4 
days at 30 °C. When the S. cerevisiae cells were successfully transformed, colonies were 
streaked onto fresh SCD plates and checked for correct insertion by colony PCR. 
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3.4 Overnight cultures 
The grown E. coli colonies were propagated in overnight cultures. For this purpose, 20 μl 
ampicillin (20 mg/ml in water, sterile-filtered) were mixed with 4 ml LB in test tubes. A 
bacterial colony was picked using sterile toothpicks and placed in a tube. The tubes were 
cultured at 37 °C and 220 rpm overnight. Thereafter, plasmids were extracted from the cells by 
plasmid preparation (see 3.5).  
 
3.5 Plasmid preparation 
Plasmids were extracted from bacteria using Qiagen’s plasmid preparation method.  
3 ml bacterial suspension of the overnight cultures were centrifuged in two steps in 1.5 ml 
reaction tubes at 3000 g for 3 minutes. The supernatant was completely discarded. The cells 
were resuspended with 250 μl buffer P1, lysed with 250 μl buffer P2 and neutralised with 350 
μl buffer N3. The solution was centrifuged for 10 minutes at 16000 g. Thereafter, the 
supernatants were pipetted to QIAprep® spin columns and centrifuged for 1 min at 16000 g. 
The flow-through was then discarded. 500 μl buffer PB and 750 μl PE were sequentially 
centrifuged through the column for 30 seconds at 11000 g. The columns were dried by 
centrifugation for 1 minute (11000 g) and 40 μl water pipetted onto the column material. After 
incubation at room temperature for 2-5 minutes, the columns were centrifuged for 1 min at 
11000 g and the flow-through containing the plasmid-DNA was collected in 1.5 ml test tubes. 
The columns were washed with 500 μl water, centrifuged and stored for the next use.  
 
3.6 Sequencing and preparation of glycerol stocks 
The vectors obtained from plasmid preparation were subjected to a restriction digest in a total 
volume of 10 μl and the product was analysed by gel electrophoresis. The plasmid solutions 
were adjusted to a concentration of 80-100 ng/μl with a total volume of 12 μl in new reaction 
tubes and sent to Seqlab® for sequencing. From colonies with correct sequences, glycerol 
stocks were established. 425 µl liquid bacteria culture (overnight cultures) was mixed with 75 
µl sterile glycerol. The mixture was frozen in liquid N2 and stored at -80°C. 
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3.7 Expression of recombinant proteins 
3.7.1 E. coli SoluBL21 strains 
Vectors containing the open reading frame in the correct reading direction were used for the 
synthesis of heterologous proteins. These were introduced into E. coli SoluBL21 by heat-shock 
transformation. 2 ml LB with 10 µl ampicillin (20 mg/ml) was inoculated with a small aliquot 
of a frozen glycerol stock and incubated overnight at 37 °C and 220 rpm. The next day, 0.75 
ml sample was taken from 100 ml liquid LB medium supplemented with 100 µg/ml ampicillin 
for the photometric reference. The overnight culture was added to the remaining LB and 
cultured at 37 °C, 220 rpm to an OD600 of 0.5. Induction of protein expression was carried out 
with 100 μl 1 M IPTG (final concentration 1 mM) and the cells were incubated for 5 h at 28 
°C, 220 rpm. Afterwards, the cells were centrifuged for 5 min at 5000 g in 50 ml tubes and the 
supernatant discarded. The cells were frozen in liquid N2 and stored at -80 °C until further 
homogenisation and purification steps. 
 
3.7.2 S. cerevisiae InvSc1 strain 
Colonies of the INVSc1 strain containing the correct pYES2/NT C construct were inoculated 
and grown for 48 h at 30 °C in 10 ml SCD medium as preculture. These were further transferred 
to 140 ml SCG or SC+G medium in 1 L baffled flasks and shaken at 220 rpm and 30 °C for 24 
h to induce expression. The next day, the cells were collected by centrifugation at 1500 g for 5 
minutes at 4 °C. 
For the expression analysis, 1 ml of the expression culture was transferred to a 1.5 ml tube after 
0, 4, 8, 12 and 24 h. The OD600 of the expression cultures was measured photometrically. Cell 
pellets were collected by brief centrifugation and analysed for protein expression by SDS-
PAGE (see V.4.6). 
 
4. Enzymology 
4.1 Isolation of microsomes  
4.1.1 Isolation of microsomes from plant cell cultures 
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Cells of Linum flavum were cultured at 26 °C and permanent light on the shaker in MS-Lf 
medium. They were harvested with the help of a water jet pump through a Büchner funnel with 
filter paper. The fresh weight was determined and about 20% of this weight of Polyclar 10 was 
added. This is intended to bind phenolic substances and thus prevent the activity of protein-
inactivating phenolases. The mixture was ground in an ice-cooled mortar along with 1 ml 
microsome buffer 1 or 2 (see IV.8) per gram fresh weight. To separate the solid cell 
components, the batch was then centrifuged for 20 minutes at 4 °C and 8000 g. 1 M MgCl2 
solution was added dropwise to the supernatant up to a final concentration of 50 mM. This 
preparation was stirred for at least 20 minutes on ice. After a 20 min centrifugation at 48000 g, 
the supernatant was discarded and the microsomes were washed with 1 ml buffer and 
resuspended in up to 2 ml of the same buffer. Forming of membrane vesicles was facilitated 
by homogenisation of the suspension by a Potter-Elvehjem glass homogenizer. Up to about 6 
ml buffer was added before the suspension was used for determination of enzyme activities.  
 
4.1.2 Isolation of microsomes from yeast cells 
The yeast cells of 200 ml culture were successively transferred to 50 ml tubes and centrifuged 
for 5 minutes at 1500 g. After discarding the supernatant, they were resuspended in 27 ml 
microsome buffer 1 or 2 (see IV.8) and incubated for 5 min at room temperature. This was 
followed by another centrifugation step for 5 min at 1500 g. The supernatant was discarded. 
All subsequent steps were performed at 4 °C or on ice. The pellet was completely resuspended 
in 2.5 ml ice-cold microsome buffer. Disintegration was conducted by vigorous shaking in a 
benchtop homogeniser (Minilys®) at 4000 rpm for 30 seconds and then cooling on ice for 30 
seconds with 4 repetitions. Afterwards, the tubes were washed four times with 5 ml microsome 
buffer each and the respective supernatants collected in a fresh tube. To remove the cell debris 
and glass beads from the extract, another centrifugation step was carried out at 8000 g for 10 
min. 1 M MgCl2 solution was added slowly to the supernatant up to a final concentration of 50 
mM and stirred for 10 minutes. The preparation was centrifuged for 20 minutes at 48000 g, the 
supernatant was discarded and the microsomes were washed with 1 ml microsome buffer and 
resuspended in 2 ml of the same buffer. A Potter-Elvehjem glass homogenizer was used to 
facilitate the formation of membrane vesicles. The microsomes were used to determine the 
activities of heterologously expressed proteins. 
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4.2 Isolation of recombinant proteins 
4.2.1 E. coli strains (genetically modified) 
Proteins were synthesized by in E. coli SoluBL21 (see V.3.7.1). Afterwards, the bacterial 
cultures were successively transferred to 50 ml tubes and centrifuged at 4 °C for 5 minutes and 
3000 g. After discarding the supernatants, the pellet was frozen in liquid N2 and stored at -80 
°C. Thereafter, the cells were mixed with 0.1 M KH2PO4/K2HPO4 buffer pH 7.5 (4 ml per 1 g 
pellet) and thawed on ice for 30 minutes. The cells were homogenised three times with an 
ultrasonic processor on ice. The intensity setting was 100%, the amplitude 0.3 for 60 seconds 
each. The suspension was then centrifuged for 10 minutes at 4 °C and 6000 g. The supernatant 
containing heterologous proteins was used for purification by metal chelate chromatography. 
 
4.2.2 Saccharomyces cerevisiae strain (genetically modified) 
Proteins were synthesised in S. cerevisiae InvSc1 for 24 hours. The cultures were transferred 
successively into 50 ml tubes and centrifuged at 4 °C for 5 min at 1500 g. The cell pellet was 
frozen in liquid N2 and stored at -80 °C. For disintegration, the cells were resuspended in 1 ml 
breaking buffer per 1 g cell pellet, thawed on ice and centrifuged for 5 min at 4 °C, 1500 g. 
Subsequently, the supernatant was discarded and the pellet was resuspended in the breaking 
buffer (1 ml/g) and the same volume of acid-washed glass beads (~ 0.5 mm ø) added. 
Disintegration was done by vigorous shaking in a benchtop homogeniser (Minilys®) at 4000 
rpm for 30 seconds, followed by cooling on ice for 30 seconds and 2-3 repetitions. Thereafter, 
the suspensions were centrifuged for 10 min at 4 °C, 13000 g. The supernatant containing 
heterologous protein was transferred to fresh tubes.  
 
4.3 Purification of histidine-tagged proteins 
A fusion protein formed with an artificially added histidine hexamer can be purified by affinity 
chromatography. The histidine tag can be located either at the N- or C-terminal end of the 
target.  
1 ml of the suspended nickel-NTA column material was pipetted into plastic columns and 
washed several times with water. 1 ml of His-tag binding buffer (see IV.8) was added to the 
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column material and the nickel-NTA equilibrated for 30 min and then drained. 500 mM KPi, 
3 M NaCl, 100 mM imidazole pH 8.0 in a 1:10 ratio was mixed with the protein sample and 
the column material. The column was then closed, covered in ice, and gently rocked for one 
hour. Thereafter, the liquid was drained and 2-3 drops were taken for the SDS-PAGE. The 
column material was then washed six times with 2 ml washing buffer (see IV.8). Aliquots of 
the washing fractions were collected for further SDS-PAGE analysis. Thereafter, the bound 
protein was eluted three times with 1 ml elution buffer each (see IV.8). These fractions were 
combined and desalted via PD-10 columns (see V.4.4). 
 
4.4 Desalting via PD-10 columns 
The desalting of samples was done with PD-10 columns based on the manufacturer’s 
instructions (GE Healthcare). Depending on expressed proteins, 25 ml of the specific buffer 
that was used later in the enzyme assays were used to equilibrate the PD-10 columns, followed 
by addition of 2.5 ml protein solution and discarding the flow-through. Thereafter, the PD-10 
column was eluted with 3.5 ml buffer and the eluate was collected. The columns were then 
washed with 25 ml water and stored in the refrigerator until further use. The protein fraction 
was aliquoted and frozen at -80 °C. 
 
4.5 Determination of protein concentration 
The method according to Bradford (1976) was used to determine the protein concentration in 
the individual samples. This is a colorimetric method in which the dye Coomassie Brilliant 
Blue G-250 is bound to the proteins in an acidic environment. The dye binds non-specifically 
to cationic and nonpolar, hydrophobic side chains of the proteins. This shifts the absorption 
maximum of the dye from 465 to 595 nm (Stoscheck, 1990). At this wavelength, the absorption 
of the samples can be measured. When the absorption is compared to bovine serum albumin 
(BSA, fraction V) standard (adjusted to 1 mg protein/ml) and a reference with buffer instead 
of protein solution, the protein concentration can be calculated. 
The Bradford reagent is composed as follows: 
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Coomassie Brilliant Blue G-250  100 mg 
96% Ethanol 50 ml 
85% Phosphoric acid 100 ml 
Dist. water 850 ml   
This solution must be filtered twice to remove the suspended particles. 
The assay for determining the protein concentration is made up as follows:  
 
10 µl buffer as a reference (usually 0.1 M Tris-HCl pH 7.5) 
or  10 µl BSA standard 1 mg/ml 
or  10 µl crude protein (also diluted)  
2 ml Bradford reagent 
 
These preparations were incubated for 15 minutes at room temperature and then measured at 
595 nm against the reference in the photometer. 
 
4.6 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was performed according to Lämmli (1970). The proteins are denatured and form 
a negatively charged protein-SDS complex. This complex moves differently in an electric field 
depending on the molecular weight.  
The discontinuous SDS gel consisted of a (lower) separating gel and a (top) collecting gel. The 
polymerization takes place by a radical reaction mechanism. The polymerization initiator 
ammonium persulphate (APS), together with tetramethylethylenediamine (TEMED) as a 
catalyst, leads to the polymerization of the acrylamide/bisacrylamide (37.5 : 1) mixture.  
 Pipetting scheme for two separating gels: 
  
 
 
After filling the gel between the glass plates, the surface was overlaid with 400 μl n-butanol. 
This was completely removed before adding the stacking gel. 
Pipetting scheme for two stacking gels: 
TRIS-HCl-buffer pH 8.8, 1.5 M   
(Bis-)/Acrylamide (30 %)   
Dist. H2O   
SDS (10 %)  
TEMED  
APS (10 %)    
2.50 ml 
4.10 ml 
2.9 ml 
400 µl  
16 µl   
70 µl 
61 
 
TRIS-HCl-buffer pH 6.8, 0.5 M 
(Bis-)/Acrylamide (30 %) 
Dist. H2O 
SDS (10 %) 
TEMED 
APS (10 %) 
1.25 ml 
0.75 ml 
2.80 ml 
200 µl 
10 µl 
40 µl 
 
The stacking gel was layered over the separating gel and a comb for pockets added. After 
complete polymerisation, the comb was removed and the glass plates containing the gel were 
fixed in the electrophoresis chamber and the buffer tank was filled with running buffer (see 
IV.8). 15 µl of the protein solutions was mixed with 5 μl 4x Roti®-Load sample buffer, heated 
at 95 °C for 10 minutes. The samples and size markers as standard were applied to the gel 
pockets, then run for 1.5 h at 150 V, 100 mA. After the blue band of bromophenol blue crossed 
the bottom edge of the gel, the run was terminated.  
After the run, the collection gel was removed and the separation gel stained with 0.3 mM 
Coomassie-Brilliant Blue R-250 in MeOH:AcOH:H2O (4.5:1:4.5; v/v) for 0.5-1 h. The 
subsequent two-fold destaining (1-2 hour each) was carried out in the same solvent mixture 
without Coomassie blue until the optimal result was achieved.  
 
4.7 Western Blot 
After successful SDS-PAGE, the presence of a specific protein extracted from cells can be 
detected by Western blotting. The SDS-PAGE separating gel was detached from the chamber 
and the stacking gel and equilibrated in transfer buffer (see IV.8) for 10-30 min. The membrane 
(PVDF, Immobilion™-P from Millipore; 0.45 µm pore size) was wetted in MeOH for 15 
seconds, then washed in dist. H2O for 2 min, followed by equilibration in transfer buffer for 5 
min. Pre-cut filter paper was briefly put into transfer buffer. The single layers were assembled 
in the correct order: cathode (-) - 6 filter papers - SDS-gel -  PVDF-membrane - 6 filter papers 
- anode (+) and the package installed in a semi-dry blotting system. A constant current, 
depending on the membrane size (length*width*2 mA), was applied for blotting for about 90 
min. After blotting, the membrane was carefully removed and analysed by immunodetection. 
The membrane was washed three times with TBS buffer (see IV.8) for 5 min. The membrane 
was blocked in TBS-T buffer with 5% milk powder for 1.5 h, then washed twice in TBS-T (see 
IV.8) for 5 min. Thereafter, the membrane was incubated with the first antibody (Pierce™6x-
62 
 
His Epitope Tag Antibody), diluted 1:10000 in TBS-T with 1% milk powder for 16 hours at 4 
°C. Subsequently, the membrane was washed eight times for 5 min in TBS-T, followed by an 
incubation with the second antibody (anti-mouse IgG alkaline phosphatase, diluted 1:20000 in 
TBS-T) for 1 h at 25 °C. The membrane was washed five times in TBS-T for 5 min. Finally, 
the membrane was equilibrated in substrate buffer (see IV.8) for 5 min and then dyed in 10 ml 
substrate buffer mixed with 80 µl BCIP (20 mg/ml in 100% dimethylformamide) and 60 µl 
NBT (50 mg/ml in 70% dimethylformamide) for 30 min. The reaction was stopped by washing 
the membrane in dist. H2O. The dyed membranes were photographed and digitalised for later 
evaluation. 
 
4.8 Enzyme activity assays 
4.8.1 Cytochrome P450 reductase (CPR) 
The CPR activity in yeast microsome preparations was determined according to Urban et al. 
(1990, 1994). The standard assay at room temperature contained: 
 
50 mM KCN (always freshly prepared) 
2 mM cytochrome c     
Microsomal protein 
6 mM NADPH 
0.5 M TRIS-HCl pH 7.6  
  
10 µl 
15 µl 
5-50 µl 
25 µl 
ad 1 ml 
The reduction of cytochrome c was monitored photometrically at 550 nm. The basal slope 
before addition of NADPH was recorded for several minutes, then NADPH was added and the 
absorbance at 550 nm was further recorded. From the difference of basal slope and NADPH- 
dependent slope, the specific enzyme activity of the CPR was calculated as follows: 
 
Specific activity = ∆A550 * ɛ550 * V * t-1 * p-1 
with ∆A550: absorption change at 550 nm 
ɛ550: differential absorption coefficient of cytochrome c (ɛ550 = 21000 M-1 cm-1) 
V: reaction volume (ml) 
t: reaction time (s) 
p: amount of microsomal protein (g) 
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4.8.2 Deoxypodophyllotoxin 6-hydroxylase and deoxypodophyllotoxin 7-hydroxylase 
The assay components were pipetted into 1.5 ml test tubes as described below: 
 
0.1 M TRIS-HCl buffer pH 7.5  
0.1 M DTT      
0.1 mM DIECA     
25 mM NADPH     
Microsomal protein     
2.5 mM DOP     
8.75 µl 
2.5 µl 
6.25 µl 
2.5 µl 
225 µl 
5 µl 
The reaction was started with addition of microsomal protein, immediate shaking and 
incubating at 25 °C and 600 rpm in an Eppendorf Thermomixer® for 60 min. Addition of 25 µl 
6 N HCl and shaking stopped the reaction. Assays directly stopped with 6 N HCl and put on 
ice were used as zero control samples. Afterwards, the products were extracted twice with 600 
µl EtOAc each. The combined EtOAc extracts were evaporated in a centrifugal evaporator 
(SpeedVac®) and the dry residues redissolved in 100 µl methanol and centrifuged at 16000 g 
for 5 min prior to HPLC analysis. 
 
4.8.3 Pinoresinol-lariciresinol reductase 
The following procedure modified according to Fujita et al. (1999) was used. The standard 
assay mixture (250 µl) consisted of: 
Purified His-tagged protein    
5 mM racemic pinoresinol   
25 mM NADPH    
0.1 M KPi buffer pH 7.1    
   
25 µl 
10 µl 
25 µl  
ad 250 µl 
Buffer, purified His-tagged protein and racemic pinoresinol were preincubated for 15 min at 
30 °C prior to assay initiation by addition of NADPH. After 30 minutes, the assays were 
stopped by adding 600 µl EtOAc and mixed. Afterwards, the products were extracted twice 
with 600 µl EtOAc each. The combined EtOAc extracts were evaporated in a centrifugal 
evaporator (SpeedVac®). The dry residues were re-dissolved in 100 µl methanol and 
centrifuged at 16000 g for 5 min prior to HPLC analysis. 
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4.8.4 Secoisolariciresinol dehydrogenase 
The enzyme assay modified according to Xia et al. (2000) was used. Each reaction was 
prepared with a total volume of 250 µl that contained: 
Purified His-tagged protein    
1 M DTT      
50 mM NAD     
5 mM SECO  
20 mM TRIS-HCl buffer pH 8.8  
 
20 µl 
1 µl 
20 µl 
8 µl 
ad 250 µl 
  
The reaction was incubated at 30 °C for 2 h. Each sample was extracted twice with 600 µl 
EtOAc, the combined EtOAc extracts were dried in a centrifugal evaporator (SpeedVac®) and 
the residue reconstituted in 100 µl methanol for HPLC analyses. 
 
4.8.5 In vivo biotransformation enzyme assays 
Colonies of the INVSc1 strain containing the correct pYES2/NT C construct were inoculated 
and grown for 48 h at 30 °C in 5 ml SCD medium as pre-culture. These were further transferred 
to 100 ml induction medium (SCG or SC+G) in 500 ml baffled flasks and shaken at 220 rpm 
and 30 °C, 24 h to induce expression. Heterologous proteins were synthesised in S. cerevisiae 
InvSc1 for 24 hours. The next day, the cultures were transferred successively into 50 ml 
reaction tubes and centrifuged at 1500 g for 5 minutes at 4 °C. Thereafter, the cell pellet was 
redissolved in 10 ml fresh induction medium and 50 µl substrate SECO or DOP in methanol 
(2 mg/ml) added, then shaken at 220 rpm, 30 °C for 24 h. Each culture was extracted twice 
with 20 ml EtOAc, the combined EtOAc extracts were dried in a centrifugal evaporator 
(SpeedVac) and the residue reconstituted in 1 ml methanol for HPLC analyses. 
 
4.9 High-performance liquid chromatography (HPLC) 
HPLC is an important method of separating and purifying substances in the laboratory. Many 
different HPLC systems can be used: analytical, semi-quantitative or quantitative HPLCs, 
normal phase (NP) or reverse phase (RP). The HPLC analyses were performed with a C18-RP 
column (Hypersil HypurityTM Elite, 4.6 mm ø, 250 mm length with 20 mm precolumn) or a 
chiral column (Chiralcel OD-H) under isocratic condition. The composition of the mobile 
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phase remained stable throughout the time. All eluents for HPLC with C18-RP column were 
supplemented with 0.01% phosphoric acid. 20 µl of the samples were applied to the column. 
HPLC parameters for the analysis of metabolites and enzyme activities are listed below: 
 
Substances Column Wavelength 
(nm) 
Mobile phase Flow rate 
(ml/min) 
Deoxypodophyllotoxin Hypersil HypurityTM Elite 280 water:acetonitrile 
60:40 
1 
α-Peltatin Hypersil HypurityTM Elite 280 water:acetonitrile 
60:40 
1 
ß-Peltain Hypersil HypurityTM Elite 280 water:acetonitrile 
60:40 
1 
Yatein Hypersil HypurityTM Elite 280 water:acetonitrile 
60:40 
1 
Secoisolariciresinol Hypersil HypurityTM Elite 280 water:acetonitrile 
75:25 
1.5 
Matairesinol Hypersil HypurityTM Elite 280 water:acetonitrile 
75:25 
1.5 
Pinoresinol Hypersil HypurityTM Elite 280 water:acetonitrile 
75:25 
1.5 
Secoisolariciresinol Chiralcel OD-H 280 ethanol:n-hexane 
50:50 
0.6 
Pinoresinol Chiralcel OD-H 280 ethanol:n-hexane 
50:50 
0.6 
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VI. Results and discussion 
1. Preliminary work 
1.1 RNA extraction 
The isolation of RNA from cells of a Linum flavum suspension culture from days 2, 3, 4, 5, and 
7 of the cultivation period was carried out according to the method of Chomczynski and Sacchi 
(1987) (see III.2.3). After isolation, the quality of total RNA preparations was examined by 
electrophoresis. On the agarose gel, the 18S and 28S RNA bands were very prominent. In 
addition, the amount of RNA and its purity were determined photometrically. Many RNA-
samples had high quality with the A260/A280 ratio in the range of 1.8-2.0. The RNA-samples 
with the best quality and highest concentration from each batch (2.2; 3.5; 4.5; 5.5; 7.4) were 
used to synthesise cDNAs (see III.2.3), which were used as templates for amplification of 
candidate genes by PCR (see III.2.4.1). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample RNA concentration (ng/µl) A260/A280 
day 2 – sample 2 886 2.00 
day 3 – sample 5 1241 1.89 
day 4 – sample 5 1128 1.76 
day 5 – sample 5 800 1.87 
day 7 – sample 4 1331 1.73 
Figure 17: Agarose gels and photometric results of the best RNA extraction samples from 
cells of a Linum flavum suspension culture of the second, third, fourth, fifth and seventh 
culture day 
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1.2 Genomic DNA (gDNA) extraction 
The extraction of gDNA from the cells of the seventh-day suspension culture of Linum flavum 
was carried out according to the method of Rogers and Bendich (1985; see IV.2.1). After 
extraction, the amount of gDNA and purity were determined photometrically. Many gDNA-
samples had high-quality with a A260/A280 ratio of 1.8-2.0. In addition, the quality of gDNA 
samples was examined by electrophoresis. The gDNA-sample 2 with the best quality (A260/A280 
ratio 1.78) and the highest concentration (1139 ng/µl) was used as a template for amplification 
of candidate genes by PCR (see III.2.4.1). 
 
2. Project 1: Identification and characterisation of a NADPH:cytochrome P450 
reductase  
2.1 Cytochrome P450 reductase candidates 
The transcriptome and the corresponding protein sequences of Linum flavum were obtained 
from the database of the Project 1KP (https://onekp.com/). In 2004, Kuhlmann had identified 
a partial nucleotide sequence of CPR of Linum flavum with a length of 975 nucleotides by using 
RACE-PCR. This sequence was used as a reference sequence to search for CPR candidates of 
Linum flavum with help of the bioinformatics tool Blastx. 
The four candidates with the best results from Blastx are shown below:  
 
Contig Score Query cover E-value Identity 
4753 404 100% 7e-141 70% 
5729 587 100% 0.0 94% 
66401 610 100% 0.0 98% 
5254 401 100% 7e-140 70% 
 
2.2 Amplification of candidates from cDNA and sequencing 
The open reading frames (ORF) of the candidates were found from the transcriptome database 
by means of the bioinformatic tool ORF Finder. In order to amplify the candidate sequences 
from cDNA by PCR, the sequences (20-30 nucleotides) located at the beginning and the end 
of ORFs were used to design primers with the help of the bioinformatic tool Oligo Calc (see 
IV.6.2). 
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Using primers and standard PCR conditions (see III.2.4.1) with cDNA as template, two CPR 
candidates 4753 and 66401 were successfully amplified. The sequences of candidate 4753 and 
66401 have a length of appr. 2100 bp. The individually numbered lanes in Fig. 18 and 19 
represent PCR products which were formed at the different annealing-temperatures. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The bands of PCR products with appropriate lengths were excised from the agarose gel and the 
DNA isolated (see III.2.6). The candidate PCR products were ligated into pDrive vectors (see 
V.2.7.1) and subsequently introduced into competent E. coli EZ cells by heat shock (see 
III.3.2). The transformed bacterial colonies were selected and grown in overnight cultures at 
37° C. The bacterial plasmids were then isolated using a Miniprep kit (see III.3.5) and sent to 
Seqlab® for verification of the sequences. 
Sample Annealing 
temperature (°C) 
4753-1 54.3 
4753-2 56.1 
5254-1 54.3 
5254-2 56.1 
5729-1 56.1 
5729-2 57.8 
66401-1 54.3 
66401-2 56.1 
Sample Annealing 
temperature (°C) 
4753-1 54.3 
4753-2 56.1 
Figure 18: PCR amplification of CPR candidates 4753, 5254, 5729 and 66401. The 
successful amplification of 66401 is marked with a box. 
Figure 19: PCR amplification of CPR candidate 4753. The successful amplification is marked 
with a box. 
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The ORF of CPR-candidate 66401 comprises 2082 nucleotides and shows high identity (95%) 
to the sequence of contig 66401 in transcriptome of L. flavum. The ORF of CPR-candidate 
66401 is shown below: 
ATGAGTTCCAGCGGTCTGGAATTGGTGCGGTTCGTGGAGTCGATCCTCGGAGTCTCCCTCAGCGGCGTCTCGTCG
GACCTCGTGGTACTGGTACTCACTACTTCTCTCGCTATTATTGTGGGATTGCTGGTGTTCTTGTGGAAGAAATCG
TCGGATCGGAGTAAAGAGGTGAAGCCGGTGGTGATAACGAAGCCGTATTCGCTCAAGGAGGAAGACGAGGACGAG
TCCGATGCGTTAGCTGGCAAGACTAAGCTCACCATCCTTTACGGTACTCAGACTGGGACTGCTGAAGGTTTCGCT
AAGGCTTTAGCTGAGGAGATCAAGGCAAGATATGAAAAGGCTGCCGTCAAAGTTGTTGACTTGGATGATTATGCT
ATGGATGATGATCAGTATGAAGAAAAATTGAAAAAGGAGTCTTTGACGTTTTTTACGGTGGCTACTTATGGTGAT
GGGGAACCGACGGATAATGCTGCAAGGTTTTATAAGTGGTTCACAGAGGAAAATGAAAGAGGCGTTTGGCTTCCA
AAGCTCAATTTTGGCGTTTTTGGCTTGGGTAATCGTCAATATGAACATTTTAATAAGATTGCAGTTGTCCTTGAT
GAAGAACTTTCTAAGCAAGGTGGTAAGCGTCTCGTGCCAGTTGGTTTAGGTGATGATGATCAATGCATTGAGGAT
GACTTCACTGCATGGAAAGAATTACTCTGGCCAGAGTTGGATCAATTACTCAGAGATGAAGATGATGTGAATACT
CCATCTACACCATATATGGCAGCTATACAAGAATACCGTTTAGTTATTCATGATCCATCTGTAACATCTTATGAG
GACAATTTTGGAAACTTGGCAAATGGCAATACTTCTTTTGACATTCACCATCCGTGCAGAGTCAATGTTGCTGTC
CAAAGAGAGCTCCACTCACCAGAGTCCGACAGATCTTGCTTGCATCTGGAGTTTGATATTTCGGGCACTCCTATT
GCATATGAAACTGGTGATCATATTGGTGTTTATGCTGAGAATTGTGAGGACACTGTTGAAGAAGCAGGGAAGTTA
TTGGATCAACCCTTGGATTTGTTGTTCTCTATTCATTCAGATAAAGAAGATGGGACTCCCCTAGGAGGTTCATTG
GCACCTCCCTTCCCAGGTCCTTGCACTCTTCGTTTGGCACTTTCACGTTATGCTGACCTCTTGAACTCTCCAAAG
AAGTCTGCTTTGGTTGCCTTGGCTGCTCATGCAAGTGAACCAAGTGAGGCAGAGAGGCTTCAATTTTTGTCTTCG
CCGCAGGGGAAGGACGAATATTCACAATGGGTTGTTGCTAGTCAAAGAAGTCTCCTTGAGGTAATGGCCGAGTTC
CCATCTGCAAAACCTCCTCTTGGCGTATTTTTTGCAGCAGTGGCTCCTCGACTGCAGCCTCGTTACTATTCAATC
TCGTCTTCTCCTAGATTTGCTCCCAATAGAGTCCATGTAACCTGCGCTGTAGTAAACGAGCCAACACCAACTGGT
AGAATCCATAAGGGAGTGTGTTCAACCTGGATGAGGCACGCTGTTCCTCTCGAGAAAAGCCGAGATTGTAGCTGG
GCTCCCGTTTTTATCAGGACCTCTAACTTCAAGTTACCAGCCGATCCTTCGACTCCTATTATCATGGTGGGACCG
GGTACTGGATTGGCGCCTTTCAGGGGTTTTCTTCAGGAAAGAATGGCTCTGAAAGAGCAGGGCCGTCAGCTTGGC
ACTGCTTTGCTGTTCTTTGGATGCAGAAACCGACGGATGGATNTTACATACGAGGAGGAGCTAAATAAATTTGCG
GAACAAGGAGCGCTCACTGAACTCATTGTTGCCTTCTCAAGGGAGGGCCCAAAGAAGGAGTATGTTCAACATAAG
ATGACAGATAAAGCTGCAGAAATATGGAGCATAATTTCTCAAGGCGGATACTTTTATGTGTGTGGTGATGCCAAA
GGGATGGCAAGAGATGTTCATCACGCTNTGCACAACATTGTCCAGGAGCAGGGAGGGTTGGATTCGTCGAAGACG
GAGTCTACAGTGAAAAAATTGCAGATGGACGGGCGGTATCTTAGAGATGTATGGTGA 
Figure 20: Agarose gel of CPR candidate 66401 in 
pDrive (colony 1-3) 
Plasmids were isolated from E. coli EZ and cut by the 
restriction enzyme EcoRI. Bands of CPR candidate 
66401 are marked with a box. 
 
 
Figure 21: Agarose gel of CPR candidate 4753 in pDrive 
(colony 1-3) 
Plasmids were isolated from E. coli EZ and cut by the 
restriction enzyme EcoRI. The sequence of candidate 
4753 contains an internal EcoRI restriction site from 
1017 to 1022. Therefore, multiple bands appeared on 
the agarose gel. The full-length bands for 4753 are 
marked with boxes. 
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The ORF of CPR-candidate 4753 comprises 2151 nucleotides and shows high identity (99%) 
to the sequence of contig 4753 in transcriptome of L. flavum. The ORF of CPR-candidate 4753 
is shown below: 
 
ATGGACTCGTCCTCGTCTGCTTCGTCGTCGGGATCTGCGTCGGCGATCGATCTGATGGCGGCAATTATCCGGAAG
AAGTTCGCCGACCCGTCCAACGCGTCGGCGGAGTTGGGAGGGTCGGCGATGGAGGTGACTTCGCTGATTCTGGAC
AACAGGGAGCTTGTTATGATTCTGACGACCTCGATTGCGGTGCTGATCGGGTGCGTGGTGGTGCTGGTGTGGAGA
AGATCGGGATTGCAGAAGCGGAGGAGTTACGAGCCTCCGACGCCTTTGGTTGTGAAGAAGAAGGAGGAGGTTGTG
GTGGACGATGGGAAGAAGAAGGTCACCTTGTTCTTCGGTACTCAGACTGGTACCGCTGAAGGATTCGCCAAGGCT
CTGGCCGAGGAGGCGAAAGCGCGGTATGAGAAAGCTGTATTCAAAGTTGTTGACATTGATGATTATGCCGGGGAT
GATGATGAATACGAGGAGAAGTTAAAGAAAGAGTCCATTGCTTTCTTCTTCCTTGCTACATATGGAGATGGTGAG
CCGACTGATAATGCAGCAAGATTCTACAAGTGGTTTACCGAGGGTAAAGAAGAGAGAGGAGAATGGCTTAAGATG
AAGTATGGAGTGTTCGGCCTTGGCAACAAGCAATATGAACACTTCAATAAGATTGCTAAGGAGGTGGATGATCTT
CTGGCCGAGCAAGGTGGCAAGCGCCTTGTTCCTGTGGGTCTAGGAGATGATGATCAATGCATGGAAGACGACTTC
TCTGCGTGGAAAGAGTTGGTATGGCCAGAGCTCGATGGATTGCTTCTTGACGAGGATGATCAAGCATCTGCTACC
ACCCCTTACACTGCTGCGGTGTTGGAATATCGGGTTGTGTTCTATGACTCCACTGATGCACCAGTAGAAGACAAA
AGCTGGAGTGGCGCCAATGGCCATACTGTCTATGATGCTCAACATCCTTGCCGGTCCAATGTTGCCGTGAGGAAA
GAGCTTCACACTCCTCTTTCTGACCGATCTTGCACTCATTTGGAATTCGACATTGCTGGCACTGGACTCTCATAT
GAAACTGGGGATCATGTTGGTGTGTACTCTGAGAATGTCGAGGAGGTTGTAGAAGAGGCACTGCAGTTGTTAGGT
TTGTCGCCCGACACTTACTTCTCCATCCATACCGATAAAGAGGACGGCACACCACTGAGTGGTAGCTCATTGACG
ACCCCATTCCCACCGTGCACCTTGAGAACAGCTCTGACTCGATATGCCGATCTTTTGAATGCACCCAAAAAGTCT
GCTTTGCTTGCTTTAGCAGCTCATGCTACTGATCCCACCGAAGCCGATAGATTAAGGTATCTTGCATCACCTGCT
GGCAAGGATGAATATGCGAAATGGGTAGTTGCAGAACAGAGAAGTCTCCTCGAGGTCATGGCTGCATTTCCCTCG
GCAAAGCCCCCACTTGGTGTATTCTTTGCCGGAGTTGCTCCTCGCTTGCAGTCTCGATTCTATTCTATCTCCTCA
TCGCCTAAGATGGCACCATCTAGAATCCACGTGACGTGTGCTCTGGTGCTTGAGAAAACTCCGGGAGGACGGCTT
CACAAGGGAGTCTGCTCAACTTGGATGAGGAATGCTGTTCCTATGGAGAAGAGCCAAGACTGCAGTTGGGCACCC
ATTTTCGTTCGGCAATCAAATTTCAGACTTCCTGCAGATACTAAAGTTCCCATCATAATGGTTGGCCCTGGGACC
GGACTGGCTCCTTTCCGCGGCTTCCTGCAGGAAAGACTAGCACTCAAAGAATCTGGAGCTGAACTTGGGCCCTCT
ATCTTCTTCTTCGGTTGCAGAAACCGTAAGACGGATTTCATCTACGAGGACGAACTCAACAACTTTGTCGAAGCT
GGTGCACTCTCTGAGCTGAACGTTGCTTTCTCGAGGGAAGGAGCTACCAAAGAGTACGTGCAACATAGAATGGTG
CAGAAGGCTTCGGAGATCTGGAACCTGATCTCTCAGGGAGCTTATGTATACGTATGTGGCGATGCCAAAGGCATG
GCCAGAGACGTTCACCGAACTCTCCACACCATTGCAATCGAACAGGGCTCGCTCGACTCATCCAAGGCCGAGAGC
TTTGTGAAGAACCTGCAAATGAGTGGTCGGTACCTGCGCGACGTTTGGTAA 
The internal restriction site GAATTC for the restriction enzyme EcoRI is underlined. The start 
codon and the stop codon are written in bold letters.  
The amino acid sequences of the two candidates were translated from cDNA with ExPASy 
translate and the molecular weight (MW) of protein was calculated by the ExPASy-Compute 
pI/Mw tool (see IV.9). 
The amino acid sequence of CPR-candidate 66401 with a MW of appr. 77.1 kDa is shown 
below: 
MSSSGLELVRFVESILGVSLSGVSSDLVVLVLTTSLAIIVGLLVFLWKKSSDRSKEVKPVVITKPYSLKEEDEDE
SDALAGKTKLTILYGTQTGTAEGFAKALAEEIKARYEKAAVKVVDLDDYAMDDDQYEEKLKKESLTFFTVATYGD
GEPTDNAARFYKWFTEENERGVWLPKLNFGVFGLGNRQYEHFNKIAVVLDEELSKQGGKRLVPVGLGDDDQCIED
DFTAWKELLWPELDQLLRDEDDVNTPSTPYMAAIQEYRLVIHDPSVTSYEDNFGNLANGNTSFDIHHPCRVNVAV
QRELHSPESDRSCLHLEFDISGTPIAYETGDHIGVYAENCEDTVEEAGKLLDQPLDLLFSIHSDKEDGTPLGGSL
APPFPGPCTLRLALSRYADLLNSPKKSALVALAAHASEPSEAERLQFLSSPQGKDEYSQWVVASQRSLLEVMAEF
PSAKPPLGVFFAAVAPRLQPRYYSISSSPRFAPNRVHVTCAVVNEPTPTGRIHKGVCSTWMRHAVPLEKSRDCSW
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APVFIRTSNFKLPADPSTPIIMVGPGTGLAPFRGFLQERMALKEQGRQLGTALLFFGCRNRRMDXTYEEELNKFA
EQGALTELIVAFSREGPKKEYVQHKMTDKAAEIWSIISQGGYFYVCGDAKGMARDVHHAXHNIVQEQGGLDSSKT
ESTVKKLQMDGRYLRDVW 
 
The amino acid sequence of CPR-candidate 4753 with a MW of appr. 78 kDa is shown below: 
MDSSSSASSSGSASAIDLMAAIIRKKFADPSNASAELGGSAMEVTSLILDNRELVMILTTSIAVLIGCVVVLVWR
RSGLQKRRSYEPPTPLVVKKKEEVVVDDGKKKVTLFFGTQTGTAEGFAKALAEEAKARYEKAVFKVVDIDDYAGD
DDEYEEKLKKESIAFFFLATYGDGEPTDNAARFYKWFTEGKEERGEWLKMKYGVFGLGNKQYEHFNKIAKEVDDL
LAEQGGKRLVPVGLGDDDQCMEDDFSAWKELVWPELDGLLLDEDDQASATTPYTAAVLEYRVVFYDSTDAPVEDK
SWSGANGHTVYDAQHPCRSNVAVRKELHTPLSDRSCTHLEFDIAGTGLSYETGDHVGVYSENVEEVVEEALQLLG
LSPDTYFSIHTDKEDGTPLSGSSLTTPFPPCTLRTALTRYADLLNAPKKSALLALAAHATDPTEADRLRYLASPA
GKDEYAKWVVAEQRSLLEVMAAFPSAKPPLGVFFAGVAPRLQSRFYSISSSPKMAPSRIHVTCALVLEKTPGGRL
HKGVCSTWMRNAVPMEKSQDCSWAPIFVRQSNFRLPADTKVPIIMVGPGTGLAPFRGFLQERLALKESGAELGPS
IFFFGCRNRKTDFIYEDELNNFVEAGALSELNVAFSREGATKEYVQHRMVQKASEIWNLISQGAYVYVCGDAKGM
ARDVHRTLHTIAIEQGSLDSSKAESFVKNLQMSGRYLRDVW 
 
Based on the PSI- and PHI-BLAST searches against the conserved domain database (CDD) of 
the National Center for Biotechnology Information, the obtained translated cDNAs were 
confirmed as cytochrome P450 reductase. Candidate 4753 showed high homology to the CPR 
genes from several plants, including Theobroma cacao (GenBank ID: EOY31887.1; 83% 
identity), Azadirachta indica (GenBank ID: AIG15452.1; 81% identity) and Gossypium 
hirsutum (GenBank ID: NP_001314398.1; 80% identity). Candidate 66401 also showed high 
homology to the CPR genes from Theobroma cacao (79% identity), Azadirachta indica (79% 
identity) and Gossypium hirsutum (79% identity). 
 
 
2.3 Heterologous expression of CPR-candidate proteins 
Since CPR is associated with the membrane of the endoplasmic reticulum, S. cerevisiae strain 
INVScI was used for the heterologous expression of CPR using the vector pYes/NTC. The 
yeast strain INVScI, a common fast-growing S. cerevisiae strain, was transformed with the 
CPR candidate genes by using the lithium acetate method (see III.3.3). The transformed yeast 
cells are transferred onto SC-U plates and incubated for 3 days at 30 °C. SC-U is a synthetic 
minimal medium for yeast containing glucose as the sole carbon source without uracil. The 
yeast cells without pYes2/NTC cannot grow on the SC-U medium. The successful 
transformations were confirmed by colony PCR (Fig. 22 and 23) (see III.2.4.4).  
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Heterologous expression of the CPR candidate-proteins was performed as described in 
III.3.7.2. Harvesting yeast cells from expression cultures in SCG after 4, 8, 12, 24, 48, 72, 96 
hours aimed at finding out the optimal induction time for CPR proteins. The molecular weight 
including His-Tag of CPR-candidate 4753 and 66401 is appr. 81.3 kDa and 80.4 kDa, 
respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: Agarose gel of colony PCR of CPR candidate 
66401 to show the transformation of Saccharomyces 
cerevisiae INVScI (colony 1-4) 
Candidate genes are marked with a box. 
 
 
 
Figure 23: Agarose gel of colony PCR of CPR candidate 
4753 to show the transformation of Saccharomyces 
cerevisiae INVScI (colony 1-4) 
 Candidate genes are marked with a box. 
 
 
Figure 24: SDS-PAGE of CPR candidate 4753 (A) and 66401 (B) after different time intervals of 
induction with galactose. The bands of heterologously synthesised CPR-proteins are marked. 
with black arrows. 
 
 
A 
B 
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The bands of the expected products on the SDS-PAGE gels are rather weak. However, faint 
bands of appr. 80 kDa appeared on the lanes 24h of both gels and, based on the colour intensity, 
12h- and 24h-lanes have the highest concentration of the putative CPR-protein. Therefore, the 
yeast cells containing candidate genes in pYes2/NTC were induced with galactose and 
incubated for 24 hour to express the protein for the next experiments. 
Since the CPR-protein integrates into the endoplasmic reticulum, microsomes of the 
transformed yeast cells were used for determining the activity of the candidate proteins.  The 
transformed yeast cells were induced 24 hours with galactose and the microsomes were isolated 
as described in III.4.1.2. The microsome preparations of the CPR-candidates and negative 
controls (microsomes from yeast cells containing the empty vector pYes2/NTC) were separated 
by SDS-PAGE (see III.4.6) and then transferred to PVDF-membranes by Western-blotting (see 
III.4.7). A poly-histidine tag for purification already present on the vector was bound to the N-
terminal end of the proteins and the expressed protein was detected with anti-His-Tag 
antibodies.  
 
 
    
 
 
 
Gene-specific bands of candidate-proteins in the expected size ranges appeared on the Western-
blot membrane (Fig. 25A). There were no bands in the same size ranges in the lanes of negative 
control samples. In order to check the specificity of the Western-blot, the membranes coloured 
with NBT/BCIP were dyed with Coomassie Brilliant Blue G-250 by the same colour reaction 
as for SDS-PAGE gels (see V.4.6) (Fig. 25B). Coomassie staining visualised a multitude of 
Figure 25: Western Blot of CPR-candidates 4753 and 66401 
A: Detection was done with anti-His-Tag antibody and secondary antibodies coupled to alkaline 
phosphatase using the NBT/BCIP colour reaction.  
B: The membrane after NBT/BCIP colour reaction was dyed with Coomassie Brilliant Blue G-250. 
Each CPR-candidate was heterologously expressed twice under the same conditions. His-tagged protein 
bands of CPR-candidates 4753 and 66401 with appropriate molecular weight are marked with boxes. 
 
A B 
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bands of different sizes. The anti-His-tag antibodies show high affinity for the heterologously 
expressed proteins and detected successfully and selectively the CPR-proteins. The result of 
the Western blot showed that the transformed yeast cells produced two different CPR proteins 
successfully after induction with galactose. 
  
2.4 Functional identification of CPR-candidates 66401 and 4753 
In order to determine the activity of the two CPR candidates, an in vitro enzyme assay was 
performed as described in III.4.8.1. CPR activity was determined by measuring its NADPH-
dependent cytochrome c reductase activity at room temperature. The recombinant proteins 
were prepared as microsomes. The time-dependent absorbance change of cytochrome c was 
monitored at 550 nm prior and after addition of NADPH. A parallel assay with membranes 
from yeast cells harbouring the empty pYes2/NTC vector was performed as a negative control. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Addition of NADPH 
Figure 26: Photometrical enzyme assay of CPR-candidate 66401 
The reduction of cytochrome c was initiated by the addition of 0.1 M NADPH at the fifth minute. 
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Time course measurements revealed a clear reductase activity towards cytochrome c with an 
explicitly increasing absorption at 550 nm in comparison to the negative control. These results 
confirm the activity of the CPR-candidates 66401 and 4753 of L. flavum in protein preparations 
from transformed yeast and thus are identified as LfCPR 66401 and LfCPR 4753. The LfCPRs 
utilized NADPH as electron donor for reducing cytochrome c. LfCPR 66401 and 4753 show a 
significant increase of specific activity, 35-fold and 33-fold higher than the negative control, 
respectively (Fig. 28). LfCPR 66401 possessed a slightly higher specific activity than LfCPR 
4753.   
 
 
 
 
 
 
 
Figure 28: Specific activities of heterolously expressed LfCPR 66401 and 4753   
The data represent mean values of four replicate assays (±s.d.). 
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Figure 27: Photometrical enzyme assay of CPR-candidate 4753 
The reduction of cytochrome c was initiated by the addition of 0.1 M NADPH at the fifth minute.  
Addition of NADPH 
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2.5 Enzyme kinetics of LfCPR 66401 and 4753 
2.5.1 Km-values for cytochrome c 
In order to calculate the Km-values for CPRs, kinetic experiments were performed at a fixed 
concentration of 0.2 mM NADPH with varying cytochrome c concentrations from 10 to 180 
µM. The Km-value and Vmax were calculated by linearization of the substrate saturation curves 
(Fig. 28 and 30) according to Hanes-Woolf (Fig. 30 and Fig. 32). The apparent Km-value for 
cytochrome c of LfCPR 66401 was 8.15 ± 0.3 µM while the value for LfCPR 4753 was 15.6 ± 
0.35 µM. Based on these Km-values, LfCPR 66401 has a much higher the affinity towards 
cytochrome c than LfCPR 4753. Both LfCPRs displayed a Vmax of 4.9 mkat/kg (Fig. 30 and 
Fig. 32) under these reaction conditions. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29: Dependence of the specific activity of LfCPR 66401 on the cytochrome c concentration 
The data represent mean values of four replicate assays (±s.d.). 
 
 
 
Figure 30: Linearisation of the data from Fig. 29 according to Hanes-Woolf 
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2.5.2 Km-values for NADPH 
 
CPRs use NADPH as electron donor to reduce cytochrome c (as artificial electron acceptor). 
In order to calculate the Km-values and Vmax of the LfCPRs, enzyme assays were performed at 
a fixed concentration of 75 µM cytochrome c with varying NADPH concentrations from 6 to 
1200 µM. The Km-values and Vmax were calculated by linearization of the substrate saturation 
curves (Fig. 33 and 35) according to Hanes-Woolf (Fig. 34 and Fig. 36). For LfCPR 66401, 
this results in a Km-value for NADPH of 29.6 ± 0.8 μM and Vmax of 4.38 mkat/kg. For LfCPR 
4753, the Km-value for NADPH is 45.2 ± 0.7 μM and Vmax is 6.4 mkat/kg. These data show 
that LfCPR 66401 has a much higher affinity towards NADPH than LfCPR 4753. 
Figure 31: Dependence of the specific activity of LfCPR 4753 on the cytochrome c concentration 
The data represent mean values of four replicate assays (±s.d.). 
 
 
 
Figure 32: Linearisation of the data from Fig. 31 according to Hanes-Woolf 
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Figure 33: Dependence of the specific activity of LfCPR 66401 on the NADPH concentration 
The data represent mean values of four replicate assays (±s.d.). 
 
 
 
Figure 35: Dependence of the specific activity of LfCPR 4753 on NADPH concentration 
The data represent mean values of four replicate assays (±s.d.). 
 
 
 
Figure 34: Linearisation of the data from Fig. 33 according to Hanes-Woolf 
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2.6 Comparison of CPR-sequences from different plants 
The alignment of the amino acid sequences of other two CPRs from Linum flavum and other 
plant CPRs including Theobroma cacao (GenBank ID: EOY31887.1), Azadirachta indica 
(GenBank ID: AIG15452.1) and Gossypium hirsutum (GenBank ID: NP_001314398.1) was 
performed using Clustal Omega and the result is shown below:  
66401-ORF      -------------MSSSGLDVVRLV-------ESVLGLSLGG---------ASSDVVVLV 
4753-ORF       MD---SSSSASSSGSASAIDLMAAIIRKKFADPSNASAESGGSAMEVTSLILDNREFVMI 
A. indica      MQSSSSSASSSNTMKVSPFDLMSAIIKGKT-DPSNV--SSSGSGLEVASIVLENKEFVMI 
T. cacao       ----MEPSSSSGSIKVSPLDLMSAIIKGKM-DPSNA--SY-DSAAEVATMLLENREFVMI 
G. hirsutum    ----MDSSSSSSSSGPSPLDLMSALVKAKM-DPSNA--SS-DSAAQVTTVLFENREFVMI 
                               * :*::  :        *    .  .          ..  .*:: 
        
               membrane-anchoring  
66401-ORF      LTTSLAVIVGLV-AFFWKRSADRSKEAKPLVITKPYSQKEEEDESEALTGKTKLTIFYGT 
4753-ORF       LTTSIAVLIGCVVVLVWRRSGSQKRRNYEP-PTPLVV--KKKEEVVVDDGKKKVTLFFGT 
A. indica      LTTSIAVLIGCVVVLIWRRSSSQKPKKIEP--LKPLV--VKEPEVEVDDGKQKITIFFGT 
T. cacao       LTTSIAVLIGCVVVLVWRRSGSQKPKQIEP--PKPLI--VKEPELEVDDGKKKVTIFFGT 
G. hirsutum    LTTSIAVLIGCVVILIWRRSASQKPKQIQL-PLKPSI--IKEPELEVDDGKKKVTILFGT 
               ****:**::* *  :.*:**..:. .              :: *  .  ** *:*:::** 
             
   FMN binding      P450 binding 
66401-ORF      QTGTAEGFAKALAEEIKARYEKAAVKVVDLDDYAMDDDQYEEKLKKETLVCFMVATYGDG 
4753-ORF       QTGTAEGFAKALAEEAKARYEKAVFKVVDIDDYAGDDDEYEEKLKKESIAFFFLATYGDG 
A. indica      QTGTAEGFAKALADEAKARYDKAIFKVVDLDDYAADDEEYEEKLKKESIAFFFLATYGDG 
T. cacao       QTGTAEGFAKALAEEAKARYDKATFKVVDLDDYAVDDDEYEEKMKTESLAFFFLATYGDG 
G. hirsutum    QTGTAEGFAKALVEEAKARYEKATFNIVDLDDYAADDEEYEEKMKKDNLAFFFLATYGDG 
               ************.:* ****:** .::**:**** **::****:*.:.:. *::****** 
 
       FMN binding 
66401-ORF      EPTDNAARFYKWFTEENE-RGVWLPKLNFGVFGLGNRQYEHFNKIAVVLDEELCKQGGKR 
4753-ORF       EPTDNAARFYKWFTEGKEERGEWL-KMKYGVFGLGNKQYEHFNKIAKEVDDLLAEQGGKR 
A. indica      EPTDNAARFYKWFTEGKE-RGEWLQNLKYGVFGLGNRQYEHFNKIAKVVDDVLAEQGGKR 
T. cacao       EPTDNAARFYKWFTEGKE-RGEWLQNMKYGVFGLGNRQYEHFNKVAKVVDDLLTEQGAKR 
G. hirsutum    EPTDNAARFYKWFTEGKE-RGEWLQNMKYGIFGLGNKQYEHFNKVAKVVDELLTEQGAKR 
               *************** :* ** ** ::::*:*****:*******:*  :*: * :**.** 
Figure 36: Linearisation of the data from Fig. 35 according to Hanes-Woolf 
 
 
 
y = 0.1563x + 7.0457
R² = 0.9962
0
50
100
150
200
250
0 200 400 600 800 1000 1200 1400
S/
v 
(µ
M
.k
g/
m
ka
t)
Concentration NADPH (µM)
80 
 
 
       Cytochrome c binding 
66401-ORF      LVPVGLGDDDQCIEDDFTAWKELLWPELDQLLRDEDDVNTPSTPYMAAIQEYRLVIHDPS 
4753-ORF       LVPVGLGDDDQCMEDDFSAWKELVWPELDGLLLDEDDQASATTPYTAAVLEYRVVFYDST 
A. indica      LVPVGLGDDDQCIEDDFSSWRELVWPELDKLLRDDDDPTTVSTPYTAAISEYRVVFYDSA 
T. cacao       LVPVGLGDDDQCIEDDFTAWRELVWPELDQLLRDEDDATTVSTPYTAAVLEYRVLFYDPA 
G. hirsutum    IVPLGLGDDDQCIEDDFTAWRELVWPELDQLLRDEDDA-TVSTPYTAAVLEYRVVFYDPA 
               :**:********:****::*:**:***** ** *:**  : :*** **: ***::::* : 
          
       FAD binding 
66401-ORF      VTSYEDNFGNLANGNTSFDIHHPCRVNVAVQRELHLAESDRSCMHLEFDILGAPIVYETG 
4753-ORF       DAPVEDKSWSGANGHTVYDAQHPCRSNVAVRKELHTPLSDRSCTHLEFDIAGTGLSYETG 
A. indica      DASIGENNWSNANGHAVYDAQHPCRSNVAVRKELHTPLSDRSCTHLEFEIAGTGLMYETG 
T. cacao       DAPVEDENRSNANGHTIYDAQHPCRSNVAVRKELHTSASDRSCTHLEFDIAGTGLSYETG 
G. hirsutum    DAPLEDKNWSNANGHATYDAQHPCRSNVAVRKELHAPESDRSCTHLEFDIAGTGLSYETG 
               :   ::  . ***:: :* :**** ****::***   ***** ****:* *: : **** 
 
 
66401-ORF      DHVGVYAENCEDTVEEAGKLLDQPLDLLFSIHSDKEDGTPLGGSLAPPFPGPCTLRLALS 
4753-ORF       DHVGVYSENVEEVVEEALQLLGLSPDTYFSIHTDKEDGTPLSGSSLTTPFPPCTLRTALT 
A. indica      DHVGVFCENLTETVEEALSLLGLSPDTYFSVHTDKEDGTPLGGSSLPPPFPPCSLRTALA 
T. cacao       DHVGVYCENLDEVVEEALTLLGLSPDTYFSVHTDKEDGTPLGGSSLPPPFPPCTLRTALA 
G. hirsutum    DHVGVYCENLDEVVDEALSLLGLSPDTYFSVHTDKEDGTPLGGSSLPSSFPPCTLRTALA 
               *****:.**  :.*:**  **.   *  **:*:********.**       **:** **: 
 
 
66401-ORF      LYADLLNSPRKSALVALAAHASEPSEAERLRVLSSPEGKDEYSQWVVASQRSLLEVMAEF 
4753-ORF       RYADLLNAPKKSALLALAAHATDPTEADRLRYLASPAGKDEYAKWVVAEQRSLLEVMAAF 
A. indica      QYADLLSSPKKSALLALAAHASDPTEADRLRHLASPAGKDEYAQWIVASQRSLLEVMAQF 
T. cacao       RYADLLSSPKKSALVALAAHASDPTEADRLRHLASPAGKDEYAQWMVASQRSLLEVMAEF 
G. hirsutum    RYADLLSSPKKAALLALAAHASDPTEADRLRHLASPAGKDEYAQWIVANQRSLLEVMAEF 
               *****.:*:*:**:******::*:**:*** *:** *****::*:**.********* * 
 
        FAD binding 
66401-ORF      PSAKPPLGVFFAAVAPRLQPRYYSISSSPRFAPNRVHVTCAVVNEPTPTGRIHKGVCSTW 
4753-ORF       PSAKPPLSVFFAGVAPRLQPRFYSISSSPKMAPSRIHVTCALVLEKTPGGRLHKGVCSTW 
A. indica      PSAKPPLGVFFAAVAPRLQPRYYSISSSPRVAPSRIHVTCALVYEKTPTGRIHKGVCSTW 
T. cacao       PSAKPPLGVFFAAVAPRLQPRYYSISSSPRMALSRIHVTCALVYEKTLTGRIHKGICSTW 
G. hirsutum    PSAKPPLGVFFAAVAPRLQPRYYSISSSPRLAPSRIHVTCALVYEKTPTGRIHKGVCSTW 
               *******.****.********:*******:.* .*:*****:* * *  **:***:**** 
   
   NADPH binding 
66401-ORF      MKHAVPLEKSRDCSWAPVFIRTSNFKLPADPSTPIIMVGPGTGLAPFRGFLQERMALKEQ 
4753-ORF       MRNAVPMEKSQDCSWAPIFVRQSNFRLPADTKVPIIMVGPGTGLAPFRGFLQERLALKES 
A. indica      MKNCVPMEKSNDCGWAPIFVRQSNFRLPADPKVPVIMIGPGTGLAPFRGFLQERFALKEA 
T. cacao       MKNSVPMEKSHDCSWAPIFVRQSNFKLPLDTKVPIIMIGPGTGLAPFRGFLQERLALKEA 
G. hirsutum    MKNAVSSGKSDDCGWAPIFVRQSNFKLPSDTKVPIIMIGPGTGLAPFRGFLQERLALKEA 
               *::.*   ** **.***:*:* ***:** * ..*:**:****************:****  
 
 
66401-ORF      GRQLGTALLFFGCRNRRMDFIYEEELNKFVEQGALSELIVAFSREGPQKEYVQHKMADKA 
4753-ORF       GAELGPSIFFFGCRNRKTDFIYEDELNNFVEAGALSELNVAFSREGATKEYVQHRMMQKA 
A. indica      GAELGPSVLFFGCRNRQMDYIYEDELNNFVQSGALSELVVAFSRQGPTKEYVQHKMMEKA 
T. cacao       GAELGPSVLFFGCRNRKMDYIYEDELNNFVNGGALSEIVVAFSREGPTKEYVQHKMMQKA 
G. hirsutum    GAELGPSVLFFGCRNRKMDFIYEDELNNFVNSGALSELVVAFSREGPTKEYVQHKMMEKA 
               * :** :::*******: *:***:***:**: *****: *****:*  ******:* :** 
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      NADPH binding 
66401-ORF      AEIWSIISQGGYFYVCGDAKGMARDVHRTLHNIVQEQGGLDSSKTESMVKKLQMDGRYLR 
4753-ORF       SDLWNLISQGAYVYVCGDAKGMARDVHRTLHTIAIEQGSLDSSKAESFVKNLQMSGRYLR 
A. indica      SDIWNMISQGGYLYVCGDAKGMARDVHRTLHTIVQEQGSVDSSKAESIVKNLQMTGRYLR 
T. cacao       SDIWNMISQGGYLYVCGDAKGMAKDVHRTLHTILQEQGCLDSSKAESMVKNLQMTGRYLR 
G. hirsutum    KDIWDMISQGGYLYVCGDAKGMARDVHRALHTIFQEQGSLDSSKAESMVKNLQMSGRYLR 
                ::*.:****.*.**********:****:**.*  *** :****:**:**:*** ***** 
 
 
66401-ORF      DVW 
4753-ORF       DVW 
A. indica      DVW 
T. cacao       DVW 
G. hirsutum    DVW 
               *** 
 
The typical motifs of the P450-, NADPH-, FMN-, FAD-binding and membrane-anchoring 
domains are shaded in grey and marked (Eberle et al., 2008; Ro et al., 2002). Gaps were inserted 
to maximise the homology. The alignment profile confirmed that CPR candidates 4753 and 
66401 are similar to other CPRs, had two binding sites each for FMN, FAD, and NADPH and 
one binding site for cytochrome P450. LfCPR 66401 and LfCPR 4753 both contain the 
conserved acidic amino acid sequence DDDQC(I/M)EDD, which interacts with cytochrome c 
and P450s, localized near the FMN binding domain. There are membrane anchor regions at the 
N-terminus of each CPR in order to ensure the membrane attachment and the interaction 
between CPR and P450 monooxygenases. LfCPR 66401 contains a short amino acid sequence 
and LfCPR 4753 has an extended anchoring sequence at the N-terminus. According to Ro et 
al. (2002), LfCPR 66401 and LfCPR 4753 are classified into class I and II, respectively. CPRs 
belonging to class I are transcribed constitutively, whereas CPRs of class II are expressed under 
stress or elicited by wounding or elicitors (Rana et al., 2013).  
In plants, multiple CPR isoforms can exist. Three CPRs have been found in Helianthus 
tuberosus and Populus jackii (Benveniste et al., 1991; Ro et al., 2002). Two different CPR 
genes have been characterised in Withania somnifera (Rana et al., 2013), Petroselinum crispum 
(Koopmann and Hahlbrock 1997) and Arabidopsis thaliana (Mizutani and Ohta 1998; Urban 
et al., 1997). During biotic and abiotic stress or differential expression at various stages of plant 
development, the demand of electron supply becomes higher than normal and the presence of 
multiple CPRs in plants might answer this demand (Ro et al., 2002; Rana et al., 2013). The 
diversity of P450s that catalyse reactions for the synthesis of primary and secondary 
metabolites might be also the reason for the occurrence of multiple CPRs in plants (Werck-
Reichhart et al., 2000; Ro et al., 2003). 
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3. Project 2: Identification of genes encoding DOP6H and DOP7H  
3.1 DOP6H und DOP7H candidates 
In 2001, deoxypdophyllotoxin 6-hydroxylase (DOP6H) was characterised in protein extracts 
from Linum flavum suspension cultures as cytochrome P450 by Molog et al. (2001). In cell 
cultures of Linum album, DOP is converted into PTOX and there are several experiments 
suggesting that deoxypdophyllotoxin 7-hydroxylase (DOP7H) is also cytochrome P450-
dependent (Fig. 37) (Henges, 1999; Kuhlmann, 2004). However, since PTOX formation by 
DOP7H was not blocked by CYP-inhibitors in suspension cultures of L. album, this 
hydroxylase is suggested by Federolf (2007) not as a cytochrome P450 monooxygenase.  
Recently, CYP71BE54 and CYP82D61 in Podophyllum hexandrum were successfully 
identified by Lau and Sattely (2015) (Fig. 38). CYP71BE54 uses DOP as a substrate like 
DOP6H and DOP7H, however, it demethylates DOP to (–)-4'-desmethyl-
deoxypodophyllotoxin. On the other hand, CYP82D61 hydroxylates on C7 of DOP like 
DOP7H. Therefore, the obtained amino acid sequences of CYP71BE54 and CYP82D61 from 
Podophyllum hexandrum were used as reference sequences to search for DOP6H and DOP7H 
candidates in the protein database of Linum flavum with the help of the bioinformatics tool 
Blastp. 
 
Figure 37: C6- and C7- hydroxylations of DOP 
Known reactions are shown by a continuous arrow and unknown with a dashed arrow. 
Figure 38: CYP71BE54 and CYP82D61 in the putative biosynthetic pathway to 
 (-)-4′-desmethylepipodophyllotoxin in Podophyllum hexandrum (Lau and Sattely, 2015) 
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The candidates, that have best Blastp-results with CYP82D61, are listed below:  
 
Contig Score Query cover E-value Identity 
27263 450 86% 1e-158 50% 
11511 449 92% 5e-157 47% 
38991 427 96% 1e-148 45% 
11862 449 100% 2e-157 44% 
5627 419 98% 4e-145 44% 
4471 279 92% 2e-91 35% 
2408 251 89% 3e-80 34% 
2227 278 90% 6e-91 34% 
2114 250 91% 7e-80 33% 
3458 234 90% 4e-97 32% 
74047 254 89% 2e-81 31% 
 
The candidates, that have best Blastp-results with CYP71BE54, are listed below: 
Contig Score Query cover E-value Identity 
2227 550 90% 0.0 56% 
2408 506 89% 2e-179 54% 
74047 482 98% 2e-170 49% 
2114 496 97% 1e-175 48% 
3458 452 96% 2e-158 46% 
4471 413 91% 7e-144 45% 
11511 257 89% 2e-82 33% 
11862 264 98% 9e-86 32% 
38991 257 95% 1e-82 32% 
27263 222 88% 2e-70 31% 
5627 217 95% 4e-67 28% 
 
3.2 Generating full-length sequences of CYP candidate genes  
3.2.1 Amplification of candidates from cDNA and sequencing 
The open reading frame (ORF) of the candidates were identified in the transcriptome database 
of Linum flavum by means of ORF Finder. In order to amplify the candidate sequences from 
cDNA through standard PCR (see III.2.4.1), the sequences (20-30 nucleotides) located in the 
beginning and the end of ORFs were used to design primers (see IV.6.1) with the help of the 
bioinformatic tool Oligo Calc. 
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As shown in Fig. 39, only five CYP-candidates 11511, 11862, 2408, 27263 and 4471 were 
successfully amplified in PCR experiments by using full-length primers with cDNA as 
template. Many attempts to amplify the other six candidates (2114, 2227, 2702, 3458, 38991, 
5627) failed. Candidate sequences containing no intron have a length of appr. 1500 bp. 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The ORF of CYP-candidate 11511 comprises 1611 bp and shows 97.8% identity to the 
sequence of contig 11511 in transcriptome of L. flavum. The ORF of CYP-candidate 11511 is 
shown below: 
ATGGATTTCTTCACTTCTCTCTCCACCGCTTCTCTCTCCACCGTCGCCATAGCCACCGCCTCCCTCGCCTTCCTC
TACTTCCTCTTCCGCACAATACTCTCACCGGCCGGCGACTCCAAACCCCATGCACAACAACAGCAACAAGCACCG
CCGCCGGTGGAGGCCAGCGGCGCGTGGCCCATCATCGGCCACCTCCACCTCCTCGCCGGACCTCAACCGGCGCAC
ATCGTCCTCGGCCAGATGGCCGAGCACCACGGCCCCATCTTCACCATCCGGATGGGAGTCCACCGCGCCGTCGTC
GTCAGCAACCGTGAAACCGCCAAAGAATGCTTAACCACCCACGACCGGGTCTTCGCCGATCGACCCGCCACCCTC
GCCATGGACCTTCTCGGGTACCGCCGCTCCATGCTCGGGTTCAGCCCGTACGGCGCTTACTGGCGGCAGATCCGG
AAGATCGTCACGCTGGAGCTCCTCTCCTCCCACCGCCTCGAAACTCTCAAACACGTCAGGGAATCGGAGATCCAC
GTGGCAACCAAGGAGCTCTACGCGGCGGCCGGAGGGGGAAACGGCGTCGTAGAGATGGGTACTTGGTTCGGGGAG
ATAACGTTGAACGTGATCTTGAAGATGATCGTGGGGAAGAACGTCGGGTACTTTTCGGGCGGAGGAGAGGGAGTG
AAGCTGAGGAAGTTGTTGAAGGATTTTTTCGAGCTGGTCGGGTGGTTTCTGGTGACCGACGGACTGCCGTTTCTG
Sample Annealing 
temperature (°C) 
4471-1 58.9 
4471-2 60.1 
27263-1 56.1 
27263-2 57.5 
27263-3 58.9 
27263-4 60.1 
2408-1 58.1 
2408-2 59.8 
11511-1 50.3 
11511-2 51.7 
Sample Annealing 
temperature (°C) 
74047-1 53 
74047-2 54.5 
3458-1 53 
3458-2 54.5 
2702-1 54.5 
2702-2 55.9 
11862-1 54.5 
11862-2 55.9 
Figure 39: Agarose gels of PCR-products of candidates 4471, 27263, 2408, 11511 and 11862  
The individual numbered lanes represent PCR-products which are formed under the indicated annealing-
temperatures. PCR-products are marked with boxes. 
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CGGTGGCTGGACGTCGGAGGGTCCGAGAAGGCGATGAGGAAGACGGCGAAGGAGTTGGACGTTGTGGTCGGAGAG
TGGATGAGGGAGCACGAAGGGAAGCGAGGTTCCGCCGGCGGCGGGAAGAAGGCGGCGGCGGAGGAGGATTTTATG
GATGTGATTATGAACGTCGTCGGCGGTGAGGAAGGCGGCGGCGTCGTGGGTCGGGATTCTGAAACGGTCAACAAA
GCTACTTGTTTGGCTCTCATCTTAGCCTCTTCAGACACGACCACCGTGACAATGACGTGGCTCATGGCTCTCCTC
GTCAACCACCCCGACGTCCTAAAAAAAGCTCAGACCGAGCTAGACGACGTCGTCGGCAAACTCCGGCGAGTTCAA
GACTCCGATCTCCATAACTTACACTACCTCAAAGCCATCATCAAAGAAACCCTCCGGCTCTACCCGGCCGCACCT
CTCTCCATCCCCCACAAGTCCACGGAGGACTGCACCGTCGCCGGCCGGTTCGTCCCCAAAGGCACCCAACTCATC
GTCAACATATCGAAGATCCAGCGCGACCCGGGTGCCTGGTCGGACCCGGACGAGTTTCGACCCGATCGGTTCGTT
ACCACGCACAAGGACGTCGACTTCCGGGGTCAATATTTCGAGCTCATACCGTTCGGTAGCGGAAGGAGGATGTGT
CCCGGAGTGACTTTCGCGATGCAGGTCATGCAGTTGACGGTGGCGACGTGGTTGCATGGGTTCGATTTCAAGAGG
ACGAGTGACGAGATGGTCGATATGACGGAGGGCGTAGGGCTGACGAATCCGAGAGCGGAGCCTCTCGAAGTTGTG
TTGTCTCCTCGCCTGCCACCGCATCTGTATGAATGA 
 
The ORF of CYP-candidate 11862 comprises 1545 bp and shows 98.2% identity to the 
sequence of contig 11862 in transcriptome of L. flavum. The ORF of CYP-candidate 11862 is 
shown below: 
ATGGATTCTCTCTTTGCTTCAATTGCTCTGGCCGTCTCCTTCCTCTGTCTCGCCGGCTTCTTCCTCACCGACGGC
CTCCGGCGCCTCGGCTCCGACAAGCAAAAGCGATATCCACCGGAACCAGCCAACAGATGGCCAGTCATCGGCCAT
CTCCCGGTAATGGCCGGATCGGAGCTCCCTCACCGAGCACTCGCCGCCTTGGCCGACAAATACGGCCCCATCTTC
ACCCTCCGCCTCGGCTTCAACCGCGTAGTGATCGTCAGCAGCCCGGAGATCGCCAAGGAGCTCTTCACGACGAAA
GACACCGTCGCGCTCTCCCGCCCCAGAATGATCGCCACCGAGACCTTCTCCTACGACTTCGCCGTCTTCGGGATG
GGTCCGCACGGAGACTACTGGCGGGAGACGAGGAAGATCGCCGTCCTCGAGCTTCTCTCCAACCGCCGGCTGGAT
CTCCTCCGGCGGTTCAAGGAATCCGAAGTCCATAACTCGATCAACGACCTCTACAAGCAAATTGGGGGTAAATCG
GAGATCGACGTGAACAAATGGATCGGCGATTTGAGCATGAACCTCATGCTGAAGCTAGTTATAGGGAAGAGCTCC
TCCTCTGCTTCCGGCGGCTCTGCTATGATGGTCAAGTTCCAGATTGCGGTGAGGGAGCTTTTCCACTTAGCCGGC
CTGTCTCTGGTCGGCGACGCGCTTCCTTTTCTCCGGTGGATGGATATCGGCGGGCACGAGAAGGCGATGAAAAGA
GCTGCGAAAGCGATGGATGGGTATCTTCAGGAGTGGCTGAATGAGCACAAGGAAAACAGGGGAGGGGAGAAAACA
GAGCATGATTTCATCGACGTTATGCTGTCGCATCTCGACGGCCAGTCTCTCCACGGCTACGATTCCGATACCATC
ATCAAAGCAATGTGTCTGGCCATGGTTGCAGGAGGAATGGATACGACCAACGCGACAGTCATGTGGGCGATTGCT
CTTATAATGAACAACCGTGACGTGCGGCTCAAGGCACAGAACGAGCTCGACGACGTCGCCTCGAGGGAAAGGCTC
GTGACGGAGGCGGACATCGGAAAGTTACCGTACCTCCAAGCCGTCGTCAAAGAGTCGATGAGGATGTACCCGGCG
ACGCCGCTCCTGGCGGCGCGTGAATTCGTTACAGACCGTAAGGTGGGCGGGTACGACGTCGAGAAGGGTACGTGG
CTGATGTTCAACGCATGGAGGGTTCAGAACGACCCGAACGTGTGGCCCGACCCGACGAAATTCGACCCGGAGAGG
TTCCTGACGTCGGAGTTTCGAGACGTCGACGTGAAGGGGCAGAGCTTCGAGCTGTTCCCGTTCTCGAGCGGGAGG
AGGTCTTGTCCCGGGATGAATCTGGGACTGCAGCTGGTGCATTTGGCGGTGGCGAACTTTCTGCACGCGTTCGAG
GTTTCGCCGGCGGGGGATGCGCCGGTGGATATGAAGGAGAGCTTTGGGATGACGAATATGAAAGCGACGCCGCTT
TCGGTCGTGGCTTCGCCGCGATTGTCTCACGATGCTTATGTTTAA 
 
The ORF of CYP-candidate 2408 comprises 1605 bp and shows 99.9% identity to the sequence 
of contig 2408 in transcriptome of L. flavum. The ORF of CYP-candidate 2408 is shown below: 
ATGGCCGCCTCGCTCACCTTCTCCCCCCTGAAATCAACATTCCCCGGCGGCAACAACCCCCCGCCGCCGTCACTC
CGCCTCCACCGCATCCCAACCAGAATCTCCTGTCAAAACCAGAAACCCCAATCCGAATCCACCACTAAAAAGCAG
CTCCCTCCGGGACCGCCAAAACTCCCCCTCATCGGAAACCTCCACAACCTCGTCGGCGCGCTACCACACCAAGCC
CTCCGAAACCTCGCCACCGAATACGGCCCTTTGATCCACCTTCAGCTAGGGGAAATCTCCGCCGCCGTCGTCTCC
AACCCGGCGATCGCCCAAGAGATAATGAAAACCCACGACCTGAACTTCGCCGACCGACCCTGCATCTTCGCCGCC
GAGATCGCCACGTGGGGGGGCCAGGACATCGCCTTCTCCCCGCACGGCGAGTACTGGAAGCAAATGAAGCGGATC
TCGCTGACGGAGCTTCTGGGTCCCCGGAAAACCCAGTCTTTCCGCGGGATCAGAGAAACAGAGGTCGCCGGAATG
ATCGAGTCGGTGAGGAAGTCGGTCGGGAAACCGGTCAATGTAACCGAGAAGGTTCTCAGCCTGACGAATACGATC
ACTTGTAAGACCGCGTTTGGTTACCAGTGTATGGATCAGGAGGAGTTCGTCGGGCTGATGAACGGGGCAGTTCAG
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GCGGCGGGGGGGTTTAACATCGCCGATTTGTACCCGTCGTTGGGGTTTCTTCAGGGGCTTACGGGCATGAAATCG
GAGCTTCTGAGGATCCGAAACGGGTTGGATCGGATCTTCGATAAGATCATTAAGCAGCACGAGGAGAAGAGAGCT
AACGGCGATGTGGAATTGGACGACGAAGATCTGATGGATGTTCTTCTCCGGCTTCAGGGGAGTGGCGGCTTCAAG
TGTCCCATTACCAGCACCAACATCAAAGCCGTTCTTGTGGATCTTTTTATAGCTGGAACCGACACGTCATCGACG
ACCGTAGAATGGGCGATGTCGGAAATGATGAAGAACCCACGAGTGATGCAGAAGGCTCAGGCCGAGGTACGAGAA
GCCATGAGAGGCAAGTCAGTAGTCACCGAAGCGGATATTCAAAACCTACCGTACTTGAGCTCGATAATCAAAGAA
ACTTTCAGACTACATCCACCAGCCCCGCTGCTCCTTCCGAGGGAAAGCAAAGCGAACTGCGAGGTTGCAGGGTAC
GAGATTCCGAAGAAGACGAAAGTGATTGTGAACGCCTGGGCGATCGGGAGGGATCCAGGAACTTGGAAGGATCCC
GAGACTTTCATTCCGGAGAGGTTCGACGGAAGCGAGATTGACTTCAAAGGGATGCATTTCGAGCTGATCCCGTTC
GGTGCCGGAAGGAGGATATGTCCCGGGATCGCATTCGGGATGGCCAACGTCGAGCTCCCGATCGCTCAGTTGCTC
TACTATTTCAACTGGGAGCTCCCCGAAGGGGTCGCCGTCGAGGATTTCGACATGGAAGAGTCGTTTGCAGCCACC
ATGGGACGGAAGAACCCATTGTTTCTGGTTCCCAGAGAGTTCAATGGTCAACCGGAGGCTGTGAATGGAAGTTCT
TCTGAAATGTTAGAGGCTGTTGCAAATTAG 
 
The ORF of CYP-candidate 27263 comprises 1386 bp and shows 100% identity to the 
sequence of contig 27263 in transcriptome of L. flavum. The ORF of CYP-candidate 27263 is 
shown below: 
ATGGCCGACAAGTACGGCTCCATATTCACCGTCCGAATGGGGAGGCAACGAGCCCTCGTCGTCAGCTCCTGGCCG
ATCGCCAAAGAGTGCTTGGTCACCGTCGACAAGCCGTTCCTCAACCGGCCGAAGAATCTCGCCGCCAAGATCATG
ACCTACGACATAGCCATGTTCGGGTTCAGCCCTTACGGCCACTACTGGCGGGAGATGCGGAAGCTCGTCTCCCTC
GAGCTCCTCTCGGCTCAACGGCTCCGGACGTTCGCTCCCGTCCGGGAGTCGGAGGTCCGGGCAGCCACGAAAGCG
TTGTACGATCTCTGCGACGGCTCCTCCGTCGCGGTGGAGATGAAGCGGTGGTTCGCCGACGTGACGTTGAATGTG
ATAATGAGGATCATCGCCGGGAAGACGATCGGGTATGGTTCGGTCGTCGCCAGAGACGGTGGCGGCGGGGCGATG
GTCGGGTGGCAGAAGTCGTTGAGGGATTTCTTCGACTTGTTGGGGAAGTTCACGGTGGCGGATGCGGTGCCGGCG
TTGAGGTGGTTGGACGTCGGAGGGTACGAGAAGGAGATGAGGAAGACGGCGAAGGAGCTGGATACGGTGGTCGGA
GGATGGTTGGAGGAGCATAAGAGGAAGAGGGTGGTGGCTGCCGCCGGCAGCGGGAAGGTGGAGGAGGATTTCATG
GACGTGATTCTTAACGTTATTGGTGATTCCGGTGGGATCGACGGCCGTGATTCCGACGTCATCAATAAAGCTACT
TGCTTGTCTCTAACCCTCGGCGGCTCCGACACGACGACGGTGACGATGTCGTGGGCGCTCTCCTTACTAGTAAAC
CACCGGAGCGTCTTGACGACGGTTCAAGAAGAGCTCGACCGCTGCGTCGGCCGGGAGAGACAAGTCCAGGACTCC
GACCTCCACAACCTGACCTACCTGAAAGCCGTCGTGAAAGAGACGCTCCGCCTCTACCCGGCGGCGCCGGTGATA
ATGCGCGACGATTCCGACGACGACGCCGTCATCGACGGCCGCCACGTGGGCAAGGGGACGAGGCTCCTCGTCAAC
CTCTTCAAGCTCCAGCGCGACCCGGCGGTGTGGTCCCCGGATCCGGACGAGTTCCGGCCGGAGAGGTTTCTGGAA
GGGCGGCACAAGGACGCCGACGTGAAGGGGCAGAGCTTCGAACTGATACCGTTCAGCAGCGGCCGGAGGATGTGC
CCCGGCGCGTCGTTCGCTCTCCAGGTTATGTACTTGACTCTGGCGACGGTCCTACAAGGGTTTGAGGTCACGACG
GCGGACGGCGGGCCGGTGGATATGACGGACGGCGCCGGGTTCACTAATCTGAGAGCTACTCCGTTGGAGGTTTTA
CTGTCTCCCCGGCTTCCAGCTCATTTGTACGGCTAA 
 
The ORF of CYP-candidate 4471 comprises 1515 bp and shows 100% identity to the sequence 
of contig 4471 in transcriptome of L. flavum. The ORF of CYP-candidate 4471 is shown below: 
ATGCCTTCACTACTTATCTACCTTCTCCTAGCTCTCCCTCCCGTCCTACTATTATTCATTTTCCAAAAGCATAAG
AAGAAGAATTCAAAGAGTGCTTCGTCTCTCCCACCTGGCCCTCGGGGACTTCCCTTGATAGGGAACTTGTTCCAG
CTTGATCCCTCAGCCCCTCATCGCTATCTATGGCAACTTTCTCAAACATACGGACCCTTATTATCTCTGAGGCTG
GGCCGTGTTCAGGCTGTCGTAGTTTCCACCGCCAAAATGGCTCAGGAAGTCATGAAAACTCAAGATCTTGTCTTC
TGCAACAGGCCACAAGCAATGGGCACAACAAAGTTGTCGTACAACCGCGTGGACTTGGCATTTGCACCCTATGAT
GCTTACTGGAGAGAGATGAGAAAAATATGTATGGTATATCTCTTTAACTCCAATAGAACTCAAAGCTTTGGTCCC
ATCAGAGAATACGAGGTCTCCCAAATGGTTGGGAAGGCTTCGAGATCTTCATTATTAGCTTCTCAGCCTTTTAAC
TTGTCAGAGGCCATGATGTCTCTGACAACTACAATTATATGTCGTGTGGCTTTCGGCAAGAGGTACGAGGAGGAG
GGAACAGAGAGAAGCAGATTCCAGTCTATGTTGAATGAAACTCAAGCCATGTTTACGAGTTTCTTTTTCTTGGAT
CATTTCCCCATTTTAGGTTTCATCGATAGGCTTACTGGGTTGACCAATCGTCTCGAGAAGAATTTCATTGAGTTT
GATGCTTTTTACCAAGAGATAATTGATGAGCATCTTGACCCAAAAAGAGTAAAGCCCGAGCAGGAAGACATTCTC
GACGTCTTGCTTCAAATATGGAAGGATCGGTCTTTCAAAGTCCAACTCTCATTCGACCACATCAAAGCCCTTCTT
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ATGAACATATTTGTTGGAGGATCGGACACAAGTGCAGCTACCGTTGTTTGGTCGATGACATATCTAATGAAGAAC
CCTCTGATGATGGGAAAAGTTCAGAAAGAAGTTAGGGATGTAGTTGGGAATAAAGGTTTCGTAAATGAAACAGAC
ATACAACAGTTACCTTACTTGAAAGCTGTGATTAAAGAGACGATGAGATTGCAACCTACGGCTCCGTTACTGCTC
CCAAGGGAATCAATTGAGAAATGCAACTTAGGTGGGTACGAAATACCAGCCAAAACTGTAGTTCATGTGAATGCA
TGGGCAATCGGAAGGGATCCTGAAGCCTGGGGCGAGAACCCAGAAGAGTTCAAGCCAGAAAGGTTCATAGGAAAG
TGTATCGATGTGAAAGGCATGGACTATGAGCTAATACCATTTGGAGCAGGAAGAAGAATATGTCCTGGGATTCAC
ATGGGGCTTGTAACGGTGGAACTTTCACTAGCTAATTTGCTTTATGCCTTCGACTGGAGGATGCCAGCCGGAGTA
AAAAGCGAAGATTTGGACATGGATGTTCTACCAGGTCTCACGATGCACAAGAAAAATGCACTATGTCTAGTAGCT
ACAAAGTTTTTATAA 
 
The start codon and the stop codon are written in bold letters. The amino acid sequences of the 
candidates were translated from cDNA with ExPASy translate. 
The amino acid sequence of CYP-candidate 11511 is as follows: 
MDFFTSLSTASLSTVAIATASLAFLYFLFRTILSPAGDSKPHAQQQQQAPPPVEASGAWPIIGHLHLLAGPQPAH
IVLGQMAEHHGPIFTIRMGVHRAVVVSNRETAKECLTTHDRVFADRPATLAMDLLGYRRSMLGFSPYGAYWRQIR
KIVTLELLSSHRLETLKHVRESEIHVATKELYAAAGGGNGVVEMGTWFGEITLNVILKMIVGKNVGYFSGGGEGV
KLRKLLKDFFELVGWFLVTDGLPFLRWLDVGGSEKAMRKTAKELDVVVGEWMREHEGKRGSAGGGKKAAAEEDFM 
DVIMNVVGGEEGGGVVGRDSETVNKATCLALILASSDTTTVTMTWLMALLVNHPDVLKKAQTELDDVVGKLRRVQ
DSDLHNLHYLKAIIKETLRLYPAAPLSIPHKSTEDCTVAGRFVPKGTQLIVNISKIQRDPGAWSDPDEFRPDRFV
TTHKDVDFRGQYFELIPFGSGRRMCPGVTFAMQVMQLTVATWLHGFDFKRTSDEMVDMTEGVGLTNPRAEPLEVV
LSPRLPPHLYE 
 
The amino acid sequence of CYP-candidate 11862 is as follows: 
 
MDSLFASIALAVSFLCLAGFFLTDGLRRLGSDKQKRYPPEPANRWPVIGHLPVMAGSELPHRALAALADKYGPIF
TLRLGFNRVVIVSSPEIAKELFTTKDTVALSRPRMIATETFSYDFAVFGMGPHGDYWRETRKIAVLELLSNRRLD
LLRRFKESEVHNSINDLYKQIGGKSEIDVNKWIGDLSMNLMLKLVIGKSSSSASGGSAMMVKFQIAVRELFHLAG
LSLVGDALPFLRWMDIGGHEKAMKRAAKAMDGYLQEWLNEHKENRGGEKTEHDFIDVMLSHLDGQSLHGYDSDTI 
IKAMCLAMVAGGMDTTNATVMWAIALIMNNRDVRLKAQNELDDVASRERLVTEADIGKLPYLQAVVKESMRMYPA
TPLLAAREFVTDRKVGGYDVEKGTWLMFNAWRVQNDPNVWPDPTKFDPERFLTSEFRDVDVKGQSFELFPFSSGR
RSCPGMNLGLQLVHLAVANFLHAFEVSPAGDAPVDMKESFGMTNMKATPLSVVASPRLSHDAYV 
 
The amino acid sequence of CYP-candidate 2408 is as follows: 
 
MAASLTFSPLKSTFPGGNNPPPPSLRLHRIPTRISCQNQKPQSESTTKKQLPPGPPKLPLIGNLHNLVGALPHQA
LRNLATEYGPLIHLQLGEISAAVVSNPAIAQEIMKTHDLNFADRPCIFAAEIATWGGQDIAFSPHGEYWKQMKRI
SLTELLGPRKTQSFRGIRETEVAGMIESVRKSVGKPVNVTEKVLSLTNTITCKTAFGYQCMDQEEFVGLMNGAVQ
AAGGFNIADLYPSLGFLQGLTGMKSELLRIRNGLDRIFDKIIKQHEEKRANGDVELDDEDLMDVLLRLQGSGGFK 
CPITSTNIKAVLVDLFIAGTDTSSTTVEWAMSEMMKNPRVMQKAQAEVREAMRGKSVVTEADIQNLPYLSSIIKE
TFRLHPPAPLLLPRESKANCEVAGYEIPKKTKVIVNAWAIGRDPGTWKDPETFIPERFDGSEIDFKGMHFELIPF
GAGRRICPGIAFGMANVELPIAQLLYYFNWELPEGVAVEDFDMEESFAATMGRKNPLFLVPREFNGQPEAVNGSS
SEMLEAVAN 
 
The amino acid sequence of CYP-candidate 27263 is as follows: 
 
MADKYGSIFTVRMGRQRALVVSSWPIAKECLVTVDKPFLNRPKNLAAKIMTYDIAMFGFSPYGHYWREMRKLVSL
ELLSAQRLRTFAPVRESEVRAATKALYDLCDGSSVAVEMKRWFADVTLNVIMRIIAGKTIGYGSVVARDGGGGAM
VGWQKSLRDFFDLLGKFTVADAVPALRWLDVGGYEKEMRKTAKELDTVVGGWLEEHKRKRVVAAAGSGKVEEDFM
DVILNVIGDSGGIDGRDSDVINKATCLSLTLGGSDTTTVTMSWALSLLVNHRSVLTTVQEELDRCVGRERQVQDS 
DLHNLTYLKAVVKETLRLYPAAPVIMRDDSDDDAVIDGRHVGKGTRLLVNLFKLQRDPAVWSPDPDEFRPERFLE
GRHKDADVKGQSFELIPFSSGRRMCPGASFALQVMYLTLATVLQGFEVTTADGGPVDMTDGAGFTNLRATPLEVL
LSPRLPAHLYG 
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The amino acid sequence of CYP-candidate 4471 is as follows: 
 
MPSLLIYLLLALPPVLLLFIFQKHKKKNSKSASSLPPGPRGLPLIGNLFQLDPSAPHRYLWQLSQTYGPLLSLRL
GRVQAVVVSTAKMAQEVMKTQDLVFCNRPQAMGTTKLSYNRVDLAFAPYDAYWREMRKICMVYLFNSNRTQSFGP
IREYEVSQMVGKASRSSLLASQPFNLSEAMMSLTTTIICRVAFGKRYEEEGTERSRFQSMLNETQAMFTSFFFLD
HFPILGFIDRLTGLTNRLEKNFIEFDAFYQEIIDEHLDPKRVKPEQEDILDVLLQIWKDRSFKVQLSFDHIKALL 
MNIFVGGSDTSAATVVWSMTYLMKNPLMMGKVQKEVRDVVGNKGFVNETDIQQLPYLKAVIKETMRLQPTAPLLL
PRESIEKCNLGGYEIPAKTVVHVNAWAIGRDPEAWGENPEEFKPERFIGKCIDVKGMDYELIPFGAGRRICPGIH
MGLVTVELSLANLLYAFDWRMPAGVKSEDLDMDVLPGLTMHKKNALCLVATKFL 
 
 
3.2.2 Generating full-length sequences of CYP-candidates from gDNA 
3.2.2.1 Amplification of CYP-candidates from gDNA and sequencing 
Standard PCR was performed firstly with cDNA as template and corresponding primers of the 
identified CYP-candidates in order to amplify these sequences. However, only five candidates 
were successfully amplified. gDNA was used as alternative template for standard PCR 
experiments (see III.2.4.1). As shown in Fig. 40, additional six CYP-candidates were 
successfully amplified. 
 
 
Sample Annealing 
temperature (°C) 
38991-1 51.2 
38991-2 52.7 
38991-3 54 
74047-1 51.2 
74047-2 52.7 
74047-3 54 
Sample Annealing 
temperature (°C) 
3458-1 51.2 
3458-2 52.7 
3458-3 54 
5627-1 51.2 
5627-2 52.7 
5627-3 54 
Sample Annealing 
temperature (°C) 
2114-1 54 
2114-2 55.5 
2114-3 58.1 
2227-1 54 
2227-2 55.5 
2227-3 58.1 
Figure 40: PCR of CYP-candidates 38991, 74047, 3458, 5627, 2114 and 2227 with gDNA as template 
The individually numbered lanes represent PCR-products which are formed at the indicated annealing 
temperature. PCR-products are marked with boxes. 
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The gDNA-sequence of CYP-candidate 2114 comprises 1991 bp incuding one intron 
(underlined) with 434 bp and is shown below: 
ATGGAGCTCCTCCAAATGTTACCTGCAATCCCACTCCCATCCCTTCTCCTCACCATCGCCACCATCTTCTTAATC
TCAATCATCATCTCCAAAAAAACCTCCCAACGCAAAAATGGGTCGTCCAACAACCTCCCGCCTGCACCCTGGAAG
CTACCGGTGCTCGGACACCTCCACCACTTCTTCACCAGCCCCGAGCCCCCACACCGCCGCCTCCGCCAGCTGGCC
CAAACCCACGGCGACGTCATGCAGCTGGAGCTCGGCGAGATCAGCCACGTCATCATTACTTCTGCTGAAGCAGCC
AAGGAAGTGATGCGGACCCACGACATCAAGTTCGCCCAGCGTCCCTTCCATCCTCACCAGGCCAAGATCATGTAC
GGCGGCATCAACCTCATCCACTCCCCCTACGGCGAGTACTGGCGCCAGCTCCGCCGCATTGCCACCCTCGAGCTC
CTCACCGCCAAGCGCGTGGAGGCTCTCCGTCGCGTGAGGGAGCCTGAGGTCCAGGCCCTCATGAGGACCATCGCG
AAGCAACGGCCCGGAGAGGTGGTGGACCTGAGCAAGGaTTTTGTTCGGTCTGTCGTACAGCATCATCTCGAAGGC
GACGTTTGGCGACGTGTCGTCGGAGCAGGAGGAGTTCATAGCGATAGCGGAGGCGCTGGTGAGGCACGGCGGTGG
GTTCGGGCTGTCGTTTTTGTTCCCTTCGAGTGGGTTGGTGCAGAAGTTATTTGGGGTGAAGGAGTGGCTGGATAA
GATGCATGAAGGGACCGACAAGTTGGCTGAGAGCATCATTAAGCAGCATAGGGCGAGGAGAGCTGTGACTAAGAA
ATCCGAGGATGAAGAGGATTTGCTGGATGTGTTGCTTAACCTTCAGGAAGATGAGACCACGCTGGGTTTCAACTT
GTCCACCGATTCCATCAAGGCTTTCCTTCTGGACGGTTAGTGGTGTGGGTGTTTGTTTATTTGCCGTTTCGGTTT
TTGTTTTTTTTTTTTNNCAATGGTTCCTTCCTGTCCTTTTCTTTGGTGGGCATGTAGGTAGCAATGGTAAGTGGG
TTCGGCTATAGTGTTATTTCTTTTTAATAATAATAATGGTATTGTTATTTGGATGTTGCATGAAAACACGCATAT
CACAAGTCACGTGCCAGTCAATACAATAAGATATAAATTTTGTTTTGTCGTATATATAACACGTGAAATGTCCAT
GTGAAGTGTCGGTCTTATCATAATTCATAATGCAAGAGGATGATAACAATTAATACTTGTTATATTCAAATTTCG
AGATCCACAAATAATTATAATAAAGAAGAGTGATGCAAAGTAATTGTTTGATCAATAAGTAACATTTATCATTGA
CTCCATGGATTACAGGACATTTTCTTAGCCGGAAGTGAGACTCCATCATCGTTGACCGAATGGGCAATGTCAGAA
TTGATGAGACATCCGGACGTATTACAAAAGGCACAAGCTGAAGTGAGAAAAGTGTTCGGTACAAAGGGAAGGGTC
GATGAAGCTGGGATTCACGAACTAACCTACTTGAAAATGGTTATCAAAGAGACACTACGACTGCATACTCCCGCG
CCACTAGYSCTTCCAAGAGAGTGTAGAGAGGAGTGCAAAATTGGCGGGTACGATATTCCTTTGAAGACAACCGTT
GTTGTGAATGCGTGGGCTATCGCAAGAGATCCTCGTTATTGGGGAAAGGAAGCTGAAAAGTTTATGCCGGAAAGG
TTTTTGAACAACGAAGTCACATTCAGAGGAGGTGATTTTGAGTTTCTTCCATTTGGAGCGGGTAGAAGGATGTGT
CCAGGAATGACGTTCGGATTAGCGGCCGTGGAACTTCCTCTCGCTAATTTGCTATACCATTTTGATTGGAAGCTT
CCAAATGGGGTCGAGCCGGCTAATTTGAATATGGATGAAATATTTGGCATCACTATCAGGAGGAAGAAGCATTTA
GAGTTGATTCCCGTGGCTCGCAACCCTGTACCAACCGTTTAG 
The gDNA-sequence of CYP-candidate 2227 comprises 1738 bp incuding one intron 
(underlined) with 211 bp and is shown below: 
ATGGAATGCTCCTACTCCCAATTCCTTTCTTTCCCACCCATCTTCGCCTCTCTTCTCTTCCTTGTCTCCTTCCTC
CTCCTCCTCAAACTCCACCGCGGATCAAACAGTTCCGCCGCAGCCCCGCCGCCTCCGGGACCCACTAAGCTGCCC
ATAATAGGAAACCTCCACAACCTCGCCGGCGGCTCCCTACCCCACCACCGCCTCCGGGACCTTGCCACCAAATAC
GGCGGCGTGATGGGGCTTCAGTTAGGCCAAGTCCCCCACTTGGTCATCACCCCCGCAGAAGCCGCCAAAGAAGTA
ACGAAGACCCACGACGTCGTTTTCGCCCAGCGCCCCGCCATGCTCGCCGCCGAGATCATCAGCTACAACTTCACC
GACATCGCTTTCGCCCCCTACGGCGCCTACTGGCGCCAGCTCCGCAAGATCTGCATTCTCGAACTCCTCAGCGCC
AAACGGGTCCAATCTTTCGGGTCGATCCGGGATGAAGAGGTATCGAACGCCGTGACTCGAATCGCTGCTTCGGCT
GGTCGGGAGCTTAATTTCAGCAGGATGCTCTTCTCCCTTACCTACGGGATCGCCGCCAGGGTCACTTTCGGAAAG
AAGTACAATGGGCAGGACGAATTCATTCCGGTGGTGGAAGAAATCACTCGGGTCGCGGGTGGATTCAGCCTCGCC
GACTTGTTCCCTTCGGTAAAACTGCTTCAGGTTGCGAGCGGGATGAGATCCACGCTTCTCAGGCTGAGAGGTGAA
GCTGATCGGATGTTGGGGAGTATAATCGCCGACCATAGAAGCAAGGGTAGTAAGGAAGATTACGCCGGCGGCGAG
GTGGAAGATTTGGTTGATGTCCTTTTGAAGCTTCAGGGTAATGGCGAGCTCGATTTCCCCCTCACCGATGACAAC
ATCAAGGCCGTCATTCTCGTAAGAAATCACCCCCCTCAAAATTTCCATCAGGCCTCAACGAATTTCAAAATACAG
TTATTTCAACTTTTTTTTTTTTTTTGTCAATCCTTTTTTAAAGGGGTGCAACACGAAGACTTCCCAATATTTCAA
CTTTTATTAATATAGGACAAAATATGAGTAGAATCTTAATGGTAAGCTTAAATAGTGTGTTTTTTTTCTTCTTTT
TAAGGATATATTTATTGCTGGGAGTGAGACTTCGTCGACCGCAGTAGAATGGGCGATGTCAGAAATGCTGAAGAA
TCGTAGAGTTCTCCATGAAGCACAAGCAGAGGTGAGGAGAGTTGTCGGAGGAAAAGGGGGAGTCGACGAAACCTT
ACTTCATGAGTTACACTATATGAAATTGGTGATCAAGGAGACGCTAAGACTACATGCTCCAGTGCCTTTGCTACT
TCCAAGAGAATGCGGTGAGGATTGCAAGATCGGTGGGTTTCAAGTAGAGGCGAAGAGCAAGGTGATTGTGAATGT
TTGGGCGTTTGGAAGGGATCCAAAGTACTGGAAGGAACCAGAGGAGTTTCGTCCCGAAAGGTTTATCGATAGTTC
AGTGGATTTCAAGGGGTCGAATTTCGAGTTCTTACCGTTTGGAGCCGGAAGGAGAATGTGTCCAGGAATGGTATT
90 
 
TGGGATGGCGAATGTTGAGTTGCCGCTGGCCAAATTTTTGTACCATTTTGATTGGGAGCTAGCGGGTGGGATGAA
GGCAGGAGATTTGGATATGGAAGAGTCGTTTGGGGCGACGCTTACAAGAAAAAACGACCTCAAATTGATTCCAAC
CCCATACCACTAG 
The gDNA-sequence of CYP-candidate 3458 comprises 1801 bp incuding one intron 
(underlined) with 253 bp and is shown below: 
ATGGAGAGGAATATCAGAGCTTTCTCTTCCTTCGATCTCCCTTTCCTCTTCTCTCTTGCAACCATCCTTGCAGTC
ACCTCATTCATCATCCGAAAGCAGAGGTCTAAACCCGCCGCCGGTTTAAACCTGCCGCCGGGGCCATGGAAGCTA
CCCATCATAGGAAACCTCCACCAGATGCTCGGCGACCAACCCCACCGCCGACTGAGGGACCTGTCCCTCAAATAC
GGCCCCGATGTGATGCAGCTTCAGCTTGGGGAGATCTCCCATATCGTGATCTCAACTCCTGAAGCAGCCAAACTA
GTGATGAAAACCCACGACATAGCTTTCGCTTCGAGGGCTTCTCTCCTGGCCACCAACATACTCTACGACGGTTGC
AAGGACATAGCGTTTGCGCCCTATGGAGAGTACTGGAGACAGATGCGCAAGATCTGCACGTTGGAGCTTTTCAGC
GCTAGAAGGGTTCAGTCTTTTCGGCACATCAGGGAAGAAGAGGTCTCCAACCTCGTGGCCTCTCTTGCTCGTTCT
GCGGGGAAGCCTGTGGATCTCACTCAGATGTTGTTTAAGCAAATGAGCACTGTTACTTCGAGGGCAGCGTTTGGT
AGAGTGCAGCAGCTAAACGATGCTTTTATGGTGGTCCTCGATAATATTTCGGATGTTCTTGCAGGTTTTACAATC
TCTGATCTCTATCCTTCCTTCAAATTCTTGCCTATCATTACTGGGTTCAGAGCTAAGTTAGAGAAGATGCATGAG
GCATCAGATTCGTTGCTAGACCGAATCATCGACGACCATAAATCGAGGAGATCGAGCAAAGGTGGTGATTATAAT
AATGATGAAAAAGAGGATCTTGTTGATGTGCTTTTGAATCTTCATGAAAATCAGAACCTTGGAGTACCCGTTACC
ATGGAAGTTATAAAAGCGGTCACTTTGGTAAGTAGATGTTAGTTCTATTCAAGTTTTGCCTCGTATATGCAAATT
TTAGCTCACTTCAATTCTCTTAGAATGTGTTTGGTTTGGATATGTGTATTTGAAATGCATATGTATTCGAAATCC
TCAATTCTAAATGTCTGCAATTGAAATGCGTGTAATTCAAATCCATTTGTTTGGATATTCATTTGCAACTTTTAG
ATATTTGAGATTTTGACTGAAAAAACTATATGTTGGATTTTGCTTTTGTTGTTAGGAACTGTTCATAGCTGGCAT
TGAGACAACAGTAACGGCGATGGAGTGGACCATGTCTGAAATTATAAAAGACTCAAGAGTACTTCAAAAGGCTCA
AAAAGAAGTCAGACATGTATTCGGCGAGCGTGGAAGTGATATTGACGAAGCAAGTCTTAATCAACTGACGTATTT
GGACATGGTTATTTCGGAAAGTTTGAGATTACACCCTCCGCTTCCATTCATTCCAAGAGAAAATAGGGAGAAGTT
GGAACTTGGTGCATATGATGTCCCCATCAACACCAAAGTTTTTGTGAATGCATGGGCGATCAATCGAGATCCTCA
TCAATGGGTCGATCCAGAGAAATTCTATCCCGAAAGATTCTTGAACTGCTCAACTGATTACAAAGGAAACGATTT
TCAGTTCCTTCCATTTGGTGCCGGAAGAAGGATATGTCCAGGGATGTCTTTCGGAATGACGAATGTTAAACTTTC
CTTGGCGAATTTGCTCTATCACTTTCAGTGGGAGCTTCCATCCGAAATGAAACAAGAAGGCATTGATATGACTGA
ACGTTTTGGAGCGTCACTTAGAGGGAAACATGCTCTTCGTTTGATTCCAATTTTATACGATGGCATGGCAGCTTG
A 
The gDNA-sequence of CYP-candidate 38991 comprises 1686 bp incuding one intron 
(underlined) with 99 bp and is shown below: 
ATGGATATCATCATCTCCCACCTCCCAGAAATCCTCGTCGCTCTAGCCGCCGCCGTGTTCATCCACCTATGGCGG
AAGCAGCAGCAGCAGAAGAACAGCGGAGGAGTCCCCGAAATCCCCGGCGGCTTGCCATTAGTCGGCCATCTCCAC
CTCCTCGCCCGCGGCAACCAGACCCTCTCCCGGAAACTAGCAGCCTTCTCCGAAAAACACGGACCCGTCTTCACC
ATCCGCTTGGGAGCCAACGCCGCCGTCGTCGTCAGCGACTACGAGTCAATGAAAGAGTGCTTCACCACCAACGAC
CGGACCCTCTCCTTCCGGCCGGACTCCAGCCAGGCCAAAGTCCTCGGCTACAACTACGCAGCCTTCGGGTTCGCT
TCCTACGGGAACTACTGGCGGGACATGAAGAAGATGCTCATGACCGAGCTCCTCTCCGTCCAGCGGATCAAAGCC
CTCCGCGGCGTCCAGATCTTCGAGGTCAATTCCTTAATCCGCGACCTCTACAAACAAAGCAAGGTTGGTGACAAG
TCGATTGTGATCAGCGACGCGCTGCAGAGCTACGTGCTGAACGTCATCACAAGCATGGTCGCGGGGAAGAGGTAC
TTTAACAAGACGGAGGAGGAGGAGGAGGTGTCGTCGACGACGACCTCCGGAGGGAGGCCGATAGGTCAGGTGATG
AGGGAGTTCATGCTCGTCACTGGAACCCTCGTCCCCTCCGATCTGATCCCGATTCTCGGGTGGTTCGGGTTCCAG
GGAGTCGTCAAGGATATGAAGCGGGTGTCGAAGGAGCTCGACGTGATCATGGAGAGCTGGCTGGACGACCACAAG
AGGAAGAAGAAACACCCGACGACGACGAACGGCGGCGCGAATCCGGACCTTATCGACGTCATGCTCTCCGAAATC
AAAGAAGAAGTCGCTTACGGCCACAAGCGCGACGACATCATCAAGGCTACCGCCATGGGTAGGTGGTAGTTTATT
CATTAACATTTTCATTCTCTGAGATGATCTTTGCCAATGGTGATTAATTATGATTATTTGTTGTGATTTATCTTT
GTTACATCTTTGATCGTGGCGGGGTCGGATACGACGTCGATTACGCTGACGTGGATCTTATCCAATCTGCTGAAC
CACGAGCGGGTGATGAAACTGGCTCAGAAAGAGATCGACGACGTGGTCGGGACAGAACAGTGGGTGGACGATTCG
GATATCGAAAAGTTGACGTATTTGGGAGCGGTGATTAAGGAGACGTTGAGAATGTACCCGCCGGGTCCGCTTTCA
GTGCCTCGAGAGGCGTCTGAGGATATCACGATTAGAGGGTACCGCGTTCCGAAAGGTACGCGGTTCTTGGCCAAC
TTTTGGAAGTTGCATAGGGATCCGAAGGTTTGGTCCGACCCGGACGAGTACAGACCGGAGAGGTTCTTGACTGAT
91 
 
AATGTCAATATGGATATATTCGGTCAGCAGTTCGAGTATCTTCCGTTCGGGTCGGGAAGGAGAGGGTGCCCCGGG
ATCAATTTCGGGATGCAGGTGACCCAATTGACTTTGGCGAGGCTGCTTCAGGGGTTCCATTGGGGTACTCCGGAC
AATAAACCTGTTGATATGACGGAAGGGTTGGGAATTGCGCTTCCGAAGGCTAATCCGCTCGAGGTCGTCCTAACG
CCGCGCCTTTCTCCCGAGTTGTATGGAGTACTTTAG 
The gDNA-sequence of CYP-candidate 5627 comprises 1716 bp incuding one intron 
(underlined) with 42 bp and is shown below: 
ATGGATCTGTTCCTTCCATCCCTGAGCTCTGCAATTCCAGGAATTGCTGTTGCTCTGTTTCTGTTTCTGTTCATC
ATCGCGAAAAACAGAGCAGGAAAGGGCAAGCGATCAGTTCCCGAAGCAGGGCGATCATGGCCGATCATCGGCCAT
CTCCTTTCGCTGGCCGGAGGAACAGAGCAGCAACTTCCCCACTTGATACTCGCAGAGCTTGCTGACAAATACGGC
CCGATCTTCATGCTCAGGATCGGCATGTTCCCGACGGTGGTCGTCAGCAGCTCGGAGATTGCTAAAGAGCTTTAT
ACTACTCACGACGCCGCCATCTCTTCCCGCCCCAACTTCACCGCTTCTGCGATTTTGGGGAACAACAGCGCCAAT
TTCGGGTTCTCGCCGTACGGCGAGTACTGGCGGATGATGAGGAAGATCACGGCGCTGGAGCTGCTCTCCGGCCGG
AGACTCGACCTTCTGAAGCGCGTCCGGACGTCCGAAGTGGAATCCGCCGTCAAGGATCTGTATATGTCGTGGGAG
AAGGAGAAGGAGAAGCACAGAGAAGAAGAGGGGACGGTCTGTGTTGAGATGAACAAGTGGTTTGGGGATATGAAC
TTGAACGTTATACTCGGGATGATCGCCGGGAAGAGGTACGGCGGCGGCGGCGAGGAGGAGGAGGAGGCGGAGCGG
TGCCGGAAGCTGATGAGAGACTTCTTCCACTACGCAGGGCAGATCGTGGCGAGAGACCTGTTCCCGTTTCTAGGG
TTTCTGGATATCGGAGGGCACGAGAGGACGATGCGGAGACTAAACGCCGATCTGAACGGACTCGCCGAGCAATGG
ATCGAGGAGCATCGCCGTCGCCGTCGTGACGGCGACGGCGAAAAGGAGGAGAAGGGAATGCGGACGACRAAGAAC
GATGAACATCGCGATTTCATCGACGTGTTGCTCTCGGTACTGAAAGATGTCGATCTCGCCGGTTACGATTTGGAC
ACTGTCTGCAAGTCCACGATCATGGTACCGTAGTAGTAGTTGTGAATTTGATTGTCGCGTCGGGATTTATAATTC
ACGCTTTATAATTTCTCGTCGGTTTATTATTTGCAGACTCTGATCGTCGGAGGTACCGACACGACGACGGTGACT
CTGACGTGGGCTCTGTCCCTGATCTTGAACAATCGGAGAACCCTAAAGAGGGTGCAGGAAGAGCTCGACGCAGTC
GTCGGGAGGGAGAGGCTGGTGGATGAATCGGACGTCCACAAGCTTCCATACTTTCAGGCCATGATCAAGGAGGTG
ATGAGGCTGTACCCGGCGGGTCCAATCGGAGGGCCTCGAGAATTCTCTCGAGACTGCTCCGTCGCCGGGTACCAT
GTCCCGGCGGGGACTCGGCTGATAGTGAACCTCTACAAGCTGCAGACCGACCCGAAGGTGTGGTTAGAGCCGATG
GAGTTCAGGCCGGAGAGGTTCCTCGATGCAGAGTGCAAGGATGTTGATGTGAAAGGGCAACACTTCGAGCTCATC
CCGTTCGGTGCTGGAAGAAGGTCGTGCCCTGGAATCAACTTTGGTATGCAGATGATCGGACTCGCCCTCGCGAGC
TTCCTGCAAGCGTTTGAGGTCTCTGTCCCGTCGGATGCACCGGTCATCGACATGACTGCGGTTTCTGGGCTGACG
GTGAGCAAAGCCACCCCGCTCGAAGTTCTGGTTAAGCCACGCTTGCCTTGGAGGCTCTACCAATAA 
The gDNA-sequence of CYP-candidate 74047 comprises 1690 bp incuding one intron 
(underlined) with 91 bp and is shown below: 
ATGGATTCCATAGCTCTACCCGTCATTTTCTCCCTCCTAACCATCTTCCTCTTCTCTTTCATCATCCTCCCGCGG
ATCCTTAACCGGAGATCAAAACCCAGACCACCGCCGCCAGAACCATGGAGGTTGCCGATAATCGGCCACATTCAC
CATTTGGCCGGCGGCGGCGGTAGCAGCGCTTTACCCCACCGCCGCCTCAGAGACCTGGCCAAAACTCACGGCCCG
GTGATGCTGCTCCGCCTCGGCGAAATCAACCACGTCATCATCTCCTCCGCCGATGCCGCCAAGCAAGTGTACAAG
ACCCACGACGTCGTTTTCGCGCAGCGGCCCTTCAACCTCGCCGCCAAGATCATCACCTACGACCGCTCCGACATC
GCCCACGCCGCCTACGGCGATTTCTGGAGGCAGCTGCGCAAGCTCTGTACCCTCGAGCTTCTCAGCCCGAAACGG
GTCCTATCGTTCCGGCCAATTCGCGAGGAGGAAGGGTTGAAATTCGTCCGGCGAATTTCCGCCGCCGCGGCGGCG
GAGGGTTCGCGGCCGGTGAATTTATCGAGGCTGATTTTCTCGCTGACGTACGGCGTGACGTCGAGGATCGCGTTC
GGGACGGTGAGGGAGGAGAAGGACGATGAGTATATTCCGGTGGTGGAGGAGATTATGGCGGCGGCGGCGGGGTTC
GGGGTGGCGGATCTGTTCCCGTCGGTGAAATGGCTGGAGAGGGTGAGCGGGATGAAAGCCAAGCTCGAGCGGCTG
CACGGAGTTCAGGATAGGTTGCTGGAGAAGATCATCGCCGATCATCGGGCGAGGAGATCGTCGCCGTCGTCGGCG
GCGGCGGCGGGAGAAAACAGGGGAGGAGGAGCAGGGGAACGATACGACGTCGCAGAGGATCTAGTGGATGCTCTG
TTGAATCTCCAGAGAGACGACGACGACGTCGGATTCAGCTTGACAAATGACAACATCAAAGCGGTTATTGGTAAT
CATTTCTTTCGGCTTCATCCTTTCATAACCCCGTCACAGTTTGGTTGTATGATTTTTTTTTTATTTCCTCGGATT
GTGGTTTTTTCAGGATGTGTTTATTGCCGGGAGCGAGACTTCGTCGACGACGGTGGAATGGGCGATTTCGGAGCT
GATAAGGAATCCGGACGCGATGAGAAGGGCACAAGAAGAAGTGAGACGAGTGTTCGGCGAGAGAGGGAGAGTCGA
CGAGGCGGGGCTGGATCGGTTGAGCTATTTGAAACTGGTGATTAAAGAGACTTTGAGACTGCACACTCCCGCTCC
TCTTTTGGTTCCAAGAGAGAGCAGGGAGGAGTGCGAGGTTGGCGGGTATTTGATACCCGTTAAAACAACTGTGTT
GGTGAATGCGTGGGCGATTGCGAGGGATCCTGGTACGTGGGACGAACCGGAAGAGTTTCGTCCGGAGAGGTTTCT
CGATGGCAAGGTGGATTATAAGGGGACGAATTTCGAGTATCTACCGTTCGGGTCGGGAAGGAGGATGTGTCCCGG
92 
 
GATAACGTTCGGCGTGGCGAATACGGAGTTACCGCTTGCCAATTTGCTTTTCTATTTTGATTGGAAGCTTCCGGG
TGATTTGAAGGTGGAGAGGTTGGATATGGATGAATCGTTTGGTGTCACGGTGAGACGGAAAAATGACCTGGAAGT
AGTTCCTGTAATTCGCTATCCTCCACCAATAATTTCTTGA 
 
In many eukaryotic genes, the coding sequences are interrupted by introns, which are cleaved 
from pre-mRNAs during splicing. The introns in gDNA sequences of the successfully 
amplified CYP-candidates were identified by comparing with the ORF-sequences obtained 
from the transcriptome database. Depending on the position of an intron in coding sequences, 
introns are classified into three different phase classes: phase 0 (located between two codons), 
phase I (located between the first and second nucleotide of a codon) or phase II (splitting 
codons between the second and third nucleotides) (Long et al., 1995). Furthermore, introns 
spliced by the major spliceosome belong to the U2-type and less abundant introns of the U12-
type are processed by the minor spliceosome (Dietrich et al., 1997). The consensus sequences 
located at the intronboundaries are important for proper recognition and removal of introns. 
Dinucleotide sequences at these boundaries are relevant for proper splicing and conserved in 
multiple introns. The vast majority of introns are flanked by GT-AG splice site dinucleotides 
(Aebi et al., 1986; Dietrich et al., 2005). The often exception to this rule are GC-AG and AT-
AC splice sites (Sheth et al., 2006). Many introns that have sequences other than GT-AG, GC-
AG or AT-AC at the intronboundaries, so-called non-canonical splice sites, have been reported 
to be efficiently removed as well (Szafranski et al., 2007). 
The intron phase and length of all introns of the six CYP-candidates identified from gDNA are 
listed below:  
CYP-
candidates 
Intron 
phase 
Length Start 
position 
Dinucleotide sequences at 
intron boundaries (5' - 3') 
2114 II 434 932 AC-GG 
2227 I 211 919 GT-AG 
3458 I 253 928 GT-AG 
38991 0 99 957 GG-CA 
5627 I 42 1006 AG-AT 
74047 II 91 971 TA-CA 
   
Introns tend to be more abundant close to the 5' end of genes (Sakurai et al., 2002). However, 
all CYP-candidates identified here contain only one intron that is located at appr. two third of 
the sequences, close to the 3' end. In most coding regions, the most common are introns phase 
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0, followed by introns phase I and the least common type is intron phase II (Tomita et al., 
1996). Whereas introns phase I are the most common in proteins with secretory signal peptides 
(Vibranovski et al., 2006). The intron phases of the sic CYP-sequences identified here are not 
consistent and the majority is phase I (50%). In addition, just two introns of CYP-candidates 
2227 and 3458 have the consensus sequences GT-AG at the intronboundaries. The other four 
candidates contain non-canonical splice sites. 
The amino acid sequences of the candidates were translated from full-length sequences and the 
molecular weight of the proteins calculated with the respective ExPASy tools. 
Candidate Number of 
amino acids 
Molecular 
weight (kDa) 
Candidate Number of 
amino acids 
Molecular 
weight (kDa) 
11511 536 59.2 2114 518 58.5 
11862 514 57.4 2227 508 56.1 
2408 534 59 3458 515 58.8 
27263 461 51 38991 528 59.3 
4471 504 57.3 5627 557 62.8 
74047 532 59.5    
 
The amino acid sequence of CYP-candidate 2114 is as follows: 
MELLQMLPAIPLPSLLLTIATIFLISIIISKKTSQRKNGSSNNLPPAPWKLPVLGHLHHFFTSPEPPHRR 
LRQLAQTHGDVMQLELGEISHVIITSAEAAKEVMRTHDIKFAQRPFHPHQAKIMYGGINLIHSPYGEYWR 
QLRRIATLELLTAKRVEALRRVREPEVQALMRTIAKQRPGEVVDLSKVLFGLSYSIISKATFGDVSSEQE 
EFIAIAEALVRHGGGFGLSFLFPSSGLVQKLFGVKEWLDKMHEGTDKLAESIIKQHRARRAVTKKSEDEE 
DLLDVLLNLQEDETTLGFNLSTDSIKAFLLDIFLAGSETPSSLTEWAMSELMRHPDVLQKAQAEVRKVFG 
TKGRVDEAGIHELTYLKMVIKETLRLHTPAPLVLPRECREECQIGGYDIPLKTTVVVNAWAIARDPRYWG 
KEAEKFMPERFLNNEVTFRGGDFEFLPFGAGRRMCPGMTFGLAAVELPLANLLYHFDWKLPHGVEPVNLN 
MDEIFGITIRRKKHLELIPVARNPVPTV 
 
The amino acid sequence of CYP-candidate 2227 is as follows: 
 
MECSYSQFLSFPPIFASLLFLVSFLLLLKLHRRSNSSAAAPPPPGPTKLPIIGNLHNLAGGSLPHHRLRDLATKY
GGVMGLQLGQVPHLVITSAEAAKEVMKTHDVVFAQRPAMLAAEIISYNFTDIAFAPYGAYWRQLRKICILELLSA
KRVQSFGSIRDEEVSNAVTRIAASAGRELNFSRMLFSLTHGIAARVTFGKKYNGQDEFIPVVEEITRVAGGFSLA
DLFPSVKLLQVASGMRSTLLRLRGEADRMLGSIIADHRSKGSTEDSAGGEVEDLVDVLLKLQGNGELDFPLTDDN 
IKAVILDIFIAGSETSSTAVEWAMSEMLKNRRVLHEAQAEVRRVFGGKGGVDETLLHELHYMKLVIKETLRLHAP
VPLLLPRECGEDCKIGGFQVEAKSKVVVNVWALGRDPKYWKEPEEFRPERFIDSSVDFKGSNFEFLPFGAGRRMC
PGMVFGMANVELPLAKFLYHFDWELAGGMKAGDLDMEESFGATLTRKNDLKLIPTPYH 
 
The amino acid sequence of CYP-candidate 3458 is as follows: 
 
MERNIRAFSSFDLPFLFSLATILAVTSFIIRKQRSKPAAGLNLPPGPWKLPIIGNLHQMLGDQPHRRLRDLSLKY
GPDVMQLQLGEISHIVISTPEAAKLVMKTHDIAFASRASLLATNILYDGCKDIAFAPYGEYWRQMRKICTLELFS
ARRVQSFRHIREEEVSNLVASLARSAGKPVDLTQMLFKQMSTVTSRAAFGRVQQLNDAFMVVLDNISDVLAGFTI
SDLYPSFKFLPIITGFRAKLEKMHEASDSLLDRIIDDHKSRRSSKGGDYNNDEKEDLVDVLLNLHENQNLGVPVT 
94 
 
MEVIKAVTLELFIAGIETTVTAMEWTMSEIIKDSRVLQKAQKEARHVFGERGSDIDEANLNQLTYLDMVISESLR
LHPPLPFIPRENREKLELGAYDVPINTKVFVNAWAINRDPHQWLDPEKFYPERFLNCSTDYKGNDFQFLPFGAGR
RICPGMSFGMTNVKLSLANLLYHFQWELPSEMKQEGIDMTERFGASLRRKHALRLIPILYDGMAA 
 
The amino acid sequence of CYP-candidate 38991 is as follows: 
 
MDIIISHLPEILVALAAAVFIHLWRKQQQQKNSLNRGGGVPEIPGGLPLVGHLHLLARGNQTLSRKLAAFSEKHG
PVFTIRLGANAAVVVSDYESMKECFTTNDRTLSFRPDSSQAKVLGYNYAAFGFASYGKYWRDMKKMLMTELLSVQ
RIKALRGVQIFEVNSLIRDLYKQSKVGDKSIVISDALQSYVLNVITSMVAGKRYFNKTEEEEVSSTTTSGGRPIG
QVMREFMLVTGTLVPSDLIPILGWFGFQGVIKDMKRVSKELDVIMESWLDDHKKKKKHPTTNGGANPDLIDVMLS 
EIKEEVAYGHKRDDIIKATAMSLIVAGSDTTSITLTWILSNLLNHERVMKLAQKEIDDVVGTDRWVDDSDIEKLT
YLGAVIKETLRMYPPGPLSVPREASEDITIRGYRVPKGTRFLANFWKLHRDPKVWSDPNEYMPERFLTANANMDI
FGQQFEYLPFGSGRRGCPGINFGMQVTQLTLARLLQGFHWGTPDNKPVDMTEGLGIALPKANPLEVVLTPRLSPE
LYGVL 
 
The amino acid sequence of CYP-candidate 5627 is as follows: 
 
MDLFLPSLSSAIPGIAVALFLSLFIIAKNRAGKGKRSVPEAGRSWPIIGHLLSLAGGTEQQLPHLILAELADKYG
PIFMLRIGMFPTVVVSSSEIAKELYTTHDAAISSRPNFTASAILGNNSANFGFSPYGEYWRMMRKITALELLSGR
RLDLLKRVRTSEVESAVKDLYMSWEKEKEKHREEEGTVRVEMNKWFGDMNLNVILGMIAGKRYGGGGEEEEEAER
CRKLMRDFFHYAGQIVARDLFPFLGFLDIGGHERTMRRLNADLNGLAEQWIEEHRRRRHGGDGEEEEKGMRTTKN
DEHRDFIDVLLSVLKDVDLXGYDLDTVCKSTIMVPLFTLYNFSSVYYLQTLIVGGTDTTTVTLTWALSLILNNRR
TLMRVQEELDAVVGRERLVDESDVHKLPYFQAMIKEVMRLYPAGPIGGPREFSRDCSVAGYHVPAGTRLMNLYKL
QTDPKVWLEPMEFRPERFLDAECKDVDVKGQHFELIPFGAGRRSCPGINFGMQMIGLALASFLQAFEVSVPPDAP
VVDMTAVSGLTVSKATPLEVLVKPRLPWRLYQ 
 
The amino acid sequence of CYP-candidate 74047 is as follows: 
 
MDSIALPAIFSLLTIFLFSLIILPRILNRRSKPRPPPPEPWRLPIIGHIHHLAGGGGSSALPHRRLRDLARTHGP
VMLLRLGEINHVIISSADAAKQVYTTHDVVFAQRPFNLAAKIITYDRSDIAHAAYGDFWRQMRKLCTLELLSPKR
VLSFRPIREEEGLKFVRRISAAVAAEGSRPVNLSRLIFSLTYGVTSRIALGTVREEKDDEYIPVVEEIMAAAAGF
GVADLFPSVKWLERVSGMKAKLERLHGVQDRLLEKIIADHRARRSSPSSSSAAGENRGGGAGERYDVAEDLVDAL
LNLQRDGDDVGFSLTNDNIKAVIGDVFIAGSETSSTTVEWAISELIRNPDVMRTAQEEVRRVFGERGRIDEAGLD
RLSYLKLVIKETLRLHTPAPLLVPRESREECEVGGYLIPVKTTVLVNVWAIARDPGTWDEPEEFRPERFLDGKVD
YKGTNFEYLPFGAGRRICPGITFGVANTELPLANLLFYFDWKLTGDLKVERLDMDESFGVTVRRKNDLEVVPVIH
YPPPIIS 
 
Amino acid sequence alignment was conducted between the ORFs of all eleven candidates by 
Clustal Omega to search for the conserved domains in the sequences and the results are shown 
in Fig. 41.  
 
4471       -------------------MPSLLIYLLLALPPVLLLFIFQKHKKKN----SKSASSLPP 37 
2408       MAASLTFSPLKSTFPGGNNPPPPSLRLHR--I-PTRISCQNQKPQSE----STTKKQLPP 53 
3458       MERNIRAFSS------FD-LPF-LFSLATILA-VTSFIIRK--QRSK----PAAGLNLPP 45 
2114       MEL-LQMLPA------IP-LPSLLLTIATIFL-ISIIISKKTSQRK-----NGSSNNLPP 46 
2227       MEC--SYSQF------LS-FPPI-FASLL-FL-VSFLLLLKLHRRSN----SSAAAPPPP 44 
74047      -------MDS------IA-LPAI-FSLLTIFL-FSLIILPR--ILNR----RSKPRPPPP 38 
38991      MDIIISH------------LPEILVALAAAVF-IHL--WRKQQQQKN---SLNRGGGVPE 42 
11511      MDFFTSLST-----ASLSTVAIATASLAFLYF-LFRTILSPAGDSKPHAQQQQQAPPPVE 54 
27263      ------------------------------------------------------------ 0 
11862      MDSLFAS------------IALAVSFLCLAGF-FLTDGLRRLG-----S--DKQKRYPPE 40 
5627       MDLFLPS------------LSSAIPGIAVALF-LSLFIIAKNR-----A--GKGKRSVPE 40 
                                                                        
                      proline-rich region 
4471       GPRGLPLIGNLFQLDPS-----APHRYLWQLSQTYGP-LLSLRLGRVQAVVVSTAKMAQE 91 
2408       GPPKLPLIGNLHNLVGA-----LPHQALRNLATEYGP-LIHLQLGEISAAVVSNPAIAQE 107 
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3458       GPWKLPIIGNLHQMLGD-----QPHRRLRDLSLKYGPDVMQLQLGEISHIVISTPEAAKL 100 
2114       APWKLPVLGHLHHFFTS---PEPPHRRLRQLAQTHGD-VMQLELGEISHVIITSAEAAKE 102 
2227       GPTKLPIIGNLHNLAGG----SLPHHRLRDLATKYGG-VMGLQLGQVPHLVITSAEAAKE 99 
74047      EPWRLPIIGHIHHLAGGGGSSALPHRRLRDLARTHGP-VMLLRLGEINHVIISSADAAKQ 97 
38991      IPGGLPLVGHLHLLARG-N--QTLSRKLAAFSEKHGP-VFTIRLGANAAVVVSDYESMKE 98 
11511      ASGAWPIIGHLHLLAGP----QPAHIVLGQMAEHHGP-IFTIRMGVHRAVVVSNRETAKE 109 
27263      ------------------------------MADKYGS-IFTVRMGRQRALVVSSWPIAKE 29 
11862      PANRWPVIGHLPVMAGS----ELPHRALAALADKYGP-IFTLRLGFNRVVIVSSPEIAKE 95 
5627       AGRSWPIIGHLLSLAGG-TEQQLPHLILAELADKYGP-IFMLRIGMFPTVVVSSSEIAKE 98 
                                         ::  :*  :: :.:*     :::     :  
 
4471       VMKTQDLVFCNRPQAMGTTKLSYNRVDLAFAPYDAYWREMRKICMVYLFNSNRTQSFGPI 151 
2408       IMKTHDLNFADRPCIFAAEIATWGGQDIAFSPHGEYWKQMKRISLTELLGPRKTQSFRGI 167 
3458       VMKTHDIAFASRASLLATNILYDGCKDIAFAPYGEYWRQMRKICTLELFSARRVQSFRHI 160 
2114       VMRTHDIKFAQRPFHPHQAKIMYGGINLIHSPYGEYWRQLRRIATLELLTAKRVEALRRV 162 
2227       VMKTHDVVFAQRPAMLAAEIISYNFTDIAFAPYGAYWRQLRKICILELLSAKRVQSFGSI 159 
74047      VYTTHDVVFAQRPFNLAAKIITYDRSDIAHAAYGDFWRQMRKLCTLELLSPKRVLSFRPI 157 
38991      CFTTNDRTLSFRPDSSQAKVLGYNYAAFGFASYGKYWRDMKKMLMTELLSVQRIKALRGV 158 
11511      CLTTHDRVFADRPATLAMDLLGYRRSMLGFSPYGAYWRQIRKIVTLELLSSHRLETLKHV 169 
27263      CLVTVDKPFLNRPKNLAAKIMTYDIAMFGFSPYGHYWREMRKLVSLELLSAQRLRTFAPV 89 
11862      LFTTKDTVALSRPRMIATETFSYDFAVFGMGPHGDYWRETRKIAVLELLSNRRLDLLRRF 155 
5627       LYTTHDAAISSRPNFTASAILGNNSANFGFSPYGEYWRMMRKITALELLSGRRLDLLKRV 158 
              * *     *               :  . :. :*:  :::    *:  .:   :  . 
 
4471       REYEVSQMVGKASRS-S--------LLASQPFNLSEAMMSLTTTIICRVAFGKRYEEE-- 200 
2408       RETEVAGMIESVR------------KSVGKPVNVTEKVLSLTNTITCKTAFGYQC-MD-- 212 
3458       REEEVSNLVASLA------------RSAGKPVDLTQMLFKQMSTVTSRAAFGRVQ-QL-- 205 
2114       REPEVQALMRTIAK-----------QRPGEVVDLSKVLFGLSYSIISKATFGDVS-SE-- 208 
2227       RDEEVSNAVTRIA------------ASAGRELNFSRMLFSLTHGIAARVTFGKKY-NG-- 204 
74047      REEEGLKFVRRISAAVA--------AEGSRPVNLSRLIFSLTYGVTSRIALGTVREEK-- 207 
38991      QIFEVNSLIRDLYKQS---------KVGDKSIVISDALQSYVLNVITSMVAGKRYFNKTE 209 
11511      RESEIHVATKELYAAA---------GGGNGVVEMGTWFGEITLNVILKMIVGKNVGYFS- 219 
27263      RESEVRAATKALYDLC---------DGSSVAVEMKRWFADVTLNVIMRIIAGKTIGYGSV 140 
11862      KESEVHNSINDLYKQI----------GGKSEIDVNKWIGDLSMNLMLKLVIGKSSSSAS- 204 
5627       RTSEVESAVKDLYMSWEKEKEKHREEEGTVRVEMNKWFGDMNLNVILGMIAGKRYGGGG- 217 
           :  *                           . .   .      :      *         
 
4471       --------GTERSRFQSMLNETQAMFTSFFFLDHFPILGFIDRLTGLTNRLEKNFIEFDA 252 
2408       --------Q---EEFVGLMNGAVQAAGGFNIADLYPSLGFLQGLTGMKSELLRIRNGLDR 261 
3458       --------N---DAFMVVLDNISDVLAGFTISDLYPSFKFLPIITGFRAKLEKMHEASDS 254 
2114       --------Q---EEFIAIAEALVRHGGGFGLSFLFPSSGLVQKLFGVKEWLDKMHEGTDK 257 
2227       --------Q---DEFIPVVEEITRVAGGFSLADLFPSVKLLQVASGMRSTLLRLRGEADR 253 
74047      --------D---DEYIPVVEEIMAAAAGFGVADLFPSVKWLERVSGMKAKLERLHGVQDR 256 
38991      EEEVSSTTTSGGRPIGQVMREFMLVTGTLVPSDLIPILGWFGF-QGVIKDMKRVSKELDV 268 
11511      -------GGGEGVKLRKLLKDFFELVGWFLVTDGLPFLRWLDV-GGSEKAMRKTAKELDV 271 
27263      VAR--DGGGGAMVGWQKSLRDFFDLLGKFTVADAVPALRWLDV-GGYEKEMRKTAKELDT 197 
11862      ------GGSAMMVKFQIAVRELFHLAGLSLVGDALPFLRWMDI-GGHEKAMKRAAKAMDG 257 
5627       ------EEEEEAERCRKLMRDFFHYAGQIVARDLFPFLGFLDI-GGHERTMRRLNADLNG 270 
                                              *    .    *    : :     :  
 
4471       FYQEIIDEHLDPKRVK------------------PEQEDILDVLLQIWKDR---SFKVQL 291 
2408       IFDKIIKQHEEKRANGDVE---------------LDDEDLMDVLLRLQGSG---GFKCPI 303 
3458       LLDRIIDDHKSRRSSKGGD------------YNNDEKEDLVDVLLNLHENQ---NLGVPV 299 
2114       LAESIIKQHRARRAVTKKS---------------EDEEDLLDVLLNLQEDET--TLGFNL 300 
2227       MLGSIIADHRSKGSTEDSA--------G------GEVEDLVDVLLKLQGNG---ELDFPL 296 
74047      LLEKIIADHRARRSSPSSSSAAGENRGGGAGERYDVAEDLVDALLNLQRDGD--DVGFSL 314 
38991      IMESWLDDHKKKKKHPT--------------TNGGANPDLIDVMLSEIKEE---VAYGHK 311 
11511      VVGEWMREHEGKRGSAGGG----K--------KAAAEEDFMDVIMNVVGGEEGGGVVGRD 319 
27263      VVGGWLEEHKRKRVVAAAG----S---------GKVEEDFMDVILNVIGD--SGGIDGRD 242 
11862      YLQEWLNEHKENRGGEK------------------TEHDFIDVMLSHLDGQ---SLHGYD 296 
5627       LAEQWIEEHRRRRHGGDGE----EEEKGMRTTKNDEHRDFIDVLLSVLKDV---DLXGYD 323 
                : :*                             *::*.::                
oxygen binding domain 
4471       SFDHIKALL----------------MNIFVGGSDTSAATVVWSMTYLMKNPLMMGKVQKE 335 
2408       TSTNIKAVL----------------VDLFIAGTDTSSTTVEWAMSEMMKNPRVMQKAQAE 347 
3458       TMEVIKAVT----------------LELFIAGIETTVTAMEWTMSEIIKDSRVLQKAQKE 343 
2114       STDSIKAFL----------------LDIFLAGSETPSSLTEWAMSELMRHPDVLQKAQAE 344 
2227       TDDNIKAVI----------------LDIFIAGSETSSTAVEWAMSEMLKNRRVLHEAQAE 340 
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74047      TNDNIKAVI----------------GDVFIAGSETSSTTVEWAISELIRNPDVMRTAQEE 358 
38991      RDDIIKATA----------------MSLIVAGSDTTSITLTWILSNLLNHERVMKLAQKE 355 
11511      SETVNKATC----------------LALILASSDTTTVTMTWLMALLVNHPDVLKKAQTE 363 
27263      SDVINKATC----------------LSLTLGGSDTTTVTMSWALSLLVNHRSVLTTVQEE 286 
11862      SDTIIKAMC----------------LAMVAGGMDTTNATVMWAIALIMNNRDVRLKAQNE 340 
5627       LDTVCKSTIMVPLFTLYNFSSVYYLQTLIVGGTDTTTVTLTWALSLILNNRRTLMRVQEE 383 
                *:                    :  .. :*      * :: ::..      .* * 
ERR triad 
4471       VRDVVGNKGF-VNETDIQQLPYLKAVIKETMRLQPTAPLLLPRESIEKCNLGGYEIPAKT 394 
2408       VREAMRGKSV-VTEADIQNLPYLSSIIKETFRLHPPAPLLLPRESKANCEVAGYEIPKKT 406 
3458       ARHVFGERGSDIDEANLNQLTYLDMVISESLRLHPPLPF-IPRENREKLELGAYDVPINT 402 
2114       VRKVFGTKGR-VDEAGIHELTYLKMVIKETLRLHTPAPLVLPRECREECQIGGYDIPLKT 403 
2227       VRRVFGGKGG-VDETLLHELHYMKLVIKETLRLHAPVPLLLPRECGEDCKIGGFQVEAKS 399 
74047      VRRVFGERGR-IDEAGLDRLSYLKLVIKETLRLHTPAPLLVPRESREECEVGGYLIPVKT 417 
38991      IDDVVGTDRW-VDDSDIEKLTYLGAVIKETLRMYPPGPLSVPREASEDITIRGYRVPKGT 414 
11511      LDDVVGKLRR-VQDSDLHNLHYLKAIIKETLRLYPAAPLSIPHKSTEDCTVAGRFVPKGT 422 
27263      LDRCVGRERQ-VQDSDLHNLTYLKAVVKETLRLYPAAPVIMRDDSDDDAVIDGRHVGKGT 345 
11862      LDDVASRERL-VTEADIGKLPYLQAVVKESMRMYPATPLLAAREFVTDRKVGGYDVEKGT 399 
5627       LDAVVGRERL-VDESDVHKLPYFQAMIKEVMRLYPAGPIGGPREFSRDCSVAGYHVPAGT 442 
                      : :: : .* *:  ::.* :*:    *.    .   .  : .  :   : 
     ERR triad    heme binding domain  
4471       VVHVNAWAIGRDPEAWGENPEEFKPERFIGK---CIDVKGMDYELIPFGAGRRICPGIHM 451 
2408       KVIVNAWAIGRDPGTWK-DPETFIPERFDGS---EIDFKGMHFELIPFGAGRRICPGIAF 462 
3458       KVFVNAWAINRDPHQWL-DPEKFYPERFLNC---STDYKGNDFQFLPFGAGRRICPGMSF 458 
2114       TVVVNAWAIARDPRYWGKEAEKFMPERFLNN---EVTFRGGDFEFLPFGAGRRMCPGMTF 460 
2227       KVVVNVWALGRDPKYWK-EPEEFRPERFIDS---SVDFKGSNFEFLPFGAGRRMCPGMVF 455 
74047      TVLVNVWAIARDPGTWD-EPEEFRPERFLDG---KVDYKGTNFEYLPFGAGRRICPGITF 473 
38991      RFLANFWKLHRDPKVWS-DPNEYMPERFLTA-NANMDIFGQQFEYLPFGSGRRGCPGINF 472 
11511      QLIVNISKIQRDPGAWS-DPDEFRPDRFVT-THKDVDFRGQYFELIPFGSGRRMCPGVTF 480 
27263      RLLVNLFKLQRDPAVWSPDPDEFRPERFLEGRHKDADVKGQSFELIPFSSGRRMCPGASF 405 
11862      WLMFNAWRVQNDPNVWP-DPTKFDPERFLTSEFRDVDVKGQSFELFPFSSGRRSCPGMNL 458 
5627       RL-MNLYKLQTDPKVWL-EPMEFRPERFLDAECKDVDVKGQHFELIPFGAGRRSCPGINF 500 
            .  *   :  **  *  :   : *:**           *  :: :**.:*** ***  : 
 
4471       GLVTVELSLANLLYAFDWRMPAGVKSEDLDMDVLPGLTMHKKNALCLVATKFL------- 504 
2408       GMANVELPIAQLLYYFNWELPEGVAVEDFDMEESFAATMGRKNPLFLVPREFNGQPEAVN 522 
3458       GMTNVKLSLANLLYHFQWELPSEMKQEGIDMTERFGASLRRKHALRLIPILYDGMAA--- 515 
2114       GLAAVELPLANLLYHFDWKLPHGVEPVNLNMDEIFGITIRRKKHLELIPVARNPVPTV-- 518 
2227       GMANVELPLAKFLYHFDWELAGGMKAGDLDMEESFGATLTRKNDLKLIPTPYH------- 508 
74047      GVANTELPLANLLFYFDWKLTGDLKVERLDMDESFGVTVRRKNDLEVVPVIHYPPPIIS- 532 
38991      GMQVTQLTLARLLQGFHWGTPDNKP---VDMTEGLGIALPKANPLEVVLTPRLSPELYGV 529 
11511      AMQVMQLTVATWLHGFDFKRTSDEM---VDMTEGVGLTNPRAEPLEVVLSPRLPPHLYE- 536 
27263      ALQVMYLTLATVLQGFEVTTADGGP---VDMTDGAGFTNLRATPLEVLLSPRLPAHLYG- 461 
11862      GLQLVHLAVANFLHAFEVSPAGDAP---VDMKESFGMTNMKATPLSVVASPRLSHDAYV- 514 
5627       GMQMIGLALASFLQAFEVSVPPDAPV--VDMTAVSGLTVSKATPLEVLVKPRLPWRLYQ- 557 
           .:    * :*  *  *.           .:*    . :  :   * ::             
 
4471       ------------ 504 
2408       GSSSEMLEAVAN 534 
3458       ------------ 515 
2114       ------------ 518 
2227       ------------ 508 
74047      ------------ 532 
38991      L----------- 530 
11511      ------------ 536 
27263      ------------ 461 
11862      ------------ 514 
 
 
The sequence conservation is relatively low among the CYP-candidates. Nevertheless, the 
amino acid sequences of CYP-candidates still have several conserved areas. The first 20-30 
Figure 41: Amino acid sequence alignment of CYP-candidates 
Gaps were inserted to maximise the homology. The typical motifs of the proline-rich region, oxygen-binding 
domain and ERR triad are shaded and marked. 
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amino acids at the N-terminus are predominantly hydrophobic and form the hydrophobic 
membrane anchor. Located near the N-terminus of seven candidates including 2114, 2227, 
2408, 3458, 38991, 4471 and 74047 is the proline-rich region with the consensus sequence 
(P/I)PGPx(G/P)xP. It provides sufficient flexibility between the membrane anchor and the 
globular part and helps to stabilise the enzyme (Kemper, 2004). About 60% away from the C-
terminus of all sequences is the oxygen-binding domain with the consensus sequence 
(A/G)Gx(D/E)T(T/S). The sequences of all candidates have the EER triad ExxR.....R 
containing the glutamine and arginine from the consensus sequence KETLR and the arginine 
from the consensus sequence PERF. It helps to stabilize and position the heme in the binding 
pocket (Hasemann et al., 1995). The heme binding region is located about 15% from the C-
terminus of all sequences. It is the most conserved domain with the consensus sequence 
PFGxGRRxCxG, in which the cysteine serves as the fifth axial ligand of heme-iron. The ERR 
triad, oxygen binding domain and heme binding domain were found in the sequences of all 
candidates.  
Furthermore, based on the PSI- and PHI-BLAST searches against the conserved domain 
database (CDD) of the National Center for Biotechnology Information, all eleven CYP-
candidates were confirmed belonging to the cytochrome P450 family.  
 
3.2.2.2 Fusion-PCR and verification of full-length sequences 
In order to generate full-length sequences with continuous coding capacity, fusion-PCR 
reactions were performed for the in-vitro removal of introns from genomic DNA sequences 
(see III.2.4.3). 
  
3.2.2.2.1 Exon fragments in the first rounds 
Distinct exon fragments were generated in the first round with Phusion® Polymerase to avoid 
replication errors (see III.2.4.3). Afterwards, the PCR products were analysed by agarose gel 
electrophoresis. Fig. 42 shows the successful amplification of two exon fragments of each of 
the CYP-candidates. 
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The bands of PCR-products with the expected size were cut out and purified via gel extraction 
(see III.2.6). After purification and determination of product concentrations, the first-round 
PCR products were diluted to the same concentration and used as templates for the second 
rounds of fusion-PCR. 
 
3.2.2.2.2 Full-length sequences of CYP-candidates  
In the second rounds of fusion-PCR, two outermost primers including specific sequences for 
restriction enzymes were used to generate the full-length sequences. Distinct exon fragments 
were fused into the elongated sequences based on the overlapping regions of the respective 
internal primers. 
  
 
 
 
Sample Annealing temperature (°C) 
3458-1 54 
3458-2 54 
38991-1 54 
38991-2 54 
74047-1 54 
74047-2 54 
Sample Annealing temperature (°C) 
5627-1 54 
5627-2 54 
2114-1 58.1 
2114-2 58.1 
2227-1 58.1 
2227-2 58.1 
Figure 42: Two distinct exon-fragments each of candidates 2114, 2227, 3458, 38991, 5627 and 74047  
PCR-products are marked with boxes. 
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3.3 Heterologous expression of CYP-candidate proteins in Saccharomyces cerevisiae 
3.3.1 Expression of CYP-candidate proteins with His-tag 
The yeast clones carrying the complete ORFs in an inducible vector (pYES2/NT C) were used 
for expression to elucidate the biochemical function of the encoded proteins. There are five 
different systems available for the expression of eukaryotic cytochrome P450, namely E. coli, 
insect cells, mammalian cells, Physcomitrella patens and yeast. Heterologous expression of 
eukaryotic cytochrome P450 basically involves several problems. First, they are associated 
with the membrane, and active protein also requires the formation of heme, which must then 
be non-covalently bound in the polypeptide. Furthermore, CYP enzymes require electron 
transfer by NADPH:cytochrome P450 reductase (CPR). The CPR is an integral membrane 
protein and transports the necessary electrons from NADPH via FAD and FMN to CYP. Since 
E. coli does not have its own reductase, a construct of CYP/CPR fusion for expression in E. 
Sample Annealing temperature (°C) 
2227-1 55.5 
2227-2 58.1 
38991-1 51.2 
38991-2 52.7 
38991-3 54 
74047-1 51.2 
74047-2 52.7 
74047-3 54 
Sample Annealing 
temperature (°C) 
2114-1 55.5 
2114-2 58.1 
3458-1 52.7 
3458-1 54 
5627-1 52.7 
5627-2 54 
Figure 43: The second-round fusion-PCR of DOP6H- and DOP7H-candidates  
Full-length sequences of candidates are marked with boxes. 
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coli is required. The NADPH:cytochrome P450 reductase of the same plant can be additionally 
added in the enzyme assays after isolating membranes of CPR-transformed E. coli (Bak et al., 
1998). In some cases, expression with the Spodoptera frugiperda baculovirus system may be 
required. Jennewein et al. (2001) were able to functionally express taxane 13α-hydroxylase 
from Taxus brevifolia only after expression with this system. This expression leads to 
expression with the same potency as yeast or E. coli. The most common expression is in 
Saccharomyces cerevisiae (Urban et al., 1994). This system is particularly useful because the 
reductase from yeast provides the electrons for the foreign VYP. In this project, Saccharomyces 
cerevisiae strain INVScI containing only the yeast's own reductase was used for the 
heterologous expression of CYP-candidate genes. The coding sequences for a polyhistidine-
tag for purification and detection of heterologous proteins is already included in the N- and C-
terminus of the pYes2/NTC vector. Since the first 17-29 amino acids in the N-terminus of P450 
enzymes function as a membrane anchor, the His-tag was attached to the C-terminus of the 
proteins in order to avoid negative effects on the function of the membrane anchor. 
The yeast strain INVScI was transformed with the CYP-candidate genes in pYes2/NTC using 
the lithium acetate method (III.3.3). The transformed yeast cells were plated onto SC-U plates 
and incubated for 3 days at 30 °C. SC-U is a synthetic minimal medium for yeast containing 
glucose as the sole carbon source without uracil. Yeast cells without the plasmid pYes2/NTC 
cannot grow on the SC-U medium. Successful transformations were confirmed by colony PCR 
(III.2.4.4).  
Firstly, the expression of candidate-proteins in Saccharomyces cerevisiae was undertaken with 
SCG medium. As negative control, the yeast cells containing the empty vector pYes2/NTC, 
were expressed as described in III.3.7.2. The microsome preparations of candidates and 
negative controls were analysed by SDS-PAGE and Western blot. The Western blot showed 
very faint bands at the expected size range from 57 kDa to 63 kDa (data not shown). In many 
reports, 5-aminolevulinic acid, a precursor of the porphyrin synthesis pathway, and iron 
compounds were added to the medium in order to improve the yields of recombinant proteins 
(Antipov et al., 2009; Dietzsch et al., 2011). 5-Aminolevulinic acid and iron could support the 
native protoporphyrin IX formation and the heme biosynthesis pathway in yeast. Therefore, an 
attempt was made to express the candidate proteins in yeast with SC+G medium (SCG medium 
with the addition of 5-aminolevulinic acid and ammonium iron (II) sulfate). The microsomes 
from cell pellets of CYP-candidates and the negative control were then analysed by SDS-PAGE 
(see III.4.6) and visualised by Western-blotting (III.4.7).  
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Distinct gene-specific bands of CYP-candidate proteins in the expected size ranges appeared 
clearly on the membranes of Western blot (Fig. 44). There were no bands in the same size 
ranges in the lanes of negative control samples. The results of Western blot showed that 
heterologous proteins with His-tag were produced successfully by the transformed yeast cells 
after induction with galactose and the use of SC+G medium for the induction yielded better 
expression of recombinant CYP-proteins. 
 
3.3.2 Enzyme assays with different substrates 
Enzyme assays as described in III.4.8.2 were conducted to test the activity of the CYP-
candidate proteins. Besides DOP, different available substrates of the lignan biosynthesis 
pathway were tested under the same conditions: MATAI, SECO, ß-peltatin, ß-peltatin A 
methyl ether, yatein, α-peltatin. The substrates tested and the expected position for 
hydroxylation marked with arrows are listed below: 
Figure 44: Western Blots of eleven CYP-candidates 
Detection was done with anti-His-Tag antibody and secondary antibodies coupled to alkaline phosphatase using 
the NBT/BCIP color reaction. The molecular weight of the His-Tag is appr. 3.5 kDa. His-tagged protein bands of 
candidates with appropriate molecular weights are marked with boxes. 
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Unfortunately, no product formation could be detected in the HPLC chromatograms and 
enzyme activity tests with heterologous proteins with His-tag were negative. The ORFs of 
CYP-candidates most probably are complete and the presence of the heterologously expressed 
proteins had been confirmed by Western blotting (Fig. 43). Since the microsomes were 
prepared analogously to the CPR microsomes and the activity of the CPR in the microsomes 
has been confirmed, a mistake in microsome preparation can be ruled out. In many cases, the 
His-tag can influence the structure as well as the function of the protein. Hence, the next 
attempts were made to express candidate proteins without His-tag.     
 
 
 
 
secoisolariciresinol 
α-peltatin ß-peltatin 
DOP matairesinol 
yatein 
ß-peltatin A methyl ether 
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3.3.3 Expression of candidate proteins without His-tag 
The N- or C-terminally attached His-tag may influence the structure as well as the function of 
proteins. Therefore, CYP-candidate proteins without His-tag were expressed to overcome this 
possible issue. New full-length primers with a restriction site for XbaI and a stop codon in the 
reverse primers were designed for PCR-amplification (see IV.6.3). The full-length sequences 
were amplified with full-length forward primers and new full-length reverse primers by 
standard PCR-experiments (see III.2.4.1). The successful transformations of the yeast strain 
INVScI with the constructs of candidate genes in pYes2/NTC were confirmed by colony-PCR 
(as shown in Fig. 45). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The transformed yeast cells were cultivated and protein expression performed as described in 
V.3.7.1. The detection of the heterologously expressed proteins without His-tag by Western 
Figure 45: Agarose-gels of colony PCR to show the transformation of yeast INVScI (colony 1-4) 
Candidate-genes are marked with boxes. 
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blotting is not possible. It is very difficult to detect the bands of the recombinant CYP-proteins 
in the microsomes, since yeast cells express also their own CYP enzymes as well as many other 
proteins of the same size. In many reports, antibodies were designed based on the specific 
sequences of proteins and Western blots were used to overcome this problem. Regarding the 
CYP enzymes, the sequence conservation is relatively low within the family, although the 
general topography and structural fold of CYP are highly conserved. The sequence of proteins 
from different superfamilies share less than 20% identity (Graham et al., 1999). Only the 
glutamic acid and the arginine of the ExxR-motif and the heme-binding cysteine are fully 
conserved among all CYP sequences (Sirim et al., 2010). On the other hand, yeasts as the host 
cells produce own CYPs. Therefore, the development of specific primary antibodies to detect 
recombinant CYP-proteins would be very challenging. 
In this work, the expression of CYP-protein without His-tag could not be proven. Nevertheless, 
enzyme assays for CYPs (see III.4.8.2) were performed with microsomes of transformed yeast 
cells and substrates listed in VI.3.3.2. However, again no product formation could be detected 
in the HPLC chromatograms and enzyme activity tests were negative. 
 
3.4 In-vivo biotransformation enzyme assays 
In many reports, the heterologously expressed protein did not show enzymatic activity in in-
vitro enzyme assays, but function normally in in-vivo biotransformation enzyme assays (Kuo 
et al., 2014). Therefore, in the next attempt in-vivo enzyme assays were conducted to test the 
catalytic activity of recombinant CYP-candidate proteins. 
The recombinant proteins of CYP-candidates were expressed and tested in in vivo enzyme 
assays with different substrates (MATAI, SECO, ß-peltatin, yatein, α-peltatin) as described in 
V.4.8.5. However, no enzymatic activity of the candidate proteins was observed in HPLC 
chromatograms.  
 
3.5 Concluding remarks 
Many potential candidates of cytochrome P450 were found in the transcriptome of Linum 
flavum. Eleven ORFs of CYP were successfully amplified from RNA/cDNA or gDNA of L. 
flavum. Many plant CYPs have been successfully expressed in yeast and showed enzymatic 
activity in in vitro enzyme assays, for example CYP98A14 of Coleus blumei (Eberle et al., 
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2009) or CYP719A23 and CYP719A24 of Podophyllum hexandrum (Marques et al., 2013). 
However, all attempts to test the activities and possible reactions for the recombinant CYP-
candidates with and without His-tag failed.  
One reason could be the limited number of lignan compounds for the enzyme assays. 
Cytochrome P450s of plants are considered to be very substrate-specific unlike cytochrome 
P450s of animals (Werck-Reichhart et al., 2002). However, only six substrates (MATAI, 
SECO, ß-peltatin, ß-peltatin A methyl ether, yatein, α-peltatin) were available for enzyme 
assays. Another aspect for consideration is the extraordinary diversity of CYPs. The first 
cytochrome P450 was discovered in liver microsomes of rats in 1958 (Klingenberg, 1958). In 
1990, it was possible to clone the first plant cytochrome P450 from avocado (Bozak et al., 
1990). Since then, a variety of cytochrome P450s have been isolated from plants. There are 
273 cytochrome P450 genes in the complete genome of Arabidopsis thaliana, which makes 
P450s one of the largest families of catalytically active proteins in plants. More than 1% of 
each plant genome is cytochrome P450s (Mizutani, 2012). CYPs are involved in the 
biosynthesis of various compounds, such as the formation of pigments (anthocyanidins), plant 
hormones (gibberellins), phenylpropanoids, fatty acids, phytoalexins (terpenes, 
furanocoumarins, glucosinolates), cyanogenic glycosides, signalling compounds (salicylic 
acid, jasmonic acid) or alkaloids. The formed substances play an important role in the plant in 
the pathogen defence, UV protection, membrane formation and pigmentation. From the 
transcriptome of L. flavum, appr. 400 contigs were annotated as CYP by the Blast2GO® 
program after searching and comparing them with the CYP-sequences in the NCBI database.  
 
Another reason could be the electron supplier system for CYP, since it is known from other 
plants that the yeast's own reductase and cytochrome b5 may not be sufficient to transfer 
electrons for plant cytochrome P450s. For example, flavonoid 3',5'-hydroxylase from 
anthocyanin biosynthesis also requires cytochrome b5 as a cofactor (De Vetten et al., 1999). 
The similarities of the yeast and plant CPRs may not be sufficient and the homology of the 
plant with yeast-specific cytochrome b5 is also often insufficient for functional expression 
(Urban et al., 1990). Furthermore, the majority of newly synthesised plant proteins requires 
post-translational modification that will finish their tertiary and quaternary structures in order 
to become functional proteins. The post-translational modification could be vital for protein 
activity, including function, dynamic interactions with other molecules, localisation and 
stability (Webster and Thomas, 2012). The CYP-candidate proteins of L. flavum were 
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successfully heterologously expressed in yeast, but the proteins possibly need to undergo some 
additional modifications and the post-translational modification system of yeast may not be 
sufficient for plant CYPs.  
Furthermore, Shiraishi et al. (2016) suggested that the podophyllotoxin biosynthetic pathway 
in Linum flavum and Podophyllum hexandrum are different and originated from convergent 
evolution. Many enzymes involved in the podophyllotoxin metabolic pathway of Podophyllum 
hexandrum were not found in the transcriptome of L. flavum. For example, CYP719A23, which 
converts matairesinol to pluviatolide was highly expressed in P. hexandrum (FPKM 
(Fragments Per Kilobase Million) > 34) but no CYP719A23-related specific contig with FPKM 
more than 10 were found in the transcriptome of L. flavum (Shiraishi et al., 2016). The feeding 
experiments by Kamil and Dewick in Podophyllum spec. (Kamil and Dewick, 1986) reported 
a turnover of yatein to podophyllotoxin. Furthermore, an enzyme catalysing the formation of 
DOP from yatein was successfully identified in P. hexandrum (Lau and Sattely, 2015). 
Nevertheless, it was not possible to detect an enzymatic conversion of yatein to DOP in Linum 
album, L. flavum and L. nodiflorum (Kuhlmann, 2004). Therefore, using CYP71BE54 and 
CYP82D61 of Podophyllum hexandrum to search for the CYP-candidates in L. flavum could 
lead to the wrong candidates. And although eleven candidates were already tested, there are 
still a large number of other candidates that are likely to be missed during the search. 
 
3.6 Outlook 
The expression could be optimized by simultaneous expression of cytochrome P450 and CPR 
from L. flavum. Ro et al. (2002) used the dual yeast expression vector pESC-Leu (Stratagene) 
with galactose induction for the concomitant expression of C4H and CPR in Saccharomyces 
cerevisiae. In case that the simultaneous expression with CPR is not successful, the co-
expression with cytochrome b5 may be necessary.  
If the recombinant proteins need special post-translational modifications that could not be done 
in yeast, the expression in insect or in plant cells could be a solution.  
Furthermore, just a limited number of substrates involved in the lignan biosynthesis pathway 
has been tested in this work. In the elucidation of the function of recombinant proteins, model 
substrates derived from the physiological substrate may possibly help (Schalk et al., 1997). 
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4. Project 3: Identification and characterisation of pinoresinol-lariciresinol reductase  
4.1 Pinoresinol-lariciresinol reductase (PLR) candidates 
The protein sequence of PLR from Linum usitatissimum (von Heimendahl et al., 2005) was 
used as a reference sequence to search for PLR-candidates in the transcriptome database of 
Linum flavum with help of Blastx. 
One candidate with convincing similarity was found:  
 
Contig Score Query cover E-value Identity 
10318 544 93% 6e-131 83% 
 
The open reading frame (ORF) of PLR-candidate 10318 was determined by ORF Finder.  
The ORF of PLR-candidate 10318 is as below: 
ATGGGTTCCCTGGGGAAAGTGATGAATAATGAGATTCCGATTAAGAGCAGCAAAGTGCTGGTGATAGGGGGAACT
GGCTACTTGGGGAAGAGGCTGGTGAAGGCTAGTTTGGATTCGGGCCACGACACCTACGTCATGCATCGCCCGGAG
ATTGGCGTCGACATCGAGAAAGTTCAGCTGCTGCTCTCCTTCAAGATGCAAGGCGCTCATCTCGTCTCCGCCTCC
TTCGACGACCAGCGCAGCCTCGTCGATGCTGTCAAGTTGGTCGACGTCGTCATCTGCGCCATCTCCGGGGTTCAC
ATCCGCAGCCACCAGATCCTTCTTCAGCTCAAGCTCGTCGAAGCCATCAAAGAAGCCGGTAACGTCAAGAGGTTT
GTACCGTCGGAGTTCGGAACAGATCCGGCGAGGATGGAAAACGCGATGGAGCCAGGAAGGATCACATTCGACGAC
AAAATGGTGGTGAGGAGAGCGATAGAGGAAGCTGGGATCCCTTTCACTTACGTCTCTGCTAATTGCTTCGCTGGC
TACTTCCTTGGCGGTCTTTGCCAACCAGGCTACATTCTTCCTTCTAGAGACCATGTTACTTTGCTTGGAGATGGC
GACAAAAAGGGGGTGTACGTGGACGAGGATGATATAGCCGCTTACACATTGAGGGCCATAGACGATCCTCGAACC
CTCAACAAGACGATCTACGTGAAGCCACCTAAGAACGTGTTGTCCCAAAGAGAAGTTGTTGGGATTTGGGAGAAA
TATATCGGCAAAGAGCTCCAAAAGACCATTCTATCCGAGCAAGACTTCCTCGCTACTATGAGAGAAGCAAATTAT
GCACAGCAAGTTGGACTGACGCACTATTATCACGTGTGTTACGAGGGGTGTCTGTCGAATTTCGAGGTTGATGAT
GAGCAGGAAGCCTCCAAGCTCTACCCTGATGTTCACTACACCACCGTCGAGGAATATCTAAAGCGTTACATCTAG 
The sequences used to design full-length primers are written in bold. For integration into the 
expression vector pET15b restriction sites for NdeI in the forward primer and XhoI in the 
reverse primer were added. 
 
4.2 Amplification of PLR-candidate 10318 from cDNA and sequencing 
PLR-candidate 10318 was PCR-amplified (see III.2.4.1) by using full-length primers (see 
IV.6.4) with cDNA as template; the annealing temperature was 54.5 °C. All lanes in Fig. 45 
represent PCR products which were formed under the same conditions. 
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The PCR products of the appropriate length were excised from the gel (see III.2.6), isolated 
(see III.2.6), ligated into pDrive vectors (see V.2.7.1) and used for transformation of competent 
E. coli cells (EZ from Qiagen) by heat shock (III.3.2). Plasmid isolation from transformed 
bacteria and sequencing verified the sequence of a PLR. 
The ORF of PLR-candidate 10318 comprises 975 bp and shows 99.8% identity to the sequence 
of contig 10318 in transcriptome of L. flavum. The ORF of CYP-candidate 10318 is shown 
below: 
ATGGGTTCCCTGGGGAAAGTGATGAATAATGAGATTCCGATTAAGAGCAGCAAAGTGCTGGTGATAGGGGGAACT
GGCTACTTGGGGAAGAGGCTGGTGAAGGCTAGTTTGGATTCGGGCCACGACACCTACGTCATGCATCGCCCGGAG
ATTGGCGTCGACATCGAGAAAGTTCAGCTGCTGCTCTCCTTCAAGATGCAAGGCGCTCATCTCGTCTCCGCCTCC
TTCGACGACCAGCGCAGCCTCGTCGATGCTGTCAAGTTGGTCGACGTCGTCATCTGCGCCATCTCCGGGGTTCAC
ATCCGCAGCCACCAGGTCCTTCTTCAGCTCAAGCTCGTCGAAGCCATCAAAGAAGCCGGTAACGTCAAGAGGTTT
GTACCGTCGGAGTTCGGAACAGATCCGGCGAGGATGGAAAACGCGATGGAGCCAGGAAGGATCACATTCGACGAC
AAAATGGTGGTGAGGAGAGCGATAGAGGAAGCTGGGATCCCTTTCACTTACGTCTCTGCTAATTGCTTCGCTGGC
TACTTCCTTGGCGGTCTTTGCCAACCAGGCTACATTCTTCCTTCTAGAGACCATGTTACTTTGCTTGGAGATGGC
GACAAAAAGGGGGTGTACGTGGACGAGGATGATATAGCCGCTTACACATTGAGGGCCATAGACGATCCTCGAACC
CTCAACAAGACGATCTACGTGAAGCCACCTAAGAACGTGTTGTCCCAAAGAGAAGTTGTTGGGATTTGGGAGAAA
TATATCGGCAAAGAGCTCCAAAAGACCATTCTATCCGAGCAAGACTTCCTCGCTACTATGAGAGAAGCAAATTAT
GCACAGCAAGTTGGACTGACGCACTATTATCACGTGTGTTACGAGGGGTGTCTGTCGAATTTCGAGGTTGATGAT
GAGCAGGAAGCCTCCAAGCTCTACCCTGATGCTCACTACACCACCGTCGAGGAATATCTAAAGCGTTACATCTAG 
 
The start codon and the stop codon are written in bold letters. The amino acid sequence of the 
PLR-candidate was translated from the cDNA sequence and the molecular weight of the protein 
was calculated.  
The amino acid sequence of PLR-candidate 10318 with a molecular weight of appr. 36.3 kDa 
is shown below: 
 
Figure 46: PCR amplification of PLR-candidate 10318 from Linum flavum cDNA 
PCR-products at appr. 1000 bp are marked with a box. 
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MGSLGKVMNNEIPIKSSKVLVIGGTGYLGKRLVKASLDSGHDTYVMHRPEIGVDIEKVQLLLSFKMQG
AHLVSASFDDQRSLVDAVKLVDVVICAISGVHIRSHQVLLQLKLVEAIKEAGNVKRFVPSEFGTDPAR
MENAMEPGRITFDDKMVVRRAIEEAGIPFTYVSANCFAGYFLGGLCQPGYILPSRDHVTLLGDGDKKG
VYVDEDDIAAYTLRAIDDPRTLNKTIYVKPPKNVLSQREVVGIWEKYIGKELQKTILSEQDFLATMRE
ANYAQQVGLTHYYHVCYEGCLSNFEVDDEQEASKLYPDAHYTTVEEYLKRYI 
 
The obtained cDNA sequence of PLR-candidate 10318 shows high similarity to known PLR-
sequences from Linum corymbulosum (Accession No. B5KRH5.1) (86.4 %), Linum 
usitatissimum (Accession No. AJ849359) (78 %) and Forsythia intermedia (Accession No. 
U8158) (70.3 %).  
 
4.3 Heterologous expression of PLR candidate 10318 in E. coli 
After ligation of the full-length sequences of 10318 into the NdeI and XhoI restriction sites of 
the pET15b vector and transformation of E. coli SoluBL21 cells by heat shock the sequence 
was verified. 
 
 
 
 
 
 
 
Heterologous expression was performed (see III.3.7.1) and the His-tagged protein was purified 
with a nickel-NTA column (see III.4.3). All fractions of the purification procedure were 
separated by SDS-PAGE and subjected to Western blotting (see III.4.7). The expressed protein 
was detected with anti-His-Tag antibody. The molecular weight including His-tag of PLR-
candidate 10318 is appr. 38 kDa. 
 
 
 
Figure 47: Agarose gel to verify the full-length sequence of the PLR-candidate 10318 in pET-15b (colony 1-6) 
Plasmids were isolated from E. coli SoluBL21 and digested by the restriction enzymes NdeI and XhoI. Candidate 
bands (appr. 1000 bp) are marked with a box. 
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The result of the Western blot showed that the transformed E. coli SoluBL21 cells produced a 
considerable amount of heterologous protein after induction with IPTG and the purification of 
the heterologously expressed protein was successful.  
 
4.4 Functional identification of PLR-candidate 10318 
The elution fraction after metal chelate chromatography desalted with PD-10 columns (see 
III.4.4) was used for enzyme assays to determine its catalytic activity. The concentration of the 
eluted protein was 0.7 mg/ml. The enzyme assay was performed as described in III.4.8.3. After 
initiation by addition of NADPH, the assays were incubated for different time intervals (0-30 
minutes) and extracted twice with 600 μl EtOAc. The products after evaporation of the solvent 
were dissolved in 100 µl methanol and used for HPLC analysis. HPLC analysis was carried 
out as described in V.4.9. The eluting compounds were detected at a wavelength of 280 nm. 
PINO and SECO showed as references significant peaks at 13.6 and 6.3 minutes, respectively 
(Fig. 49).  
 
 
 
Figure 48: Western Blot of PLR-candidate 10318 
M: marker; D: flow through fraction; W1: wash fraction 1; W2: wash fraction 2; W6: wash fraction 6; E1: elution 
fraction 1; E2: elution fraction 2. His-tagged protein bands of PLR-candidate 10318 with appropriate molecular 
weight in the elution fractions are marked with boxes.    
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Figure 50: Chromatograms of PLR enzyme assays with different reaction times 
Racemic PINO and NADPH were incubated with the heterologously expressed LfPLR. The reaction time is 
A: 0 min; B: 1 min; C: 2 min; D: 5 min; E: 10 min, F: 30 min. Peaks of PINO, SECO and LARI on the 
chromatograms are marked with undashed arrows, dashed arrows, and arrows with a round head, 
respectively.  
A
H
B 
Figure 49: Chromatograms of standards: racemic pinoresinol (A) and secoisolariciresinol (B) 
PINO and SECO showed significant peaks at 13.6 and 6.3 minutes, respectively.  
 
PINO 
SECO 
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The reaction product SECO and the remaining PINO were identified by using authentic 
standards for comparison of retention times. The chromatogram of the enzyme assay with a 
reaction time of 1 minute (Fig. 50B) showed a high peak for an intermediate and a smaller peak 
at 6.3 minutes for SECO. After 2 minutes reaction time, the peak for SECO increased and the 
peak for the intermediate decreased. According to Heimendahl et al. (2005), the intermediate 
could be identified as LARI. Unfortunately, no standard was available for LARI. Racemic 
PINO was used in enzyme assays and only one enantiomer of PINO was converted into SECO. 
Therefore, from 5 to 30 minutes reaction time (Fig. 50), there were two peaks in the 
chromatograms, one peak for SECO and another one for the remaining enantiomer of PINO.  
No activity was detected either in the absence of substrate and cofactor or when the protein 
was denatured by boiling. Extracts from cells containing the expression vector lacking an insert 
did not show any catalytic activity as well. The HPLC-results showed that PLR-candidate 
10318 was highly active and catalysed the conversion of PINO via an intermediate (presumably 
LARI) into SECO in the dependence of NADPH.  
Furthermore, HPLC with a chiral column (Chiralcel OD-H) was used to analyse the 
stereospecificity of the enzymatic reaction. The (+)- and (-)-enantiomer of SECO and PINO 
were identified by comparing with the chiral HPLC-chromatograms of SECO and PINO 
published by Heimendahl et al. (2005). 
 
 
 
 
 
 
 
 Figure 51: Chromatogram of racemic PINO as standard 
The arrows indicate the peaks for (-)-PINO and (+)-PINO at 14.4 and 42.5 minutes, respectively.  
 
(+) 
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The chiral HPLC showed that the formed product was (-)-SECO and the remaining substrate 
was (-)-PINO. The reaction from PINO to SECO catalysed by PLR-candidate 10318 is 
stereospecific, namely only (+)-PINO is used to form (-)-SECO. 
 
4.5 Characterisation of PLR  
4.5.1 Time course experiment  
Figure 53: Chromatogram of a PLR enzyme assay (30 minutes) 
The arrows indicate the peaks for (-)-SECO and (-)-PINO at 6.7 and 14.4 minutes, respectively 
 
(-) 
(-) 
Figure 52: Chromatogram of racemic SECO as standard 
The arrows indicate the peaks for (-)-SECO and (+)-SECO at 6.7 and 7.6 minutes, respectively.  
 
(+) 
(-) 
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A time course experiment was performed with different amounts of purified PLR. The aim was 
to determine the optimal protein concentration and incubation time for linear product 
formation. 
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Figure 55: Formation of SECO 
Time-dependent formation of SECO from racemic PINO with different amounts of recombinant purified PLR 
(1 µg, 2 µg, 3.5 µg, 7 µg, 14 µg, 35 µg)  
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Figure 54: Formation of lariciresinol  
Time-dependent formation of LARI from racemic PINO with different amounts of recombinant purified PLR 
(1 µg, 2 µg, 3.5 µg, 7 µg, 14 µg, 35 µg)  
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Protein concentrations as low as 1 µg/250 µl assay only formed LARI within 30 minutes. With 
higher protein concentrations LARI concentrations reached a maximum within 10 minutes. 
Afterwards, the concentration of SECO increased, while the amount of LARI decreased.  
 
4.5.2 Optimal temperature 
The temperature optimum was determined by incubation of enzyme assays at various 
temperatures between 21 °C and 42 °C.  
 
Fig. 55 shows an increase of specific activity from 21 °C to a maximum of about 3 mkat/kg at 
27-33 °C. At higher temperatures, the specific activity decreases continuously.  
 
4.5.3 pH-optimum of PLR 
In order to determine the exact impact of the pH during the reaction, a series of enzyme assays 
at different pH values was performed. The pH values of the 0.1 mM KPi buffer systems ranged 
between 5.5 and 9 in steps of 0.5 pH units 
 
 
 
Figure 56: Temperature optimum of PLR  
Dependence of the specific PLR activity on the incubation temperature. The data represent mean values 
of three replicate assays (±s.d.). 
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In Fig. 57, PLR of L. flavum showed first activity at a pH of 6 and reached a maximum of about 
4.4 mkat/kg at pH 7. Under more alkaline conditions the activity dropped significantly and no 
activity was observed at pH 9. 
 
4.5.4 Km-value for NADPH 
 
Kinetic experiments were performed at a fixed concentration of purified PLR and racemic 
PINO with varying NADPH concentrations from 0 to 750 µM. PLR displayed a Km-value for 
NADPH of 22.4 ± 1.2 μM and a Vmax of 4.9 mkat/kg (Fig. 59).  
 
 
 
 
 
 
 
 
 
Figure 57: pH-optimum of PLR 
Dependence of the specific PLR activity on the pH of the 0.1 M KPi-buffer. The data represent mean 
values of three replicate assays (±s.d.).  
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Figure 58: Dependence of the specific PLR activity on the NADPH concentration 
The data represent mean values of three replicate assays (±s.d.). 
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4.6 Comparison of PLR sequences from different plants 
 
Amino acid sequence alignment was conducted between PLRs with specificity to form (-)-
SECO from Linum flavum (PLR-Lf), Thuja plicata (PLR-Tp2, accession No. AF242504), 
Linum perenne (PLR-Pp, accession No. ABM68630.1), Forsythia intermedia (PLR-Fi, 
accession No. U81158), Linum album (PLR-La, accession No. AJ849358), and PLRs with 
specificity to form (+)-SECO from Thuja plicata (PLR-Tp1, accession No. AF242503), Linum 
usitatissimum (PLR-Lu1, accession No. AJ849359) with Clustal Omega (Fig. 60). The 
conserved sequence motif ‘‘GxxGxxG’’ plays a crucial role in the correct positioning of 
NAD(P)H (Dinkova-Kostova et al., 1996). More importantly, a lysine residue (Lys138 in PLR-
Tp1 from Thuja plicata) is conserved among all PLRs and is believed to be involved in catalysis 
as a general base (Min et al., 2003). 
 
PLR-Lf     MGSLGKVMNNEIPIK---SSKVLVIGGTGYLGKRLVKASLDSGHDTYVMHRPEIGVDIEK 57 
PLR-Tp2    ---------------MEESSRILVVGGTGYIGRRIVKASIALGHPTFILFRKEVVSDVEK 45 
PLR-Lp     ----------------MKPCSVLVVGGTGYIGKRIVSASLYLGHDTYVLKRPGTGLDIEK 44 
PLR-Fi     ----------------MGKSKVLIIGGTGYLGRRLVKASLAQGHETYILHRPEIGVDIDK 44 
PLR-La     MGSLGKVN-NEIPTKSSGGSKVLVIGGTGYLGKRLVKASLDSGHDTYVMHRPEIGVDIEK 59 
PLR-Tp1    ---------------MDKKSRVLIVGGTGFIGKRIVKASLALGHPTYVLFRPEALSYIDK 45 
PLR-Lu1    ----------------MGRCRVLVVGGTGYIGKRIVKASIEHGHDTYVLKRPETGLDIEK 44 
                              . :*::****::*:*:*.**:  ** *::: *      ::* 
 
PLR-Lf     VQLLLSFKMQGAHLVSASFDDQRSLVDAVKLVDVVICAISGVHIRSHQVLLQLKLVEAIK 117 
PLR-Tp2    VEMLLSFKKNGAKLLEASFDDHESLVDAVKQVDVVISAVAGNHMRH-HILQQLKLVEAIK 104 
PLR-Lp     LQLLLSFKKRGAHLVEASFSDHDSLVRAVRLVDVVICTMSGVHFRSHNILLQLKLVEAIK 104 
PLR-Fi     VEMLISFKMQGAHLVSGSFKDFNSLVEAVKLVDVVISAISGVHIRSHQILLQLKLVEAIK 104 
PLR-La     VQLLLSFKMQGAHLVSASFDDQRSLVDAVKLVDVVICAISGVHIRSHQILLQLKLVEAIK 119 
PLR-Tp1    VQMLISFKQLGAKLLEASLDDHQGLVDVVKQVDVVISAVSGGLVRH-HILDQLKLVEAIK 104 
PLR-Lu1    FQLLLSFKKQGAHLVEASFSDHESLVRAVKLVDVVICTVSGAHSR--SLLLQLKLVEAIK 102 
           .::*:***  **:*:..*:.*  .** .*: *****.:::*   *   :* ********* 
Figure 59: Linearisation of the data from Fig. 58 according to Hanes-Woolf 
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PLR-Lf     EAGNVKRFVPSEFGTDPAR-MENAMEPGRITFDDKMVVRRAIEEAGIPFTYVSANCFAGY 176 
PLR-Tp2    EAGNIKRFVPSEFGMDPGL-MDHAMAPGNIVFIDKIKVREAIEAAAIPHTYISANIFAGY 163 
PLR-Lp     EAGNVKRFIPSEFGMDPAR-MGQAMEPGRETFDQKMVVRKAIEEANIPHTYISANCFAGY 163 
PLR-Fi     EAGNVKRFLPSEFGMDPAKFMDTAMEPGKVTLDEKMVVRKAIEKAGIPFTYVSANCFAGY 164 
PLR-La     EAGNVKRFVPSEFGTDPAR-MENAMEPGRITFDDKMVVRRAIEEAGIPFTYVSANCFAGY 178 
PLR-Tp1    EAGNIKRFLPSEFGMDPDV-VEDPLEPGNITFIDKRKVRRAIEAATIPYTYVSSNMFAGF 163 
PLR-Lu1    EAGNVKRFIPSEFGMDPAR-MGDALEPGRETFDLKMVVRKAIEDANIPHTYISANCFGGY 161 
           ****:***:***** **   :   : **. .:  *  **.*** * **.**:*:* *.*: 
 
PLR-Lf     FLGGLCQP---GYILPSRDHVTLLGDGDKKGVYVDEDDIAAYTLRAIDDPRTLNKTIYVK 233 
PLR-Tp2    LVGGLAQL---GRVMPPSDKVFLYGDGNVKAVWIDEEDVGIYTIKAIDDPRTLNKTVYIR 220 
PLR-Lp     FVGNLSQL---GTLTPPSDKVIIYGDGNVKVVYVDEDDVAKYTIKAIEDDRTVNKTVYLR 220 
PLR-Fi     FLGGLCQF---GKILPSRDFVIIHGDGNKKAIYNNEDDIATYAIKTINDPRTLNKTIYIS 221 
PLR-La     FLGGLCQP---GYILPSRDHVTLLGDGDKKGVYVDEDDTAAYTLRAIDDPRTLNKTIYVK 235 
PLR-Tp1    FAGSLAQLQDAPRMMPARDKVLIYGDGNVKGVYVDEDDAGIYIVKSIDDPRTLNKTVYIR 223 
PLR-Lu1    FVGNLSQL---GPLTPPSDKVTIYGDGNVKVVYMDEDDVATYTIMTIEDDRTLNKTMYLR 218 
           : *.*.*      : *  * * : ***: * :: :*:* . * : :*:* **:***:*:  
 
PLR-Lf     PPKNVLSQREVVGIWEKYIGKELQKTILSEQDFLATMREANYAQQVGLTHYYHVCYEGCL 293 
PLR-Tp2    PPLNVLSQKEVVEKWEKLSRKSLDKIYMSVEDFLAGMEGQSYGEKIGISHFYQMFYKGDL 280 
PLR-Lp     PPENMMSQRELVAVWEKLSGNQLEKIELPPQDFLALMEGTTVAEQAGIGHFYHIFYEGCL 280 
PLR-Fi     PPKNILSQREVVQTWEKLIGKELQKITLSKEDFLASVKELEYAQQVGLSHYHDVNYQGCL 281 
PLR-La     PPKNVLSQREVVGIWEKYIGKELQKTILSEQDFLATMREQNYAEQVGLTHYYHVCYEGCL 295 
PLR-Tp1    PPMNILSQKEVVEIWERLSGLSLEKIYVSEDQ-LLNMKDKSYVEKMVRCHLYHFFIKGDL 282 
PLR-Lu1    PPENVITHRQLVETWEKLSGNQLQKTELSSQDFLALMEGKDVAEQVVIGHLYHIYYEGCL 278 
           ** *:::::::*  **:    .*:*  :  :: *  :.     ::    * :..  :* * 
 
PLR-Lf     SNFEVDD---EQEASKLYPDAHYTTVEEYLKRYI 324 
PLR-Tp2    YNFEIGPN--GVEASQLYPGVKYTTVDSYMERYL 312 
PLR-Lp     TNFEINAENGEEEASRLYPEVEYTRVHDYLKIYL 314 
PLR-Fi     TSFEIGD---EEEASKLYPEVKYTSVEEYLKRYV 312 
PLR-La     SNFEVDD---EQEASKLYPDVHYTTVEEYLKRYV 326 
PLR-Tp1    YNFEIGPN--ATEGTKLYPEVKYTTMDSYMERYL 314 
PLR-Lu1    TNFDIDAAQDQVEASSLYPEVEYIRMKDYLMIYL 312 
            .*::.      *.: *** ..*  :..*:  *: 
 
 
4.7 Enantiospecific conversion and PLR-mutants 
PLRs catalyse the enantiospecific conversions from (+)- and (-)-PINO to (-)- and (+)-SECO, 
respectively. The protein structure of PLR-Lf was predicted by the bioinformatic tool Phyre2 
(Kelley et al., 2015) and the ligand (+)-PINO docked into the binding pocket of PLR-Lf (Fig. 
61). The crystal structure of PLR-Tp1 and the energy-minimized model of PLR-Tp2 obtained 
by Min et al. (2003) (Fig. 62) and the predicted protein structure of PLR-Lf allowed us to study 
more closely the structure-function relationship of the enantiospecific enzymatic conversion, 
Figure 60: Amino acid sequence alignment of PLRs with specificities to form (-)-SECO (black) and (+)-SECO 
(grey) 
Linum flavum: PLR-Lf, Thuja plicata: PLR-Tp2, Linum perenne: PLR-Lp, Forsythia intermedia: PLR-Fi, Linum album: 
PLR-La, Thuja plicata: PLR-Tp1, Linum usitatissimum: PLR-Lu1. The conserved sequence motif ‘‘GxxGxxG’’ of the 
NADPH binding domain is marked with a box. Amino acid positions predicted to be involved in stereospecificity 
by Min et al. (2003) are indicated by triangles and the Lys residue involved in general base catalysis is indicated 
by a dot (Min et al., 2003).  
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namely PLR-Tp1 with the specificity to utilise (-)-PINO and PLR-Tp2 and PLR-Lf with the 
specificity to use the opposite enantiomer (+)-PINO. The overall secondary and tertiary 
structures of PLR-Tp1 and PLR-Tp2 are very similar. The only functionally significant 
differences are in the substrate and cofactor binding sites. The structures of PLR-Tp1 and PLR-
Tp2 show remarkable differences in the local environment of the substrate binding site. In 
PLR-Tp1, (-)-PINO fits tightly between the side chains of Phe164, Val268, and Leu272, but in 
PLR-Tp2, favouring the binding of the (+)-enantiomer of PINO, there are Leu164, Gly268 and 
Phe272 (Min et al., 2003). The position Phe164 in (+)-SECO-forming PLR-Tp1 was found in 
sequences of many (-)-SECO-forming PLRs as well (e.g Phe174 in PLR-Lf or Phe165 in PLR-
Fi) (see Fig. 60), thus this position might not play a relevant role in determining the 
enantiospecificity. The position Phe272, an unpolar amino acid, in PLR-Tp2 is not conserved 
among all (-)-SECO-forming PLRs and can be replaced by tyrosine, a polar amino acid (e.g. 
Tyr284 in PLR-Lf or Tyr272 in PLR-Fi). Therefore, not the polarity but the size of amino acid 
residues in this position might be important for the enantiospecific conversion.  
An attempt was made in this work to seek the explanation for the enantiospecific differences 
of PLRs and to prove whether the varying size of the amino acids in the binding pocket is 
responsible. Mutagenesis of the coding sequence of PLR from Linum flavum was carried out: 
the small amino acid glycine (G280) was replaced by tyrosine (mutant G280Y) and the amino 
acid tyrosine (Y284) was changed to glycine (mutant Y284G).  
 
Figure 61: Schematic representations of the predicted protein model of PLR-Lf from Linum flavum 
The position of the substrate (+)-PINO in the binding pocket and the potential key residues and surfaces 
that form substrate contact points are highlighted. 
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4.7.1 LfPLR G280Y 
In this mutant, the amino acid glycine was replaced by the polar and aromatic amino acid 
tyrosine (G280Y) using site-directed mutagenesis (see III.2.9). The mutated PLR-Lf inserted 
into pET15b was used to transform E. coli SoluBL21, express and purify the mutant protein. 
SDS-PAGE (Fig. 63) showed the successful expression of LfPLR-G280Y. 
 
In the elution fraction, a band in the expected size-range was detected on the SDS-PAGE gel. 
The result of SDS-PAGE showed that the transformed E. coli SoluBL21 cells produced the 
heterologous protein after induction with IPTG and that the purification of the His-tagged 
Figure 63: SDS-PAGE of heterologously expressed PLR-Lf mutant G280Y purified by metal chelate 
chromatography 
M: marker; D: flow through fraction; W1: wash fraction 1; W2: wash fraction 2; W6: wash fraction 6; E: elution 
fraction. The His-tagged protein band of LfPLR-G280Y in the elution fractions is marked with a box.    
 
Figure 62: Schematic representation of the crystal structures of PLRs from Thuja plicata (Min et al., 2003) 
A: Schematic representation of the crystal structure of PLR-Tp1; B: energy minimized model of PLR-Tp2. 
NADPH, PINO and the potential key amino acids are highlighted.  
A B 
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protein was successful. Then, PLR enzyme assays were performed with His-tagged purified 
protein as described in III.4.8.3 in order to test the enzymatic activity of this mutant. After 
initiation by addition of NADPH, the assays were incubated for 2 hours. The substances formed 
in the enzyme assays were analysed by HPLC. However, no peak for any product (SECO or 
LARI) was observed on the HPLC chromatogram. Another attempt was made to test the 
activity of this mutant with a ten-fold higher concentration of PINO and longer incubation time 
(24 hours). Nevertheless, again no activity of the mutant LfPLR-G280Y was detected and the 
catalytic activity of the mutated LfPLR-G280Y was totally abolished. 
In order to explain why the mutation from G to Y at the position 280 of wild-type LfPLR led 
to the loss of the enzyme’s function, the single amino acid variants (SAVs) were analysed by 
Phyre2 Investigator (Kelley et al., 2015). These predictions are made using the SuSPect method 
(Yates et al., 2014). The mutational analysis graph (Fig. 64) represents the predicted effect of 
mutations at position 280 in the wild-type LfPLR sequence. In the graph, the 20 possible amino 
acids are labelled along the x-axis with their one-letter code. The coloured bars indicate the 
probability that a mutation to the corresponding residue will have some effect on the function 
of PLR. In position 280 of the LfPLR sequence, the mutation to Y has the highest likelihood 
to affect the function of the enzyme, similar as R, C, Q, K or F.  
 
 
 
 
 
 
 
 
 
 
 
Additionally, the protein sequence of LfPLR-G280Y was submitted to Phyre2 (Kelley et al., 
2015) to predict the protein structure. Subsequently, the position of the ligand (+)-PINO in this 
mutant was predicted by Swiss Dock. The best-ranked position of PINO in the protein structure 
according to the average full fitness of the elements is shown in Fig. 65 (Grosdidier et al., 2007) 
Figure 64: Mutational analysis graph of position 280 of wild-type PLR-Lf 
performed by Phyre2 Investigator 
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and compared to the wild-type (Fig. 61). When viewing the images depicting the location of 
(+)-PINO in the binding pockets in both cases, the difference of the positions due to the steric 
effect of Y280 in the mutant is very clear. Tyr with the phenolic residue is much larger than 
Gly, thus encroaching on the methoxyphenol position of the ligand. This leads to a big change 
in the position of the tetrahydrofurofuran ring of the ligand. Hence, in the binding pocket of 
the mutant, the distance between PINO and the cofactor NADPH could be too long to enable 
the transfer of the hydride ion from NADPH to the tetrahydrofurofuran ring. That might be the 
reason why the mutated enzyme is ineffective and cannot catalyse the reaction. 
  
4.7.2 LfPLR-Y284G 
In the mutant LfPLR-Y284G, the amino acid tyrosine was replaced by the amino acid glycine 
(Y284G) using site-directed mutagenesis (see III.2.9). The mutated PLR-Lf inserted into 
pET15b was used to transform E. coli SoluBL21, express and purify the mutated protein. SDS-
PAGE (Fig. 66) showed the successful expression of LfPLR-Y284G. 
  
 
 
 
 
Figure 65: Schematic representations of the predicted protein model of the mutant LfPLR-G280Y 
The position of the substrate (+)-PINO in the binding pocket and the potential key residues and surfaces that 
form substrate contact points are highlighted. 
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In the elution fraction, a band in the expected size-range was detected on the SDS-PAGE gel. 
The result of the SDS-PAGE showed that the transformed E. coli SoluBL21 cells produced the 
heterologous protein after induction with IPTG and that the purification of the His-tagged 
protein was successful.  
Enzyme assays were performed with the His-tagged purified mutant protein as described in 
III.4.8.3 in order to test the enzymatic activity of this mutant. After initiation by addition of 
NADPH, the assays were incubated for 2 hours. The enzyme assays were analysed by HPLC. 
However, no peak for any product (SECO or LARI) was observed on the HPLC chromatogram. 
Another attempt was made to test the activity of this mutant with a ten-fold higher 
concentration of PINO and longer incubation time (24 hours). Nevertheless, again no activity 
of the mutant LfPLR-G280Y was detected and the catalytic activity of the mutated LfPLR-
G280Y was totally abolished. 
The single amino acid variants (SAVs) at the position 284 of wild-type PLR was analysed by 
Phyre2 Investigator (Kelley et al., 2015) in order to elucidate why the mutant LfPLR-Y284G 
lost its catalytic activity. The mutational analysis graph (Fig. 67) represents the predicted effect 
of mutations at position 284 in the wild-type PLR sequence. At position 284 of the PLR 
sequence, it can be seen that the mutation to G has the highest likelihood to affect the function 
of the enzyme, similar as D.  
 
 
Figure 66: SDS-PAGE of heterologously expressed PLR-Lf mutant Y284G and purification sequence by metal 
chelate chromatography 
M: marker; D: flow through fraction; W1: wash fraction 1; W2: wash fraction 2; W6: wash fraction 6; E: elution 
fraction. The His-tagged protein band of LfPLR-Y284G in elution fractions is marked with a box.    
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 In addition, the protein structure of mutant Y284G and the position of the ligand (+)-PINO 
were predicted by the same methods used for mutant G280Y. The position of the ligand in the 
predicted protein structure in the mutant (Fig. 68) was compared to the ligand position in wild-
type LfPLR (Fig. 61). When comparing the position of (+)-PINO in the binding pockets in both 
cases, the difference is obvious. In the binding pockets of wild-type LfPLR, the position of the 
ligand (+)-PINO is very close to Tyr284, which acts as an anchor point due to the hydrophobic 
interaction between the Tyr-residue and the methoxyphenol ring of PINO. However, in the 
binding pockets of mutated LfPLR Y284G, the position of PINO is far from Gly284 and 
located deeper in the binding pocket. Hence, PINO could push the cofactor NADPH out of the 
binding pocket and thus cannot receive the hydride ion from the cofactor. That might be the 
reason why the mutated LfPLR-Y284G lost the catalytic activity. 
Figure 68: Schematic representations of the predicted protein model of the mutant LfPLR-Y284G 
The position of the substrate (+)-PINO in the binding pocket and the potential key residues and surfaces 
that form substrate contact points are highlighted. 
 
Figure 67: Mutational analysis graph of position 284 of wild-type PLR-Lf performed by Phyre2 Investigator 
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4.8 Concluding remarks 
From the transcriptome database of L. flavum one contig that potentially encodes the enzyme 
PLR was found. The ORF of PLR-candidate 10318 was amplified with cDNA from a 
suspension culture of L. flavum. This ORF was heterologously expressed in E. coli SoluBL21 
and the recombinant protein catalysed the formation of (-)-secoisolariciresinol from (+)-
pinoresinol in in-vitro enzyme assays. PLR is the first gene encoding an enzyme in lignan 
biosynthesis successfully identified in L. flavum.  
Two mutants of PLR-Lf were constructed to investigate the role of the varying size of important 
amino acids in the binding pocket. The loss of enzymatic activity of mutants LfPLR G280Y 
and Y284G showed that the size of amino acids at two positions 280 and 284 in the binding 
pocket are not only important for the enantiospecificity but also crucial for the catalytic activity 
of the enzyme. Y284 and G280 might play a vital role in the positioning of ligand in the binding 
pocket. Further experiments and mutageneses need to be employed to fully understand the 
steric effect of other amino acids on the stereospecificity of PLR.   
 
5. Project 4: Identification of secoisolariciresinol dehydrogenase  
5.1 Secoisolariciresinol dehydrogenase (SDH) candidates 
The amino acid sequence of SDH from Forsythia intermedia (Xia et al., 2001) was used as a 
reference gene to search for SDH candidates in the transcriptome database of Linum flavum 
with the help of Blastp. 
The five candidates with the best Blastp-results are shown below:  
 
 
 
 
 
 
 
Contig Score Query cover E-value Identity 
36067 393 99% 3e-143 68% 
28880 260 90% 5e-91 53% 
73995 244 95% 6e-85 51% 
5591 239 94% 9e-83 54% 
7665 234 90% 5e-80 49% 
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5.2 Amplification of candidates from gDNA and sequencing 
The open reading frames (ORF) of the candidates were found in the transcriptome database by 
ORF Finder and Oligo Calc was used to design the primers (see IV.6.3) based on the sequences 
(20-30 nucleotides) located at the beginning and the end of the identified ORFs. Many attempts 
to perform standard PCR reactions (see III.2.4.1) with cDNA as template and the corresponding 
primers failed. The suitability of the cDNA is dependent on the transcription of the respective 
gene and therefore highly dependent on external factors, such as cultivation time, medium, etc. 
The next attempts, therefore, were made with gDNA as a template for standard PCR 
experiments and the five SDH candidates were successfully amplified. 
 
 
 
 
 
 
 
 
 
 
 
The PCR products (Fig. 69 and 70) considerably varied in their sizes from appr. 800 bp to 1600 
bp. The PCR products were excised from the agarose gel and isolated from the gels (see III.2.6). 
The candidate PCR products were ligated into pDrive vectors (see V.2.7.1) and subsequently 
introduced into competent E. coli EZ cells by heat shock (see III.3.2). The transformed bacterial 
Sample Annealing temperature (°C) 
5591-1 52.7 
5591-2 54 
5591-3 55.7 
73995-1 54 
73995-2 55.7 
73995-3 57.2 
28880-1 54 
28880-2 55.7 
Sample Annealing temperature (°C) 
36067-1 54 
36067-2 55.7 
36067-3 57.2 
7665-1 54 
7665-2 55.7 
7665-3 57.2 
Figure 69: PCR of SDH-candidates 5591, 73995 and 
28880 
PCR-products are marked with boxes. 
 
Figure 70: PCR of SDH-candidates 36067 and 
7665  
 PCR-products are marked with boxes. 
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colonies were selected and grown in overnight cultures at 37° C. The bacterial plasmids were 
then isolated (see III.3.5) and sent to Seqlab® for verifying the sequences. 
The gDNA-sequence of SDH-candidate 28880 comprises 938 bp incuding one intron 
(underlined) and is shown below: 
ATGGGCTCTGATATCTGTGCACCCTCTGTCACCAAGACGTACGTAGGGATTTACACGTTATATTCCACCACCAGT
TAATGTTTTATCGTAATTTACTGGTTATCGATGCATATGTTCATTTTAGTTAGTTGGTTAATACATACTTCTGCA
GGCTAGAAGGCAAAGTGGCGCTCATAACTGGAGGAGCAAGCGGCATAGGCGAGAGCGCTGTCAGGCTGTTCATGC
AACACGGAGCCAAGGCTCTCATCGCCGACCTTCAAGATAAACTCGGCGAATCCCTCGCCACGGAACTCGGTCCAC
CGGAGATTGTCTCCTTCGTCCACTGCAATGTCACTGTAGACTCCGATGTGGGAAACGCTGTGGATACTGCGGTTT
TGAGGTACGGACAGTTGGACATCATGTACAACAACGCTGGAATCGGAGGCAACCTCGACACCACGATTTTAAACT
CCGACAATGACGATTTCAAAAGGGTATTGGAAATAAACCTGTTCGGATCGTTCCCCGGAGCCAAACACGCTGCTA
GAGTGATGATTCCGGCGAGGAAAGGTTGCATACTATTTACGGGAAGCGTGGCGTCGTCAATAAGCGGGGATTTAT
CATACGCTTACAAGGCTTCGAAGCACGCGTTGTTGGGGCTAGCCAATAATTTGACTGTGGAGATGGGGAAGTACG
GGATTAGGGTCAACACTATATCCCCGTATGGAGTGGCCACTCCTATGGTGACACGTGGCCTGCAAATGGATAAGA
AGGCTGTCGAGCAGTTCATGTCGGCAGCGGGGAACCTAAGAGGGGCGATTTTGGAGCCAGAGGATGTTGCCAAGG
CGGCGCTGTACTTGGCTAGCGATGATGCGAAATATGTGAGTGGGCTGAACTTGATTGTTGACGGTGGCCACAATC
ACAACCATCCTCTCTTTGGCGCTTCCGCTGAAGCATGA 
 
The gDNA-sequence of SDH-candidate 36067 comprises 1061 bp incuding one intron 
(underlined) with 212 bp and is shown below: 
ATGGCGGCAGCAGCACCAGCTTCCTTTATCTCCTCCGTCGCCAGAAGGTAACCTCTTACCAGTCCTTTAGTTCTT
GCTTAATTCAATCCTTTCCTCTTTCTCAAATCCTTCCATTTCCAGTCTCTGATCTAGTATACCCTATCACCCCAT
CTCTCTGTTCACTCCCTGGTTTTGTCTTTATTTGATCTGTTCTTGATTGATTCTTCAGTTCGGATATCAACTGAT
CCACCTCGTGTTGATTTCTCTGACATTTCTGCAGGCTGGAAGGCAAAGTAGCGCTAATCACCGGAGGAGCAAGCG
GGATCGGCGAATTCACCGCCAGAGTGTTCGCCCACCACGGCGCCAAAGTCGTGATCGCCGACGTCCAAGACGACC
TTGGCCAATCCGTCGTGGCCGACACCCTGGGCCGCGCCAACTCCACCTACGTCCGCTGCGACGTCACCGAGGAGT
CCCAAATCAAAGACGCCGTCGACAAGGCCGTCTCCACCTACGGCAAGCTCGACATCATGTTCAACAACGCCGGCA
TCGCCGACCCCAACAAGCCCCGCATAGTCGACAACGAGAAGTCCGACTTCGAGCGCGTCCTCAGCGTCAACGTCA
CCGGTGTCTTCCTCGGGATGAAGCACGCGGCGCGGGTGATGATCCCGCGCCGCACGGGGGCCATAATCTCGACCG
CCAGCATCAGCTGCGCCATGGGCGGCGCAGCCTCGCACGCATACTGCTGCTCGAAGCACGCCGTGCTGGGGCTGA
CCCGGAACGCGGCGGTCGAGCTGGGGCAGTTCGGGATCAGGGTGAACTGCCTGGCGCCGTACGCGATGGCGACGC
CTCTGGCGACGAAGTTCGTGGGGTTGCCGGATGAGGAGTTGGAAGGGGCGATGAATGCTCTGGCGAATTTGAAAG
GAGTGACCCTGAAAACAGAGGATGTGGCGAACGCTGCTCTGTTCTTGGCTAGCGACGAAGGTAGGTATGTTAGTG
GGCATAGTTTGGTTGTGGATGGAGGGTTTAGCATTCATAATACTGCGTTTAGGATCTTCAATTACCCGGAAGATG
GATCTTCATGA 
 
The gDNA-sequence of SDH-candidate 5591 comprises 1619 bp incuding two intron 
(underlined) and is shown below: 
ATGGCCGCCACTAACTTCGTTTCTTCCATCATAAAAAGGTTCTCATCACTTTCTTACTAATCTCAACCCTTCACT
ATACTTCACTATGCATTTCCCGATCAAATTTTTCATTAATTCTCAGGCTGGAAGGCAAAGTAGCGCTGATCACCG
GCGGAGCCAGCGGAATCGGCGAGGCCACCGCCAGCCTTTTCGTCCAACACGGCGCCAAAGTCCTAATCGCCGACG
TCCAAGACCAACTCGGCGAATCCTTAGCCCGAAACCTAGGCCCGCCGGACACGGTCTCCTACGTCCGCTGCGATG
TTACCAGTCCTCCCGAAGTCGGGGCCGCCGTGGACGAGGCGGTGTCGAGGTACGGCCAGCTGGACATCATGCACA
ACAACGCCGGCATCGCCGGGGGCCTAGACCAGCGTATCGTTCACTCCGACGACGATGACTTCCGGCGGGTCCTGG
ACGTCAACCTCTTCGGATCCTACCTTGGGGCTAAGCACGCCGCCAGGGTGATGGTAAGTAAATGTTGAGAAGTAG
TTAACAATACTGTAGTTGAAATGGCGTTTTTTATCTTAAAATTTTACGCTTTTATCAAAATAATGTACGTTTTCG
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TATAATTTTTTTTACGAACAGATGTAAATTGGATGGATGTTCACCAAAATTGTTCGCTTCTTATCGAAAAAATAT
TAATTTTTTATGTACTCTTTTAAATATAGAGTAAATATAATTATTAAAAGTCTATAATATTATATTTTAAATAAT
ACTTGTTGTTAAAAATATTTCTATCAATTTTATACGATATATAAAATCAAAATTTGTAAAATTATATCCGAATTT
ATTCGGAACAAGTTAGTGGTAAAGTACTATCATGGTTTGAAGACAATGTACCGTTGTTAAAATGATATTAAAATA
AAAATTATATATTCAACCTGTAATGTACCGCAATAATATCATTTAAAACCAAAAAAATCGACTGATATATCGTTG
ATTAATAATTTAACCTTCTTGTACTAATCATATTAAAATTGTCCAACCTTAATATAATACTGTATCATAAGGTAT
CCGTTTTTTACACCTTAACACTTTCATCCATATTTCCATTTATACGATTGCGCTCTTTACTACATTAATAGTAGA
GTTATATGTTCGGTTGAGAAGTGACAGACGACGTAATATATTATATATAACACTTGGTATATACTTTGCCAGGTA
CCGGCGGGGAGAGGCGGGTGCATTCTGTTCACGGCGAGCAGCGCGGCGGTGACGAGCGGGAACATTACGTACGCG
TACAAGGCGTCGAAGAACGGGGTGTTGGGGCTGGCGAACAACCTGTGCGTGGAGCTGGGTCAGTACGGGATCCGG
GTAAACGCGATCTCGCCGTTCACGGTGGTGACTCCGCTGTTGGTGAGTGTGCTGGGAGGCGGCGGGCTGGGGAAG
GGGGAGGTGGAGAGGCTGTGGCGGCGGCGACGAAGCCGAACTTGAAAGGAGCGGTGTTGGAAGCGGCGGATATTG
CCAAGGCGGCGCTGTTTTTGGCGAGCGATGATGCCAAGTACGTGAGTGGGTTGAATTTGGTCGTCGATGGTGGGC
ATAATCACAACCGTCCGATCTTTGATGATTTGAGGTTCGCTTGA 
 
The gDNA-sequence of SDH-candidate 73995 comprises 908 bp incuding one intron 
(underlined) and is shown below: 
ATGTCTTCTTCCTACCAGCCGGCGGCGGCGAGTTCTCACTGGTACGGCGAACTGAAACTCTGAAACCCTAAAACC
CTACTCTGTATCGTCTCTGTTCGTTCAGCTTATAAACGATGTCGTTTAATTTGTTTAAGCAGACTAGAAGGCAAG
GTGGCAGTGATTACCGGCGGCGCGAGCGGGATCGGCGCAGCGACGGCCAAGCTCTTCGCCCTCAACGGCGCCAGA
GTCATAATCGCCGACGTCCAATCCGAACTGGGCCGCTCCGTCGCCGAAGAAATCAGCTCCGTATCTCCCCACCCG
GTCACCTACGTGGACTGCGACGTCAGCAAGGAGTCCGACGTGGCGAGCGCGGTGGACGGCGCCGTTTCGGCGTAC
GGGAAGCTGGACATTATGTACAGCAACGCCGGGATCATGGGGAGCTGACCGGGATGGGGATCGCCACGGTGGACA
GCGGCGATCTCGCCAGAGTGTTTGAAGTCAACGTCAAGGGAGCTTTCCACTGCGCCAAGCAGGCGGCGAGGGTGA
TGATACCGGAGAAGAAGGGGACGATTTTGTTCACGGCGAGTAGCGTTACGGCGACGTATGGGAACGCGCCGCACC
CTTATACGGCGTCGAAGCACGCGGTGGTCGGGCTGATGAAGAATTTGACGGTGGAGTTGGGAGGGTATGGGATTC
GGGTGAACTCGATTTCGCCGGACGGGGTGCCGACGCCGATGGCGATGAAGTTGATGGGGATGGACCGGAAGGCGG
TTCAGGAGCTGGGGTCACAGAGGGCGAGCTTGAAGGGGACGGTTCTGGACGAGAACGACGTCGCAGAGGCGGCTA
TGTACCTCGCCGGCGACGAGTCGAAGTTTGTGAGCGGGTTGAACCTCGTGTTGGACGGCGGTTGTAGTTTGAAGA
GTGCTTGA 
 
The gDNA-sequence of SDH-candidate 7665 comprises 1626 bp incuding two introns 
(underlined) and is shown below: 
ATGTCGAAGCTGGTCATGGGTTCTTCCAGGTGATTAACGAGAAAGCTAACGTCTTTTCTTTTTTCTTCTCTCTTT
GCTTCTTCTGCATAGTGGTAGACTCTATTAATTATCATATTCCGATGTGATTATGAACAGAGATCTGGCGTTAAA
AGCCCGGTCACCGGCGGCCAACGTTCTTAGACGCTTATTCTCTACCTTACCCGGAGAAGCTGTTGCAAGTGGCAA
TGAAAGCAGGTAAGTGGCTCTTTCCTCTTGTTCAATTTAATTACGTTAGTAATCACCTCCCACCTTTTTCACTGT
ATTATTTACCCTCTGCTTCGTTCTCTCTGTTTTCCCCTTTTCTTCTAGCTGGTAGTCAATTTTCCAGGAACTGGA
GCGGTTAAATTGATTAGGACTGGAAAACTAATCTCATTAGGCAGTAGGGTAGTTCTGACAATGCATGTGTTTTCT
CTCTGTCTCTGCAACTTGCTCGACTCTAATCTAAATCTAAATCTAATCATTAAACAAAACGAATGAGGCCTGTTT
GTCTTATACTATGGGTCTCATATTTCTTGTAATTTTTTATGGGAACTGATTCCATCTTCACTGACTAGTGGCCCC
TCCCTATTTACGTTTGCATGTCCCTGTCGGCTGCCGTCCATGTTGGCACGGGCCCACATTTTTGGGCCCACTCGT
GTCTTTGTCCAATCAAACATATCCGTACTATTGGGCCTTATTTTTAAGCTACGGCCCAGAGTCACAACAAAGAGA
GTCGACCTCGGCCCGGACTTGTTCATATATGTTTGGGCTTTGTAAATACACTTGGCAACGTGATTAACCAGCAGG
AAGCTAGAGGGGAAAGTAGCGGTGATCACGGGAGGAGCAAATGGGATTGGAAGAGAAACCGCCGTCAAATTCATC
GCCAACGGCGCCAAAGTCATAATAGCCGACATCAACAAGGAACTCGGCCTCCAAACAGCGCGCCAGCTAGGCCCC
AACGCATCGTTCATCCCATGTGACGTGGCCAATGAATCCGACGTGTCGGACGCCGTGGACTTTGCAGTGTCCCAG
CACAGCCGCCTCGACATCATGTACAACAATGCTGGCATCGCCTGCAGAACTCCTCCCAGCGTCGCCGACCTCGAC
CTGGCAGCCTTCGATACGGTGATGGGGATAAACGTGAGGGGAGCGCTGGCGGGAGTGAAGCACGCGGCGCGGGTG
ATGATCCCGAGGCAGAGCGGGGCCATCTTGTGCACGGCGAGCGTGACGGGGATCATGGCAGGGATGGCTCAGCTG
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ACGTATTCGGTGTCGAAGGCGGGGGTGGTGGCCATCGTGAAATCGGCGGCGGCGGAGCTGTGCCAGCACGGGGTG
AGGGTGAACTGCATCTCCCCGTTCGCCATCCCGACGGCATTCGTGATGGAGGAGCTGCAGCATTACTACGCCGGG
GAGAGGCCGGAGCGGATCATGGAGAACGTGTACGCCATGGGGTCGCTGAAGGGAGGGAGGTGCGAGCCGGGTGAC
GTGGCGAACGCGGCGGTTTATCTGGCGTCGGAGGATGCAAAGTACGTTACGGGGCATAACTTGGTGGTGGATGGT
GGGTTTACGTCGTTCAAGACTCTTGGGTTGCCTCCAAGGAATAGCCAGTGA 
The introns (underlined) in the gDNA sequences of SDH candidates were identified by 
comparing the gDNA sequences with the ORF-sequences obtained from the transcriptome 
database.  
The intron phases and lengths of all introns of the five SDH-candidates are listed below: 
 
SDH-
candidate 
Intron start 
position 
Intron 
phase 
Length Dinucleotide sequences at intron 
boundaries (5' - 3') 
28880 38 II 113 GT-AG 
36067 45 0 212 AG-GC 
5591 38 II 83 GT-AG 
420 0 694 GT-AG 
73995 38 II 96 CT-AG 
7665 29 II 106 GT-AG 
122 II 587 AA-TT 
 
All SDH-candidates contain one or two introns that are located close to the 5'-end of the 
sequences. Generally, the most common introns are phase 0 introns, followed by phase I introns 
and the least common are phase II introns (Tomita et al., 1996). In proteins with secretory 
signal peptides, phase I introns are the most common (Vibranovski et al., 2006). However, the 
intron phases in the five SDH-candidates is not consistent and the majority is phase II (71%). 
In addition, four of the seven introns have the consensus sequences GT-AG at the intron 
boundaries. The other four candidates contain non-canonical splice sites. 
 
5.3 Fusion-PCR and verification of full-length SDH-candidate sequences 
Fusion-PCR (see III.2.4.3) was performed for the in-vitro-removal of introns from genomic 
DNA in order to generate a full-length sequence of continuous coding capacity.  
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5.3.1 Exon fragments in the first rounds 
Distinct exon fragments were generated in the first PCR rounds with Phusion® Polymerase to 
avoid replication errors (see III.2.4.3). The first exon fragments of all SDH-candidates are 
shorter than 50 nucleotides and were synthesized directly by Eurofins.  
 
 
 
 
 
 
 
 
 
 
 
 
 
The PCR products of the expected size were cut out, purified via gel extraction. After 
purification and determination of product concentrations, the first-round PCR products were 
diluted to the same concentration and used as template in the next rounds. 
 
5.3.2 Full-length sequences of SDH-candidates in the second and third rounds 
Candidates 28880, 36067 and 73995 each contain one intron. Hence, only two rounds of PCR 
were required to finish the generation of full-length sequences. Candidates 5591 and 7665 
contain two introns each and three rounds of fusion-PCR were performed to excise all introns 
Sample Annealing temperature (°C) 
28880-2-1 61.3 
28880-2-2 63.4 
36067-2-1 65.2 
36067-2-2 67.5 
Sample Annealing temperature (°C) 
5591-2 55.5 
5591-3 55.5 
7665-2 56.7 
7665-3 56.7 
73995-2 62.4 
Figure 71: PCR amplification of the second exon 
fragments of SDH-candidates 28880 and 36067  
PCR-products are marked with a box. 
 
 
Figure 72: PCR amplification of the second and third 
exon fragments of SDH-candidates 5591, 7665 and 73995  
PCR-products are marked with boxes. 
PCR-products were marked with box. 
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from the sequences. Two outermost primers including specific sequences for restriction 
enzymes were used in the last rounds of fusion-PCR. 
 
 
 
 
 
 
 
 
 
 
 
The full-length PCR products of the SDH-candidates with the appropriate lengths were excised 
and isolated from the agarose gel. The amplicons were then ligated into the pDrive vector in 
order to multiply and verify the sequences.  
 
 
 
 
Sample Annealing temperature 
(°C) 
F28880-1 61.3 
F28880-2 63.4 
F36067-1 65.2 
F36067-2 67.5 
F73995-1 61.3 
F73995-2 63.4 
Sample Annealing 
temperature 
(°C) 
7665-2+3-1 56.7 
7665-2+3-2 56.7 
5591-2+3-1 55.5 
5591-2+3-2 55.5 
Sample Annealing 
temperature 
(°C) 
F5591-1 55.5 
F5591-2 55.5 
F7665-1 56.7 
F7665-2 56.7 
Figure 74: The second-round 
fusion-PCR of SDH-candidates 
7665 and 5591 
The second and the third exon- 
fragments of candidates were 
amplified together. PCR-products 
are marked with boxes. 
 
 
Figure 75: The third-round 
fusion-PCR of SDH-candidates 
7665 and 5591 
 Full-length sequences are 
marked with boxes. 
 
 
Figure 73: The second-round 
fusion-PCR of SDH-candidates 
28880, 36067 and 73995 
Full-length sequences are 
marked with boxes. 
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5.3.3 Verification of full-length sequences 
 
 
The ORF of SDH-candidate 28880 comprises 825 bp and shows 99.6% identity to the sequence 
of contig 28880 in transcriptome of L. flavum. The ORF of CYP-candidate 28880 is as below: 
ATGGGCTCTGATATCTGTGCACCCTCTGTCACCAAGACGCTAGAAGGCAAAGTGGCGCTCATAACTGGAGGAGCA
AGCGGCATAGGCGAGAGCGCTGTCAGGCTGTTCATGCAACACGGAGCCAAGGTTCTCATCGCCGACCTTCAAGAT
AAACTCGGCGAATCCCTCGCCACGGAACTCGGTCCACCGGAGATTGTCTCCTTCGTCCACTGCAATGTCACTGTA
GACTCCGATGTGGGAAACGCTGTGGATACTGCGGTTTTGAGGTACGGACAGTTGGACATCATGTACAACAACGCT
GGAATCGGAGGCAACCTCGACACCACGATTTTAAACTCCGACAATGACGATTTCAAAAGGGTATTGGAAATAAAC
CTGTTCGGATCGTTCCTCGGAGCCAAACACGCTGCTAGAGTGATGATTCCGGCGAGGAAAGGTTGCATACTATTT
ACGGGAAGCGTGGCGTCGTCAATAAGCGGGGATTTATCATACGCTTACAAGGCTTCGAAGCACGCGTTGTTGGGG
CTAGCCAATAATTTGACTGTGGAGATGGGGAAGTACGGGATTAGGGTCAACACTATATCCCCGTATGGAGTGGCC
ACTCCTATGGTGACACGTGGCCTGCAAATGGATAAGAAGGCTGTCGAGCAGTTCATGTCGGCAGCGGGGAACCTA
AGAGGGGCGATTTTGGAGCCAGAGGATGTTGCCAAGGCGGCGCTGTACTTGGCTAGCGATGATGCGAAATATGTG
AGTGGGCTGAACTTGATTGTTGACGGTGGCCACAATCACAACCATCCTCTCTTTGGCGCTTCCGNTGAAGCATGA 
 
The ORF of SDH-candidate 36067 comprises 849 bp and shows 96.5% identity to the sequence 
of contig 36067 in transcriptome of L. flavum. The ORF of CYP-candidate 36067 is as below: 
ATGGCGGCAGCAGCACCAGCTTCCTTTATCTCCTCCGTCGCCAGAAGGCTGGAAGGCAAAGTAGCGCTAATCACC
GGAGGAGCAAGCGGGATCGGCGAATTCACCGCCAGAGTGTTCGCCCACCACGGCGCCAAAGTCGTGATCGCCGAC
GTCCAAGACGACCTCGGCCAATCCGTCGTGGCCGACACCCTGGGCCGCGCCAACTCCACCTACGTCCGCTGCGAC
GTCACCGAGGAGTCCCAAATCAAAGACGCCGTCGACAAGGCCGTCTCCACCTACGGCAAGCTGGACATCATGTTC
AACAACGCCGGCATCGCCGACCCCAACAAGCCCCGCATAGTCGACAACGAGAAGTCCGACTTCGAGCGCGTCCTC
AGCGTCAACGTCACCGGTGTCTTCCTCGGGATGAAGCACGCGGCGCGGGTGATGATCCCGCGCCGCACGGGGGCC
ATAATCTCGACCGCCAGCATCAGCTGCGCTATGGGCGGCGCAGCCTCGCACGCATACTGTTGCTCGAAGCACGCC
GTGCTGGGGCTGACTCGGAACGCGGCGGTCGAGCTGGGGCAGTTCGGGATCAGGGTGAACTGCCTGGCGCCGTAC
GGAATGGCGACGCCTCTGGCGACGAAGTATGTGGGGCTGCCGGATGAGGAGTTGGAAGGGTCGATGAATGCTCTG
GCGAATTTGAAAGGAGTGACGCTGAAAACAGAGGATGTGGCGAACGCTGCTCTGTTCTTGGCTAGCGATGAAGGT
Figure 76: Agarose gels to verify the full-length sequences of SDH-candidates in the vector pDrive 
(colony 1-3) 
Plasmids were isolated from E. coli EZ and cut with EcoRI. The sequence of candidate 36067 contains a 
restriction site for EcoRI. Hence, two bands for 36067 appeared on the agarose gel. Candidate genes are 
marked with boxes. 
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AGGTATGTTAGTGGGCATAGTTTGGTTGTGGATGGAGGGTTTAGCATTCATAATACTGCGTTTAGGATCTTCAAT
TACCCGGAAGATGGATCTTCATGA 
The specific sequence GAATTC for restriction enzyme EcoRI is underlined. 
The ORF of SDH-candidate 5591 comprises 843 bp and shows 100% identity to the sequence 
of contig 5591 in transcriptome of L. flavum. The ORF of CYP-candidate 5591 is as below: 
ATGGCCGCCACTAACTTCGTTTCTTCCATCATAAAAAGGCTGGAAGGCAAAGTAGCGCTGATCACAGGCGGAGCC
AGCGGAATCGGCGAGGCCACCGCCAGCCTTTTCGTCCAACACGGCGCCAAAGTCCTAATCGCCGACGTCCAAGAC
CAACTCGGCGAATCCTTAGCCCGAAACCTAGGCCCGCCGGACACGGTCTCCTACGTCCGCTGCGATGTTACCAGT
CCTCCCGAAGTCGGGGCCGCCGTGGACGAGGCGGTGTCGAGGTACGGCCAGCTGGACATCATGCACAACAACGCC
GGCATCGCCGGGGGCGTAGACCAGCGTATCGTTCACTCCGACGACGATAACTTCCGGCGGGTCCTGGACGTCAAC
CTCTTCGGATCCTACCTTGGGGCTAAGCACGCCGCCAGGGTGATGGTACCGGCGGGGAGAGGCGGGTGCATTCTG
TTCACGGCGAGCAGCGCGGCGGTGACGAGCGGGAACATTACGTACGCGTACAAGGCGTCGAAGAACGGGGTGTTG
GGGCTGGCGAACAACCTGTGCGTGGAGCTGGGTCAGTACGGGATCCGGGTAAACGCGATCTCGCCGTTCACGGTG
GTGACTCCGCTGTTGGTGAGTGTGCTGGGAGGCGGCGGGCTGGGGAAGGAGGAGGTGGAGAGGCTGGTGGCGGCG
GCGACGAAGCCGAACTTGAAAGGAGCGGTGTTGGAAGCGGCGGATATTGCCAAGGCGGCGCTGTTTTTGGCGAGC
GATGATGCCAAGTACGTGAGTGGGTTGAATTTGGTCGTCGATGGTGGGCATAATCACAACCGTCCGATCTTTGAT
GATTTGAGGTTCGCTTGA 
 
The ORF of SDH-candidate 73995 comprises 813 bp and shows 96.7% identity to the sequence 
of contig 73995 in transcriptome of L. flavum. The ORF of CYP-candidate 73995 is as below: 
ATGTCTTCTTCCTACCAGCCGGCGGCGGCGAGTTCTCACAGACTAGAAGGCAAGGTGGCAATGATCACCGGCGGC
GCGAGCGGGATCGGCGCAGCGACGGCCAAGCTCTTCGCCCTCAACGGCGCCAGAGTCATAATCGCCGACGTCCAA
TCCGAACTGGGCCGCTCCGTCGCCCAACAGATCAGCTCCGTCGCACCCCACCCGGTCACCTACGTCCACTGCGAC
GTCAGCAACGAGTCCGACGTGGCGAGCGCGGTGGACGGCGCCGTTTCGGCCTACGGCAAGCTGGACATCATGTAC
AGCAACGCCGGGATCATGGGGGAGCTGACGGGGATGGGGATCACCACGGTGGACAGTGGCGATCTCGCCAGAGTG
TTTGAAGTCAACGTCAAGGGAGCTTTCCACTGCGCCAAGCAGGCGGCGAGGGTGATGATACCGGAGAAGAAGGGG
ACGATTTTGTTCACGGCGAGTAGCATAACGGCGACGTATGGGAACGCGCCGCATCCTTATACGGCGTCGAAGCAC
GCGGTGGTCGGGCTGATGAAGAATTTGACGGTGGAGTTGGGAGGGTATGGGATTCGGGTCAACGCGATTTCGCCG
GACACGGTGCCGACGCCGATGGCGATGAACTTGTTGGGGATGGACCGGAAGGCGGTTCAGGAGTTTGGGTCGCAG
AGGGCGAGCTTGAAAGGGACGGTTCTGGACGAGAACGACGTCGCACAGGCGGCTATGTACCTCGCCGGCGACGAG
TCGAAGTTTGTGAGCGGGTTGAACCTCGTGTTGGACGGCGGTTGTAGTTTGAAGAGTGCTTGA 
 
The ORF of SDH-candidate 7665 comprises 933 bp and shows 98.1% identity to the sequence 
of contig 7665 in transcriptome of L. flavum. The ORF of CYP-candidate 7665 is as below: 
ATGTCGAAGCTGGTCATGGGTTCTTCCAGAGATCTGGCGTTAAAAGCCCGGTCACCGGCGGCCAACGTTCTTAGA
CGCTTATTCTCTACCTTACCCGGAGAAGCTGTTGCAAGTGGCAATGAAACCAGCAGGAAGCTAGAGGGGAAAGTA
GCGGTGATCACGGGAGGAGCAAATGGGATTGGAAGAGAAACCGCCGTCAAATTCATCGCCAACGGCGCCAAAGTC
ATAATAGCCGACATCAACAAGGAACTCGGCCTCCAAACAGCGCGCCAGCTAGGCCCCAACGCATCGTTCATCCCA
TGTGACGTGGCCAATGAATCCGACGTGTCGGACGCCGTGGACTTTGCAGTGTCCCAGCACAGCCGCCTCGACATC
ATGTACAACAATGCTGGCATCGCCTGCAGAACTCCTCCCAGCGTCGCCGACCTCGACCTGGCAGCCTTCGATACG
GTGATGGGGATAAACGTGAGGGGAGCGCTGGCGGGAGTGAAGCACGCGGCGCGGGTGATGATCCCGAGGCAGAGC
GGGGCCATCTTGTGCACGGCGAGCGTGACGGGGATCATGGCAGGGATGGCTCAGCTGACGTATTCGGTGTCGAAG
GCGGGGGTGGTGGCCATCGTGAAATCGGCGGCGGCGGAGCTGTGCCAGCACGGGGTGAGGGTGAACTGCATCTCC
CCGTTCGCCATCCCGACGGCATTCGTGATGGAGGAGCTGCAGCATTACTACGCCGGGGAGAGGCCGGAGCGGATC
ATGGAGAACGTGTACGCCATGGGGTCGCTGAAGGGAGGGAGGTGCGAGCCGGGTGACGTGGCGAACGCGACGGTT
TATCTGGCGTCGGAGGATGCAAAGTACGTTACGGGGCATAACTTGGTGGTGGATGGTGGGTTTACGTCGTTCAAG
ACTCTTGGGTTGCCTCCAAGGAATAGCCAGTGA 
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The start codon and the stop codon are written in bold. The amino acid sequences of the SDH-
candidates were translated from ORFs with the help of ExPASy-translate and the molecular 
weights of the proteins were calculated by the ExPASy-Compute pI/Mw tool. 
The amino acid sequence of candidate 28880 with a molecular weight of appr. 28.7 kDa is 
shown below: 
MGSDICAPSVTKTLEGKVALITGGASGIGESAVRLFMQHGAKVLIADLQDKLGESLATELGPPEIVSF
VHCNVTVDSDVGNAVDTAVLRYGQLDIMYNNAGIGGNLDTTILNSDNDDFKRVLEINLFGSFLGAKHA
ARVMIPARKGCILFTGSVASSISGDLSYAYKASKHALLGLANNLTVEMGKYGIRVNTISPYGVATPMV
TRGLQMDKKAVEQFMSAAGNLRGAILEPEDVAKAALYLASDDAKYVSGLNLIVDGGHNHNHPLFGASX
EA 
 
The amino acid sequence of candidate 36067 with a molecular weight of appr. 29.6 kDa is 
shown below: 
MAAAAPASFISSVARRLEGKVALITGGASGIGEFTARVFAHHGAKVVIADVQDDLGQSVVADTLGRAN
STYVRCDVTEESQIKDAVDKAVSTYGKLDIMFNNAGIADPNKPRIVDNEKSDFERVLSVNVTGVFLGM
KHAARVMIPRRTGAIISTASISCAMGGAASHAYCCSKHAVLGLTRNAAVELGQFGIRVNCLAPYGMAT
PLATKYVGLPDEELEGSMNALANLKGVTLKTEDVANAALFLASDEGRYVSGHSLVVDGGFSIHNTAFR
IFNYPEDGSS 
 
The amino acid sequence of candidate 5591 with a molecular weight of appr. 29 kDa is shown 
below: 
MAATNFVSSIIKRLEGKVALITGGASGIGEATASLFVQHGAKVLIADVQDQLGESLARNLGPPDTVSY
VRCDVTSPPEVGAAVDEAVSRYGQLDIMHNNAGIAGGVDQRIVHSDDDNFRRVLDVNLFGSYLGAKHA
ARVMVPAGRGGCILFTASSAAVTSGNITYAYKASKNGVLGLANNLCVELGQYGIRVNAISPFTVVTPL
LVSVLGGGGLGKEEVERLVAAATKPNLKGAVLEAADIAKAALFLASDDAKYVSGLNLVVDGGHNHNRP
IFDDLRFA 
 
The amino acid sequence of candidate 73995 with a molecular weight of appr. 27.9 kDa is 
shown below: 
MSSSYQPAAASSHRLEGKVAMITGGASGIGAATAKLFALNGARVIIADVQSELGRSVAQQISSVAPHP
VTYVHCDVSNESDVASAVDGAVSAYGKLDIMYSNAGIMGELTGMGITTVDSGDLARVFEVNVKGAFHC
AKQAARVMIPEKKGTILFTASSITATYGNAPHPYTASKHAVVGLMKNLTVELGGYGIRVNAISPDTVP
TPMAMNLLGMDRKAVQEFGSQRASLKGTVLDENDVAQAAMYLAGDESKFVSGLNLVLDGGCSLKSA 
 
The amino acid sequence of candidate 7665 with a molecular weight of appr. 32.5 kDa is shown 
below: 
MSKLVMGSSRDLALKARSPAANVLRRLFSTLPGEAVASGNETSRKLEGKVAVITGGANGIGRETAVKF
IANGAKVIIADINKELGLQTARQLGPNASFIPCDVANESDVSDAVDFAVSQHSRLDIMYNNAGIACRT
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PPSVADLDLAAFDTVMGINVRGALAGVKHAARVMIPRQSGAILCTASVTGIMAGMAQLTYSVSKAGVV
AIVKSAAAELCQHGVRVNCISPFAIPTAFVMEELQHYYAGERPERIMENVYAMGSLKGGRCEPGDVAN
ATVYLASEDAKYVTGHNLVVDGGFTSFKTLGLPPRNSQ 
 
All five SDH-candidates were confirmed to belong to the short-chain 
dehydrogenases/reductase family (SDR) based on the PSI- and PHI-BLAST searches against 
the conserved domain database (CDD) of the National Center for Biotechnology Information. 
The obtained amino acid sequenses of the SDH-candidates were compared to already known 
SDH sequences from Forsythia x intermedia (accession No. AAK38665.1) and Podophyllum 
peltatum (accession No. AAK38664.1) by Blastp. All five SDH-candidates of L. flavum have 
appr. 50% identity with SDH from Forsythia x intermedia and Podophyllum peltatum. 
Especially, candidate 36067 showed high homology to SDH from Forsythia x intermedia 
(68%). Furthermore, the alignment of the amino acid sequences of these SDH-candidates from 
Linum flavum and SDH from Forsythia x intermedia and Podophyllum peltatum was performed 
using Clustal Omega and the result is shown below:  
 
SDH-Pp      -------------------------------MGS-TSTPDSSTNRLQDKVAIITGGAGGI 28 
SDH-Fi      -------------------------------MAATSQVLTAIARRLEGKVALITGGASGI 29 
28880       -------------------------------MGS-DICAPSVTKTLEGKVALITGGASGI 28 
36067       -----------------------------MAAAAPASFISSVARRLEGKVALITGGASGI 31 
5591        -------------------------------MAA-TNFVSSIIKRLEGKVALITGGASGI 28 
73995       -------------------------------MSSSYQPAAASSHRLEGKVAMITGGASGI 29 
7665        MSKLVMGSSRDLALKARSPAANVLRRLFSTLPGEAVASGNETSRKLEGKVAVITGGANGI 60 
                                            .          . *:.***:*****.** 
 
SDH-Pp      GETTAKLFVRYGAKVVIADIADDHGQKVCNNIG--SPDVISFVHCDVTKDEDVRNLVDTT 86 
SDH-Fi      GETTAKLFSQHGAKVAIADVQDELGHSVV-EAI--GTSNSTYIHCDVTNEDGVKNAVDNT 86 
28880       GESAVRLFMQHGAKVLIADLQDKLGESLATELG--PPEIVSFVHCNVTVDSDVGNAVDTA 86 
36067       GEFTARVFAHHGAKVVIADVQDDLGQSVVADTL--GRANSTYVRCDVTEESQIKDAVDKA 89 
5591        GEATASLFVQHGAKVLIADVQDQLGESLARNLG--PPDTVSYVRCDVTSPPEVGAAVDEA 86 
73995       GAATAKLFALNGARVIIADVQSELGRSVAQQISSVAPHPVTYVHCDVSNESDVASAVDGA 89 
7665        GRETAVKFIANGAKVIIADINKELGLQTARQLG----PNASFIPCDVANESDVSDAVDFA 116 
            *  :.  *   **:* ***: .. * .   :         ::: *:*:    :   ** : 
 
SDH-Pp      IAKHGKLDIMFGNVGVLSTTP-YSILEAGNEDFKRVMDINVYGAFLVAKHAARVMIPA-K 144 
SDH-Fi      VSTYGKLDIMFSNAGISDPNR-PRIIDNEKADFERVFSVNVTGVFLCMKHAARVMIPA-R 144 
28880       VLRYGQLDIMYNNAGIGGNLD-TTILNSDNDDFKRVLEINLFGSFLGAKHAARVMIPA-R 144 
36067       VSTYGKLDIMFNNAGIADPNK-PRIVDNEKSDFERVLSVNVTGVFLGMKHAARVMIPR-R 147 
5591        VSRYGQLDIMHNNAGIAGGVD-QRIVHSDDDNFRRVLDVNLFGSYLGAKHAARVMVPAGR 145 
73995       VSAYGKLDIMYSNAGIMGELTGMGITTVDSGDLARVFEVNVKGAFHCAKQAARVMIPE-K 148 
7665        VSQHSRLDIMYNNAGIACRTP-PSVADLDLAAFDTVMGINVRGALAGVKHAARVMIPR-Q 174 
            :  :.:****..*.*:        :       :  *: :*: *     *:*****:*  : 
 
SDH-Pp      KGSIVFTASISSFTAGEGVSHVYTATKHAVLGLTTSLCTELGEYGIRVNCVSPYIVASPL 204 
SDH-Fi      SGNIISTASLSSTMGG-GSSHAYCGSKHAVLGLTRNLAVELGQFGIRVNCLSPFGLPTAL 203 
28880       KGCILFTGSVASSISG-DLSYAYKASKHALLGLANNLTVEMGKYGIRVNTISPYGVATPM 203 
36067       TGAIISTASISCAMGG-AASHAYCCSKHAVLGLTRNAAVELGQFGIRVNCLAPYGMATPL 206 
5591        GGCILFTASSAAVTSG-NITYAYKASKNGVLGLANNLCVELGQYGIRVNAISPFTVVTPL 204 
73995       KGTILFTASSITATYG-NAPHPYTASKHAVVGLMKNLTVELGGYGIRVNAISPDTVPTPM 207 
7665        SGAILCTASVTGIMAG-MAQLTYSVSKAGVVAIVKSAAAELCQHGVRVNCISPFAIPTAF 233 
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             * *: *.*      *      *  :* .::.:  .  .*:  .*:*** ::*  : : : 
 
 
SDH-Pp      LTDVFGVD---SSRVEELA--HQAANLKGTLLRAEDVADAVAYLAGDESKYVSGLNLVID 259 
SDH-Fi      GKKFSGIK--NEEEFENV--INFAGNLKGPKFNVEDVANAALYLASDEAKYVSGHNLFID 259 
28880       VTRGL---QMDKKAVEQFMS--AAGNLRGAILEPEDVAKAALYLASDDAKYVSGLNLIVD 258 
36067       ATKYVGLP--DE-ELEGS--MNALANLKGVTLKTEDVANAALFLASDEGRYVSGHSLVVD 261 
5591        LVSVLGGGGLGKEEVERLVAAATKPNLKGAVLEAADIAKAALFLASDDAKYVSGLNLVVD 264 
73995       AMNLLGM---DRKAVQEFGS--QRASLKGTVLDENDVAQAAMYLAGDESKFVSGLNLVLD 262 
7665        VMEELQHYYAGERPERIMENVYAMGSLKGGRCEPGDVANATVYLASEDAKYVTGHNLVVD 293 
                           .         .*:*      *:*.*. :**.::.::*:* .*.:* 
 
SDH-Pp      GGYTRTNPAFPTALKHGLA-- 278 
SDH-Fi      GGFSVCNSVIKVFQYPDS--- 277 
28880       GGHNHNHPLFGASXEA----- 274 
36067       GGFSIHNTAFRIFNYPEDGSS 282 
5591        GGHNHNRPIFDDLRFA----- 280 
73995       GGCSLKSA------------- 270 
7665        GGFTSFKTLG----LPPRNSQ 310 
            ** .                  
 
Conserved amino acids associated with the NAD-binding motif are shown in boldface type 
(Xia et al., 2001). All five SDH-candidates contain the catalytic triad Serine - Tyrosine - Lysine 
of SDH (Moinuddin et al., 2006). The catalytic triad residues are shaded in grey. 
 
5.4 Heterologous expression of SDH-candidate proteins  
5.4.1 Expression in E. coli as prokaryotic cell line   
Initially, in order to express large protein quantities in a short time, the discovered sequences 
were expressed in E. coli SoluBL21 cell lines. The full-length sequences of all SDH-candidates 
were ligated into the NdeI and XhoI restriction sites of the pET15b vector (see V.2.7.2) and 
then transferred into E. coli SoluBL21 cells by heat shock (see III.3.2). Heterologous 
expression of SDH-candidate proteins in E. coli SoluBL21 was performed as described in 
III.3.7.1. Subsequently, the recombinant proteins were purified by metal-chelate 
chromatography (see III.4.3). All fractions from the purification of the recombinant proteins 
were analysed on SDS-PAGE gels (see III.4.6). 
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The molecular weight including His-Tag of SDH-candidate 28880, 36067, 5591, 73995 and 
7665 is appr. 30.8 kDa, 31.7 kDa, 31.1 kDa, 30 kDa and 34.6 kDa, respectively. As can be seen 
in Fig. 77, gene-specific bands in the expected size ranges appeared in elution fractions on all 
SDS-PAGE gels. The result of SDS-PAGE showed that the transformed E. coli SoluBL21 cells 
carrying all SDH-candidates produced significant amounts of proteins after induction with 
IPTG and the purifications of heterologous proteins were successful.  
The activities of the heterologous putative SDH-proteins were tested in enzyme assays 
modified according to Xia et al. (2000) (see V.4.8.4). However, no product formation 
(matairesinol) could be detected using SECO and NAD+ as substrate in the HPLC 
chromatograms and enzyme activity tests with heterologously expressed proteins were 
negative.  
Figure 77: SDS-PAGE of the expression and 
purification of five SDH-candidates  
A: Candidate 28880, B: Candidate 36067; C: 
Candidate 5591; D: Candidate 73995; E: Candidate 
7665. 
M: marker; D: flow through fraction; W1: wash 
fraction 1; W2/5/6: wash fraction 2/5/6; E: elution 
fraction. His-tagged protein bands of SDH-
candidates with the appropriate molecular weight 
in the elution fractions are marked with boxes.    
 
 
E 
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5.4.2 Expression in Saccharomyces cerevisiae INVScI 
5.4.2.1 Heterologous expression of candidate proteins with His-tag 
Post-translational modifications could probably be responsible for the correct structure of 
SDH-proteins and are major problems for E. coli-based expression systems because of its 
limited ability for post-translational processing of proteins. Hence, the heterologous expression 
was performed in the eukaryotic cell line Saccharomyces cerevisiae INVScI to overcome this 
possible issue.  
The full-length sequences of all SDH-candidates were amplified with new full-length primers 
by standard PCR reactions (see III.2.4.1). The full-length sequences were ligated into the 
HindIII and XbaI restriction sites of the pYes2/NTC vector (see V.2.7.2). Saccharomyces 
cerevisiae INVScI was transformed with the respective constructs (see III.3.3). 
 
 
 
Figure 78: Chromatograms of racemic secoisolariciresinol (A), racemic matairesinol (B) and enzyme assays 
with different reaction times (C and D) 
Racemic SECO and NAD+ were incubated with the heterologously expressed protein of SDH-candidate 28880. 
SECO and MATAI showed significant peaks at 6.3 minutes and 14 minutes, respectively. The reaction time is 
C: 0 min; D: 2 hours.  
 
A D C 
SECO 
MATAI 
SECO SECO 
B 
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Heterologous expression of candidate proteins was undertaken as described in III.3.7.2. As a 
negative control, the yeast cells containing the empty vector pYes2/NTC were expressed under 
the same condition. The crude protein from cell pellets of the SDH-candidates, negative 
controls and marker were separated by SDS-PAGE and then transferred to PVDF-membranes 
by Western blotting (see III.4.7). The His-Tag present on the vector was attached to the C-
terminal end of the sequences facilitating the immunodetection of the expressed proteins with 
the anti-His-Tag antibody. 
 
 
 
 
 
 
 
 
Figure 79: Agarose gels of colony PCR to verify the transformation of Saccharomyces cerevisiae INVScI 
with the plasmids pYES2/NTC carrying SDH candidate sequences (colony 1-3) 
Bands of the candidate genes are marked with boxes. 
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In Fig. 80, significant specific bands of all candidate-proteins in the expected size range 
between 32 and 36 kDa appeared on the membrane. There were no bands in the same size in 
the lane of the negative control. The result of the Western blot showed that the transformed 
yeast cells of all five SDH-candidates produced the respective heterologous proteins. 
The activity of heterologously expressed proteins was tested in enzyme assays as described in 
III.4.8.4. Furthermore, 20 mM TRIS/HCl buffer with different pH-values from 6 to 10 as well 
as 7-hydroxysecoisolariciresinol as alternative substrate were used in enzyme assays to test the 
enzymatic activity of the expressed proteins. However, no product formation could be detected 
in the HPLC chromatograms.  
 
5.4.2.2 Heterologous expression of candidate proteins without His-tag 
The N- or C-terminally attached His-tag may influence the structure as well as the function of 
proteins. Hence, the next attempts were conducted to express SDH-candidate proteins without 
His-tag. Full-length primers with a restriction site for XbaI and a stop codon in the reverse 
primers were designed for PCR-amplification (see IV.6.3). The full-length sequences were 
amplified with full-length forward primers and new full-length reverse primers in standard 
PCR reactions (see III.2.4.1). The successful transformations of the yeast strain INVScI with 
Figure 80: Western blot of SDH-candidates expressed in yeast  
Detection was done with anti-His-Tag antibody and secondary antibodies coupled to alkaline 
phosphatase using the NBT/BCIP color reaction. The molecular weight of the attached His-Tag is appr. 
3 kDa. His-tagged protein bands of SDH-candidates with appropriate molecular weights are marked 
with boxes. 
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the constructs of the candidate genes in pYes2/NTC were confirmed by colony-PCR (as shown 
in Fig. 81). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At this stage, the detection of expressed SDH-candidate proteins without His-tag via anti-His-
tag antibodies was not possible. The activity of potentially heterologously expressed proteins 
was still tested in enzyme assays with SECO as well as 7-hydroxysecoisolariciresinol as 
described in III.4.8.4. Additionally, 20 mM TRIS/HCl buffer with different pH-values from 6-
10 were used to test the enzymatic activity of the expressed proteins. Unfortunately, no 
additional peak of the formed product was detected in the HPLC-chromatograms.  
 
5.5 Concluding remarks and outlooks 
SDH was firstly identified in Forsythia intermedia and Podophyllum peltatum by Xia et al. 
(2001). Since then, only a few researchers published information about the enzymatic activity 
of SDH. In 2006, the crystal structure of SDH of Podophyllum peltatum was reported by 
Moinuddin et al. (2006). The enzyme SDH is a homotetramer and consists of an α/β single 
domain monomer that contains seven parallel β-strands flanked by eight α-helices on both 
sides. The catalytic triad Ser153, Tyr167 and Lys171 of SDH of Podophyllum peltatum was 
determined. The order of binding, and a catalytic mechanism for the enantiospecific conversion 
Figure 81: Agarose gels of colony PCR to verify the transformation of yeast INVScI (colony 1-4) 
Candidate genes are marked with boxes. 
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of SECO into MATAI has also been proposed. Recently, SDH of the endophytic fungus 
Phialocephala podophylla was identified by Arneaud and Porter (2015). Nonetheless, the 
sequence of SDH of Phialocephala podophylla is 99% identical to the sequence of SDH of 
Podophyllum peltatum and differs only in six nucleotides. 
From the transcriptome of L. flavum, five potential candidates of secoisolariciresinol 
dehydrogenase were obtained. All five SDH-candidates were successfully amplified from 
gDNA of L. flavum and the open reading frames were generated by fusion-PCR. Subsequently, 
recombinant SDH-candidate proteins were successfully expressed in E. coli and yeast. 
However, all attempts to test the activity and possible reaction of recombinant proteins with 
and without His-tag failed. The main reason could be the post-translational modification that 
will finish their tertiary and quaternary structures in order to become functional. The post-
translational modification system of E. coli and yeast is possibly not sufficient to finish the 
modifications of SDH-proteins of plant. The expression in insect or in plant cells could be a 
solution for this problem.  
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VII. Summary  
Lignans are phenolic specialized plant metabolites derived from the amino acids phenylalanine 
or tyrosine. Lignans are widely distributed throughout the plant kingdom and have multiple 
biological and pharmacological activities. An example of a medicinally used substance is the 
aryltetralin lignan podophyllotoxin and its derivatives that have cytotoxic activities. 
Podophyllum spec. are currently the major source of podophyllotoxin. However, aryltetralin 
lignans can also be detected in some flax species (Linum spec.). The biosynthesis of aryltetralin 
lignans is divided into the early and late steps. While the early reaction steps have been 
completely identified, most enzymes and reactions as well as their encoding genes are unknown 
regarding the late steps. In the present work, studies on the biosynthesis of lignans such as 
podophyllotoxin or 6-methoxypodophyllotoxin in suspension cultures of L. flavum are 
described. The roles of pinoresinol-lariciresinol reductase, secoisolariciresinol dehydrogenase, 
deoxypodophyllotoxin 6-hydroxylase and deoxypodophyllotoxin 7-hydroxylase are of 
particular interest. Deoxypodophyllotoxin 6-hydroxylase was already characterised in Linum 
flavum and belongs to the cytochrome P450 family. Hence, the identification of 
NADPH:cytochrome P450 reductase, which is essential for cytochrome P450-dependent 
reactions, was also an objective in this work. 
The basis for the search of lignan biosynthetic genes was the transcriptome database of the 1KP 
project (https://onekp.com/). In the beginning, RNA and gDNA were isolated from suspension 
cultures of L. flavum. From cDNA two NADPH:cytochrome P450 reductases (CPR) were 
successfully identified, heterologously expressed and characterised. In order to determine the 
apparent Km-values, enzyme assays were performed with varying concentrations of NADPH 
and cytochrome c. Both CPRs 66401 and 4753 showed high catalytic activity towards 
cytochrome c with Km-values of 8.15 ± 0.3 µM and 15.6 ± 0.35 µM, respectively. Towards 
NADPH as an electron donor, CPR 66401 showed a Km-value of 29.6 ± 0.8 μM and CPR 4753 
had a Km-value of 45.2 ± 0.7 μM. Two binding sites each for FMN, FAD, and NADPH and 
one binding site for cytochrome P450 were identified in the sequences of the two CPRs. Based 
on the membrane anchor regions at the N-terminus the NADPH:cytochrome P450 reductases 
66401 and 4753 are classified into class I and II, respectively, according to Ro et al. (2002). 
Pinoresinol-lariciresinol reductase is a bifunctional enzyme that catalyses the formation of 
secoisolariciresinol from pinoresinol via lariciresinol. From the transcriptome of L. flavum, one 
contig with the highest similarity to pinoresinol-lariciresinol reductase of Forsythia intermedia 
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was found. This contig was successfully amplified from the RNA/cDNA of suspension cultures 
of L. flavum, expressed in E. coli and subsequently characterised as pinoresinol-lariciresinol 
reductase. Pinoresinol-lariciresinol reductase of L. flavum catalyses stereospecifically the 
conversion of (+)-pinoresinol via (+)-lariciresinol to (-)-secoisolariciresinol. Pinoresinol-
lariciresinol reductase of L. flavum displayed a Km-value for NADPH of 22.4 ± 1.2 μM and has 
the highest catalytic activity at pH 7 and at a temperature of 27 °C to 33 °C. In order to 
investigate the role of the varying size of important amino acids in the binding pocket, two 
mutants of pinoresinol-lariciresinol reductase of L. flavum, G280Y and Y284G, were 
constructed. The loss of enzymatic activity of both mutants LfPLR G280Y and Y284G showed 
the crucial role of the two positions G280 and Y284 for the catalytic activity of this enzyme.   
In addition, multiple candidates of cytochrome P450 and secoisolariciresinol dehydrogenase 
were obtained from the transcriptome of L. flavum.  Eleven open reading frames of cytochrome 
P450 and five open reading frames of secoisolariciresinol dehydrogenase (SDH) were 
successfully amplified from RNA/cDNA or gDNA of L. flavum. The cytochrome P450s were 
successfully expressed in Saccharomyces cerevisiae and SDH in E. coli and yeast. The 
conserved domains for cytochrome P450 and secoisolariciresinol dehydrogenase were 
observed in the sequences of each candidate. Nevertheless, the recombinant proteins were not 
catalytically active with the applied putative substrates. Maybe a post-translational 
modification is essential for these enzymes and bacteria and yeast are not sufficient to conduct 
the required modifications. A more suitable expression system, for example in plant or insect 
cultures, could be a solution for this problem. The search for candidates should be refined to 
look for other candidates for cytochrome P450 and secoisolariciresinol dehydrogenase as well. 
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VIII. Zusammenfassung 
Lignane sind phenolische Verbindungen des pflanzenspezifischen Stoffwechsels, die von den 
Aminosäuren Phenylalanin oder Tyrosin abgeleitet sind. Lignane sind im Pflanzenreich weit 
verbreitet und haben zahlreiche biologische und pharmakologische Aktivitäten. Ein Beispiel 
für eine medizinisch verwendete Substanz ist das Aryltetralin-Lignan Podophyllotoxin und 
seine Derivate, die cytotoxische Aktivitäten aufweisen. Podophyllum spec. sind derzeit die 
Hauptquelle für Podophyllotoxin. Aryltetralin-Lignane können jedoch auch in einigen 
Flachsarten nachgewiesen werden (Linum spec.). Die Biosynthese von Aryltetralin-Lignanen 
ist in die frühen und späten Schritte unterteilt. Während die frühen Reaktionsschritte 
vollständig identifiziert wurden, sind die meisten Enzyme und Reaktionen sowie ihre 
kodierenden Gene hinsichtlich der späten Schritte unbekannt. In der vorliegenden Arbeit 
werden Untersuchungen zur Biosynthese von Lignanen wie Podophyllotoxin oder 6-
Methoxypodophyllotoxin in Suspensionskulturen von Linum flavum beschrieben. Die Rollen 
der Pinoresinol-Lariciresinol Reduktase, der Secoisolariciresinol Dehydrogenase, der 
Desoxypodophyllotoxin 6-Hydroxylase und der Desoxypodophyllotoxin 7-Hydroxylase sind 
von besonderem Interesse. Desoxypodophyllotoxin 6-Hydroxylase wurde bereits in Linum 
flavum untersucht und gehört zur Cytochrom P450 Familie. Daher war die Identifizierung der 
NADPH:Cytochrom P450 Reduktase, die für Cytochrom-P450-abhängige Reaktionen 
unerlässlich ist, auch ein Ziel dieser Arbeit. 
Als Basis für die Suche nach Genen der Lignan-Biosythese diente die Transkriptom-Datenbank 
des 1KP Projekts (https://onekp.com/). Zu Beginn wurden RNA und gDNA aus 
Suspensionskulturen von Linum flavum isoliert. Mithilfe der cDNA wurden zwei 
NADPH:Cytochrom P450 Reduktasen erfolgreich identifiziert, heterolog exprimiert und 
charakterisiert. Zur Bestimmung der apparenten Km-Werte wurden Enzymtests mit 
unterschiedlichen Konzentrationen von NADPH und Cytochrom c durchgeführt. Beide 
NADPH:Cytochrom P450 Reduktasen 66401 und 4753 zeigten eine hohe enzymatische 
Aktivität mit Cytochrom c mit Km-Werten von 8,15 ± 0,3 µM bzw. 15,6 ± 0,35 µM. Gegenüber 
NADPH als Elektronendonor zeigte NADPH:Cytochrom P450 Reduktase 66401 einen Km-
Wert von 29,6 ± 0,8 μM und NADPH:Cytochrom P450 Reduktase 4753 einen Km-Wert von 
45,2 ± 0,7 μM. In den Sequenzen der beiden NADPH:Cytochrom P450 Reduktasen wurden 
jeweils zwei Bindungsstellen für FMN, FAD und NADPH und eine Bindungsstelle für 
Cytochrom P450 identifiziert. Basierend auf den Membranankerregionen am N-Terminus 
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werden NADPH:Cytochrom P450 Reduktase 66401 und 4753 gemäß Ro et al. (2002) in Klasse 
I bzw. II klassifiziert. 
Pinoresinol-Lariciresinol Reduktase (PLR) ist ein bifunktionelles Enzym, das die Bildung von 
Secoisolariciresinol aus Pinoresinol über Lariciresinol katalysiert. Aus dem Transkriptom von 
Linum flavum wurde ein Contig mit der höchsten Ähnlichkeit mit Pinoresinol-Lariciresinol 
Reduktase von Forsythia intermedia gefunden. Dieses Contig wurde erfolgreich aus der 
RNA/cDNA von Suspensionskulturen von Linum flavum isoliert, in E. coli exprimiert und 
anschließend als Pinoresinol-Lariciresinol Reduktase charakterisiert. Die Pinoresinol-
Lariciresinol Reduktase von Linum flavum katalysiert die stereospezifische Umwandlung von 
(+)-Pinoresinol über (+)-Lariciresinol in (-)-Secoisolariciresinol. PLR zeigte einen Km-Wert 
für NADPH von 22,4 ± 1,2 µM und hatte die höchste katalytische Aktivität bei pH 7 und bei 
einer Temperatur von 27 °C bis 33 °C. Um die Rolle der Größe wichtiger Aminosäuren in der 
Bindungstasche zu untersuchen, wurden zwei Mutanten von PLR, G280Y und Y284G, 
konstruiert. Der Verlust der enzymatischen Aktivitär beider Mutanten der PLR, G280Y und 
Y284G, zeigte die entscheidende Rolle der beiden Positionen G280 und Y284 für die 
katalytische Aktivität dieses Enzyms. 
Darüber hinaus wurden mehrere Kandidaten für Cytochrom P450 (CYP) und 
Secoisolariciresinol Dehydrogenase (SDH) aus dem Transkriptom von Linum flavum erhalten. 
Elf offene Leserahmen von CYP und fünf offene Leserahmen von SDH wurden erfolgreich 
aus RNA/cDNA oder gDNA von Linum flavum amplifiziert. CYP wurde erfolgreich in 
Saccharomyces cerevisiae und SDH in E. coli und Hefe exprimiert. Die konservierten 
Domänen für Cytochrom P450 und Secoisolariciresinol Dehydrogenase wurden in den 
Sequenzen jedes Kandidaten beobachtet. Trotzdem waren die rekombinanten Proteine mit den 
getesteten mutmaßlichen Substraten nicht katalytisch aktiv. Möglicherweise ist eine 
posttranslationale Modifikation für diese Enzyme unerlässlich und die verwendeten Bakterien 
und Hefen reichen nicht aus, um die erforderlichen Modifikationen durchzuführen. Ein besser 
geeignetes Expressionssystem, zum Beispiel in Pflanzen- oder Insektenkulturen, könnte eine 
Lösung für dieses Problem sein. Die Suche nach Kandidaten sollte verfeinert werden, um auch 
nach anderen Kandidaten für Cytochrom P450 und Secoisolariciresinol Dehydrogenase zu 
suchen. 
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